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The scientists of today think deeply instead of clearly.  
One must be sane to think clearly, but one can think deeply and be quite insane. 
Nikola Tesla 
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1. INTRODUCTION 
1.1. Host recognition of pathogen 
For a long time, mechanisms of action that are used by organisms causing infectious 
diseases, collectively called pathogens, have been a target of investigation. However, 
mechanisms that evolved to protect host from the pathogen infection, called immune 
responses, are also extensively researched. 
In order to successfully invade the host, pathogens need to overcome host’s 
mechanisms of protection. The first lines of defense that pathogens need to face during 
infection are the surface barriers of the host. These barriers can be: mechanical, like skin or 
cuticle; chemical, like gastric acid or defensins; and biological, like commensal flora. The 
second line of immunity represents non-specific, but relatively immediate defense, named 
the innate immune system. The third layer of defense comprises the more sophisticated 
adaptive immune system that is specific for the particular pathogen and provides long lasting 
protection once activated (Reviewed in (Murphy et al., 2012)). 
Vertebrate host defense is often seen as a defense by specialized sets of 
professional immune cells. However, this view greatly underestimates a capacity of most cell 
lineages, the majority of which fall outside of traditional immune system cells, to defend 
themselves against infection. This ancient and ubiquitous form of host protection is called 
cell-autonomous immunity (Howard, 2007) (Randow et al., 2013).  
 
Discrimination between the components of the host and the pathogen is crucial for 
host defense. Charles Janeway and colleagues proposed three strategies that vertebrates 
use to distinguish pathogens: (1) recognition of “microbial non-self”, (2) recognition of 
“induced or altered self” and (3) recognition of “missing self” (Medzhitov and Janeway, 2002).  
Recognition of “microbial non-self” is based on the detection of conserved molecular 
patterns that are essential microbial products, but are not produced by the host, named 
pathogen associated molecular patterns (PAMPs) (reviewed in (Medzhitov and Janeway, 
2002)). Lipopolysaccharides (LPS) or peptidoglycan that are exclusively produced by 
bacteria are prominent examples of PAMPs. The PAMPs are recognized by the receptors of 
the innate immune system called pattern recognition receptors (PRRs), like for example Toll-
like receptors (TLRs) (Trinchieri and Sher, 2007) (Kawai and Akira, 2010). 
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Recognition of “induced self” is based on detection of markers of abnormal self that 
are expressed only upon infection and can tag the affected cells for elimination by the 
immune system. For example, viral infection is followed by cellular transformation and 
expression of particular self-proteins that can be recognized by the immune system as 
altered self (Medzhitov and Janeway, 2002).  
Recognition of “missing self” relies on the detection of markers of normal self, namely 
gene products and products of metabolic pathways that are unique to the host and absent 
from the pathogen. Therefore, host immunity effectors can target non-labeled structures for 
destruction (Medzhitov and Janeway, 2002) (Coers, 2013). The most prominent example of 
the “missing self” recognition are natural killer cells (NK cells). MHC class I protein is 
constitutively expressed on all nucleated cells and often downregulated as a consequence of 
viral infection. Hence, recognition of cells lacking MHC class I proteins on the surface targets 
them for destruction by NK cells (Karre et al., 1986). 
 
IFNγ-inducible Immunity-related GTPases (IRGs), which are further investigated in 
this study, represent one of the weapons of cell-autonomous immunity in vertebrates 
(Reviewed in (Martens and Howard, 2006)). Recently, it has been proposed that IRGs also 
recognize the pathogens by the “missing self” principle (Martens, 2004) (Hunn and Howard, 
2010) (Coers, 2013) (da Fonseca Ferreira-da-Silva et al., 2014). Therefore, further properties 
of these interferon-stimulated genes will be discussed. 
 
1.2. Interferon-stimulated genes in cell-autonomous immunity 
Interferons (IFN) are pro-inflammatory cytokines secreted by immune and non-
immune cells in a brief and self limiting manner. According to their sequence homology and 
receptor specificity, interferons can be classified into three groups: Type I interferons, which 
include IFNα, IFNβ, IFNω, IFNκ, IFNε, IFNδ and IFNτ; Type II interferon, which includes only 
IFNγ; and Type III interferons encompassing IFNλ1, IFNλ2 and IFNλ3. Type I Interferons are 
produced by almost every cell type, while IFNγ, a type II interferon, is mainly produced by 
professional immune cells (Reviewed in (Borden et al., 2007)). 
Interferons are among the most potent vertebrate-derived signals for mobilizing 
antimicrobial effector functions against intracellular pathogens (Nathan et al., 1983) 
(Schroder et al., 2004). Up to now, more than 2000 human and mouse interferon-stimulated 
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genes (ISG) have been identified (Hertzog et al., 2011) (Rusinova et al., 2013), with most of 
them still being uncharacterized.  
Interferons induce cell-autonomous host defense genes through three receptor 
complexes with high affinities for their ligands, which are named Interferon Type I, Type II 
and Type III receptor complexes. Following receptor-ligand engagement, Signal Transducer 
and Activator of Transcription 1 (STAT1) and/or STAT2 form dimers and localize to the 
receptor complexes. STAT molecules at receptor complexes are phosphorylated by receptor-
bound tyrosine kinases: Janus kinases (JAK) and Tyrosine kinase 2 (TYK2). In Type I 
signaling, phosphorylated STAT1-STAT2 heterodimers form a complex with IRF9 to produce 
IFN-stimulated gene factor 3 (ISGF3). ISGF3 translocates to the nucleus and binds to IFN-
stimulated response elements (ISREs) that further induce IFN-stimulated effector genes. In 
Type II signaling, phosphorylated STAT1 homodimers translocate to the nucleus and bind to 
IFNγ-activated site (GAS) promoter elements to stimulate IFN-induced expression of 
antimicrobial effector genes (Reviewed in (MacMicking, 2012)). 
IFN-stimulated genes (ISGs) contribute to cell-autonomous immunity by very different 
mechanisms: 
a) IFN-induced oxidative and nitrosative defense  
Cytotoxic gases, collectively called Reactive Oxygen Species (ROS) and Reactive 
Nitrogen Species (RNS), are one of the most ancient forms of cell-autonomous defense. 
They are generated by oxidoreductases and target bacterial DNA, lipids, and haem-groups 
or iron-sulphur clusters within bacterial enzymes. A large proportion of the redox damage 
caused by these gases can be traced to derivatives of O2
- and NO (Nathan and Shiloh, 2000) 
(Nathan and Ding, 2010). In mammals, three classes of IFN-inducible oxidoreductases 
control ROS and RNS production: (1) NAPDH oxidases (NOXs) that catalyze production of 
O2
-; (2) dual oxidases (DUOXs) that mediate H2O2 production; and (3) nitric oxide synthases 
(NOSs) that are involved in NO production. These enzymes are either directly inducible by 
interferons, like NOS2, NOX1 and DUOX2, or indirectly require IFN-induced components for 
its activity, like NOX2 (Reviewed in (MacMicking, 2012)). 
b) Competing for intracellular cations and nutrients 
Intracellular pathogens often require particular metal cation concentrations for their 
proliferation in the host. IFN-mediated mechanisms have evolved to restrict phagosomal or 
cytosolic availability of Mn2+, Fe2+ and Zn2+. IFNγ inducible Natural Resistance-Associated 
Macrophage Protein-1 (NRAMP-1) is a proton-dependent Mn2+ and Fe2+ efflux pump that 
prevents sequestration of these ions by phagosomal pathogens (Jabado et al., 2000). Fe2+ 
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exporter ferroportin 1 and transferring receptor expression are also both influenced by IFNγ 
(Nairz et al., 2008). IFNγ also stimulates relocation of Cu+ pump ATP7A to the phagosome. 
Cu+ in the phagosome enhances production of hydroxyl radicals and therefore 
intraphagosomal killing of bacteria (White et al., 2009).  
Interferon inducible Indoleamine-2,3-dioxygenases (IDOs) are oxidoreductases 
responsible for the initial rate-limiting step of the kynurenine pathway. In this pathway L-
Tryptophan, which some pathogens cannot produce, and thus have to exploit from the cell, is 
degraded. Therefore growth of a large number of pathogens, including Toxoplasma gondii, is 
inhibited (Pfefferkorn, 1984).  
c) Blocking viral entry, replication, assembly and budding 
IFN-inducible proteins, especially type I IFN inducible proteins, are also involved in 
anti-viral immune responses. IFN-inducible transmembrane (IFITM) proteins and Tripartite-
motif (TRIM) proteins interfere with viral entry (Brass et al., 2009) (Stremlau et al., 2004). 
Moreover, RNA-activated protein kinase (PKR),  2’-5’ oligoadenylate synthases (OAS),  
APOBEC3 (apolipoproten B mRNA-editing enzyme, catalytic polypeptide 3) and ADAR1 
(adenosine deaminase, RN-specific 1) manipulate viral RNA (Sadler and Williams, 2008). In 
addition, tetherin and viperin interfere with viral release (Neil et al., 2008) (Evans et al., 2010) 
(Hinson and Cresswell, 2009) (Wang et al., 2007). 
IFN-inducible GTPases named Myxoma resistance proteins (Mx) (chapter 1.3.) are 
involved in defense against orthomyxoviruses, bunyaviruses, togaviruses and rhabdoviruses 
(Haller and Kochs, 2011). It has been proposed that these proteins, analogously to 
dynamins, form oligomer ring-like structures which trap nucleocapsids and associated 
polymerases (Gao et al., 2010) (Haller and Kochs, 2011). 
d) Targeting parasitophorous vacuole 
Immunity-related GTPases (IRGs), which are further investigated in this study, play a 
crucial role in host response to a heterogeneous subset of intracellular pathogens in a 
heterogeneous subset of vertebrates (chapters 1.4., 1.5. and 1.6.). This interferon-γ (IFNγ) 
inducible resistance system accumulates at the parasitophorous vacuolar membrane (PVM) 
of Toxoplasma gondii, inclusions of Chlamydia trachomatis, vacuolar membranes of 
Encephalitozoon cuniculi  and Neospora Caninum (Boehm et al., 1998) (Bekpen et al., 2005) 
(Martens et al., 2005) (Coers et al., 2008) (Reid et al., 2012) (Spekker et al., 2013) (da 
Fonseca Ferreira-da-Silva et al., 2014). IRG loading to the PVM of T. gondii is shortly 
followed by PVM disruption and necrotic cell death (Zhao et al., 2009b).  
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Guanylate-binding proteins (GBPs) (chapter 1.3.) also accumulate at the membranes 
of Listeria monocytogenes and Toxoplasma gondii and play a role in the resistance to these 
pathogens (Kim et al., 2011) (Degrandi et al., 2007). The mechanism of GBP action in 
pathogen resistance remains to be investigated. 
 
1.3. The Interferon-inducible GTPases 
Guanosine triphosphatases (GTPases) are enzymes that can bind and hydrolyze 
guanosine 5'-triphosphate (GTP). They are involved in diverse cellular functions: signal 
transduction, endocytosis, vesicle trafficking, nuclear transport, cytoskeleton regulation, 
synthesis and translocation of proteins and cell division (Leipe et al., 2002) (Takai et al., 
2001).  
Nearly all GTPases have a more or less modified Ras-like GTPase domain (G-
domain). A classical G-domain, with a molecular mass of roughly 20 kDa, is composed of six 
β-strands which are surrounded by five α-helices. The G-domain harbors five (G1 to G5) 
nucleotide-binding motifs and two flexible regions, switch I and II, which undergo nucleotide-
dependent conformational rearrangements (Leipe et al., 2002). 
 
 
 
Figure 1.  The GTPase cycle. The transition between the GDP- and GTP-bound states of GTPases 
can be regulated by various reactions that are often, but not exclusively, influenced by other proteins. 
GDI activity inhibits dissociation of GDP and keeps the GTPase in the inactive form. GEF activity 
enhances the release of bound GDP from the GTPase. Contrary, GAP activity triggers GTP hydrolysis 
and restores the inactive GDP form (Modified from (Martens and Howard, 2006)). 
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GTPases often work as molecular switches. They cycle between two alternative 
conformations: the guanosine 5'-diphosphate (GDP) bound form, which is considered to be 
inactive; and GTP bound form, which is considered to be active. A conformational 
rearrangement between the GDP- and GTP-bound form, which primarily happens in the 
switch regions, enables GTPases to interact specifically with different downstream factors.  
Other molecules, such as guanine nucleotide exchange factors (GEFs), GTPase activating 
proteins (GAPs) and guanine nucleotide dissociation inhibitors (GDIs) can regulate the 
GTPase cycle at various positions (Figure 1) (Reviewed in (Martens and Howard, 2006)).  
The IFN-inducible GTPases share certain structural and mechanistical features with 
dynamins (Martens and Howard, 2006), which are able to deform and tubulate cellular 
membranes and are involved in vesicular processing (Praefcke and McMahon, 2004). 
Up to this point, four GTPase families were reported to be IFN-inducible: Mx proteins 
(Staeheli et al., 1986), (Haller et al., 2007); Guanylate binding proteins (GBPs) (Cheng et al., 
1983); Immunity-related GTPases (IRGs) (Chapter 1.4.); and Very Large Inducible GTPases 
(VLIG) (Klamp et al., 2003). 
a) Mx proteins 
Mx proteins (Lindenmann et al., 1963) are Type I and Type III Interferon inducible 
dynamin-like GTPases that are present in  nearly all vertebrate genomes, including mouse 
(Mx1 and Mx2) and human (MxA), and play an important role in anti-viral defense (reviewed 
in (Martens and Howard, 2006) (Haller and Kochs, 2011) (Verhelst et al., 2013)). Mx proteins 
are members of the family of large GTPases and their primary aminoacid sequence suggests 
existence of N-terminal GTPase domain, a middle domain (MD) and C-terminal GTPase 
effector domain (GED) (Haller and Kochs, 2002). Unlike dynamins, Mx proteins lack 
pleckstrin-like homologly domain, which is involved in membrane targeting, and proline rich 
domain, which is involved in protein-protein interactions (Praefcke and McMahon, 2004). The 
crystal structure of GTP-free human MxA protein, which was resolved in 2011, shows three-
domain structure that does not coincide with the domains identified in the primary aminoacid 
sequence: the GTP domain is connected to the bundle signaling element (BSE) and then to 
stalk (Gao et al., 2011). 
At low protein concentrations Mx proteins form tetramers in solution and in higher 
protein concentrations, these tetramers form ring-like oligomers with characteristic criss-
cross pattern between stalk domains. The interaction of adjacent rings is GTP-dependent (Di 
Paolo et al., 1999) (Gao et al., 2010).  
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Mx genes play an important role in the immune response to many RNA viruses 
including the ones from Orthomyxoviridae (Mx1 was firstly identified in response to 
Influenza), Rhabdoviridae, Bunyaviridae and Paramyxoviridae families (Reviewed at 
(Verhelst et al., 2013)). Even though the mechanism of their action is not fully understood, in 
general, Mx proteins recognize the capsid proteins of different viruses and interfere with the 
activity of viral polymerases (Reviewed at (Verhelst et al., 2013)), in the case of influenza by 
targeting of the viral ribonucleoprotein (vRNP) (Huang et al., 1992) .  
b) Guanylate binding proteins (GBPs) 
GBPs, with molecular weight of 65-72 kDa, were among first IFN-inducible proteins 
identified (Cheng et al., 1983). These proteins can be directly or indirectly induced with IFNγ, 
IFNα, interleukin-1β (IL-1β), tumor necrosis factor α (TNFα) and Lipopolysaccharide (LPS). 
They are well conserved through most of the vertebrates and a number of GBPs are 
described in mouse and human genome (Cheng et al., 1991) (Luan et al., 2002) (Fellenberg 
et al., 2004) (Olszewski et al., 2006) (Boehm et al., 1998) (Wynn et al., 1991) (Robertsen et 
al., 2006).  
Although the structure and biochemical properties of GBPs are reasonably well 
understood, their role in the pathogen resistance is not fully clarified (Martens and Howard, 
2006). siRNA knock-down of 11 mouse GBPs had revealed that the cells lacking Gbp1, 
Gbp6, Gbp7 or Gbp10 show increased susceptibility to Listeria monocytogenes and 
Mycobacterium bovis. The growth of these pathogens was additionally enhanced in the cells 
which had multiple GBPs silenced and it was reported that different GBPs accumulate at 
Listerial and Mycobacterial phagosomes (Kim et al., 2011). Moreover, it has been shown that 
Gbp1 KO mice (Kim et al., 2011) and Gbp5 KO mice (Shenoy et al., 2012) are susceptible to 
Listeria monocytogenes infection, while Gbp2 KO mice are not (Degrandi et al., 2013). In 
contrast, it has been also shown that GbpChr3-/- (Gbp1/2/3/5/7 KO) mice are not susceptible to 
L. monocytogenes, disputing the importance of these GBPs in Listeria response (Yamamoto 
et al., 2012).  
Recently, it has been proposed that GBP proteins are required for Caspase-11-
dependent pyroptosis upon infection with intracellular pathogens. In these reports, it has 
been suggested that after phagosomal accumulation, GBPs can kill the bacteria and lyse the 
phagosome itself. Exposure of LPS to the cytosol would then trigger Caspase-11-dependent 
pyroptosis of the host cell bacteria (Meunier et al., 2014) (Pilla et al., 2014).  
Together with IRGs, GBPs are also known to accumulate at the parasitophorous 
vacuolar membrane of Toxoplasma gondii (Degrandi et al., 2007). In addition, GbpChr3-/- 
(Gbp1/2/3/5/7 KO) mice are reported to be susceptible to T. gondii infection with over 80 
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percent of GbpChr3-/- mice succumbing to the infection. The reintroduction of Gbp1, Gbp5 or 
Gbp7 into GbpChr3-/- cell had partially restored IFNγ-induced anti-T. gondii response 
(Yamamoto et al., 2012).  
It has been questioned whether human GBP proteins, analogously to IRG proteins in 
mice, are involved in T. gondii resistance (Virreira Winter et al., 2011). However, recent 
CRISPR/Cas9 knock out of hGbp1-7 in human cells had revealed that T. gondii growth in 
these cells is not affected, indicating that these GBPs do not play a role in T. gondii 
resistance in humans (Ohshima et al., 2014). 
c) Very Large Inducible GTPase (VLIG)  
Very Large Inducible GTPases have molecular mass of about 200-280 kDa. In 
C57BL/6 mice, a representative VLIG-1 is a member of a cluster of at least six similar genes 
on chromosome 7 (Klamp et al., 2003). However, gene and copy number in VLIG family 
greatly varies between mouse strains (Lilue, personal communication). In humans, VLIG 
family is represented by a single close VLIG-1 homologue on chromosome 11 (Klamp et al., 
2003). Up to now, it has been shown that VLIG-1 is strongly induced by IFNγ and IFNβ. 
Basally expressed VLIG-1 is predominantly located at the nucleus, while induced one is 
located at the nucleus and the cytoplasm (Klamp et al., 2003). The further biological role of 
VLIG protein family is not understood and remains to be investigated. 
d) Immunity-related GTPases (IRGs) 
IRG proteins are 47kDa GTPases shown to be crucial in resistance to a variety of 
pathogens. These proteins will be further discussed in the rest of the manuscript. 
 
1.4. Immunity-related GTPases (IRGs) 
1.4.1. IRG gene presence in different species 
a) IRG genes in mouse 
The immunity-related GTPases (IRGs) or p47-GTPases are Interferon-inducible 
guanine nucleotide binding proteins (Boehm et al., 1998). Up to date, 23 IRG genes are 
identified in the C57BL/6 laboratory mouse genome and they are localized on chromosomes 
11 (Irgm1-3, Irgb1-10, Irgd), 18 (Irga1-8) and 7 (Irgc) (Bekpen et al., 2005) (Figure 2). 
Striking protein polymorphism, copy number variation and presence/absence polymorphism 
have been reported in different wild mouse strains (Lilue et al., 2013).  
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The open reading frame of Irg genes is typically encoded on a single 3’ exon that 
follows one or more 5’ untranslated exons (Bekpen et al., 2005). Irgm1-3 genes are encoded 
on two alternative 5’ exons and one 3’ exon, which yield two isoforms of both Irgm1 and 
Irgm2 (Bekpen et al., 2005). Irgb2 and Irgb1, as well as Irgb5 and Irgb3; Irgb5 and Irgb4; and 
Irgb9 and Irgb8 are transcribed together leading to expression of so called tandem IRG 
proteins with apparent molecular weight of about 94 kDa (Bekpen et al., 2005), (Lilue et al., 
2013). 
Mouse Irga1-6, Irgb1-10, Irgc and Irgd proteins posses the universally conserved 
sequence (GXXXXGKS) in the G1 motif of the GTP binding site and are informally called 
GKS proteins. However, Irgm1, Irgm2 and Irgm3 proteins contain the non-canonical 
GXXXXGMS sequence in the G1 motif and are therefore named GMS proteins (Boehm et 
al., 1998) (Bekpen et al., 2005). 
In addition to conventional IRG genes, a family unconventionally called quasi-IRG 
genes was identified in mouse (Irgq), in human (IRGQ) and other vertebrates (Bekpen et al., 
2005) (Martens and Howard, 2006) (Hunn, 2008).  Typical for this family is the disruption of 
the universally conserved G1 motif, which leads to a radically modified GTP-binding site. 
Therefore, these proteins are almost certainly not functional as GTPases (Bekpen et al., 
2005) (Martens and Howard, 2006). 
Most of the IRG genes contain GAS and ISRE elements, but no other motifs in their 
promoter region. Thus, they can be induced by Interferon Type I and Type II, with IFNγ being 
their strongest inducer and LPS or TNFα as secondary inducers (Bekpen et al., 2005) 
(Boehm et al., 1998) (Bekpen et al., 2005, Gilly et al., 1996) (Taylor et al., 1996) (Bafica et 
al., 2007). However, the promoter of Irgc does not contain an ISRE or GAS sequences and is 
not inducible by IFNs. Mouse Irgc is expressed exclusively in haploid spermatids in the 
Figure 2. Linear order of IRG gene clusters on Chromosome 11 and Chromosome 18 of mouse 
strain C57BL/6 (Modified from (Lilue et al., 2013)). 
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mature testis, but a genomic disruption of Irgc gene in mice did not lead to any obvious 
abnormality or to male sterility  (Bekpen et al., 2005) (Rhode, 2007).  
In healthy mouse tissues, IRG proteins, with exception of Irgc, are expressed at very 
low levels, with their expression levels drastically increased after induction (Taylor et al., 
1996) (Collazo et al., 2001). However, bone marrow derived hematopoetic stem cells (HSCs) 
show high expression levels of IRG proteins without external induction (Ivanova et al., 2002) 
(Ramalho-Santos et al., 2002). 
b) IRG genes in human 
In humans, only two IRG genes are described: IRGM on chromosome 5 and IRGC on 
chromosome 19 (Bekpen et al., 2005) (Hunn, 2008). In addition, quasi-IRG gene IRGQ is 
also located at chromosome 19. Human IRGC is 90 percent identical to mouse Irgc and 
human IRGQ is over 80 percent identical to mouse Irgq at the amino acid level (Hunn, 2008). 
However, human IRGM encodes only an N- and C-terminally truncated G-domain 
homologous to mouse GMS proteins (Bekpen et al., 2005) (Hunn, 2008). While mouse GMS 
proteins are about 400 amino acids long, human IRGM is truncated to 183 amino acids and 
is only 54 %, 53 % and 51 % identical to Irgm1, Irgm2 and Irgm3 respectively (Bekpen et al., 
2005). Interestingly, none of the human IRGs is interferon inducible (Bekpen et al., 2005) and 
the role of these proteins is not fully understood. 
c) IRG genes in other species 
IRG genes have been identified in many vertebrates (Figure 3), including mammals, 
reptiles, amphibians and fish (Bekpen et al., 2005) (Hunn, 2008) (Li et al., 2009) (Lilue, 2012) 
(Gazzinelli et al., 2014). All rodents analyzed so far, like rat, Guinea pig and squirrel have a 
number of IRG representatives from GKS and GMS subfamiles. Domestic dog, cattle, 
zebrafish and reptiles, like lizard also have representatives of both GKS and GMS IRG 
proteins. However, only IRGC and IRGQ-related sequences could be identified in the 
domestic cat, only IRGC could be identified in pig and no IRGs could be found in chicken 
(Hunn, 2008). 
Not only humans, but also many other higher primates, have lost full length IFN-
inducible IRG genes. For example, chimpanzee, orangutan and rhesus monkey posses only 
IRGM, IRGC and IRGQ sequences, which are similar to human ones. However, lower 
primates like bushbaby (Otolemur garnettii) and grey mouse lemur (Microcebus murinus) 
have IRG genes from IRGA and IRGD subfamilies (Hunn, 2008). 
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As for the presence of other IRGs, presence of IRGM also varies from species to 
species and is, for example, not expressed in the Old and New world monkeys due to the 
open reading frame (ORF) disruption by AluSc sequence insertion. Human and African great 
apes restore an ORF of about 20 kD in length, possibly due to insertion of the retroviral 
promoter element ERV9. Hence, it has been proposed that the IRGM gene became non-
functional about 40 million years ago, but was resurrected about 20 million years ago in the 
common ancestor of humans and apes (Bekpen et al., 2009). Whether the function of IRGM 
remained the same before and after “resurrection” remains to be investigated. 
 
1.4.2. Nucleotide binding and structural properties of IRG proteins 
The first biochemical studies of IRG proteins were performed on Irgm3 and Irgb6 and 
demonstrated their ability to hydrolyse GTP to GDP (Taylor et al., 1996) (Taylor et al., 1997) 
(Carlow et al., 1998). It has been also shown that Irga6 is stable in the absence of 
nucleotides and shows a relatively low affinity for guanine nucleotides in the micromolar 
range (Uthaiah et al., 2003).  Recombinant Irga6 has 10-15 fold higher affinity for GDP-, than 
for GTP. The basal GTP-ase activity of Irga6 is low, but it is elevated at higher 
concentrations of the protein, indicating cooperative behavior of Irga6 molecules. A GMS 
protein Irgm3 can bind to GTP and hydrolyze it to GDP only at minor extent, indicating that 
GXXXXGKS to GXXXXGMS mutation does not fully abolish GTPase activity (Taylor et al., 
Figure 3. Distribution of IRG genes in certain mammalian species (Modified from (Gazzinelli et 
al., 2014)). 
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1996) (Taylor et al., 1997). In solution, in the presence of GDP or in the absence of 
nucleotides, Irga6 is monomeric, whereas in the presence of GTP it forms oligomers. The 
oligomers are largely resolved upon GTP hydrolysis (Uthaiah et al., 2003), with low levels of 
remaining lrga6 oligomers that probably represent denatured Igra6 proteins (Howard, 
personal communication). 
The crystal structure of Irga6 reveals that this protein is built of three domains: a Ras-
like G-domain and N- and C-terminal helical domains (Ghosh et al., 2004) (Figure 4A).  The 
G-domain consists of six stranded β-sheets (S1-S6) and six α-helices (H1-H5 and d). The 
H1-S2 loop corresponds to the switch I region and is extended in Irga6, while the switch II 
region is located between H1 and H2 helix. The helical domain of Irga6 comprises ten 
helices (αA-L). αA, αB and αC form the N-terminal region preceding the G-domain, whereas 
αF-L constitute the C-terminal region following the G-domain and linker helix αE connects the 
G-domain to αF. The first 13 amino acids of Igra6 could not be properly resolved in the 
crystal structure. Thus, little information concerning the structure of Irga6 N-terminus  is 
available (Ghosh et al., 2004). 
 
 
 
 
It has been shown that Irga6 forms GTP-dependent oligomeric complexes in vitro 
(Uthaiah et al., 2003), and that it forms at least dimers in vivo (Papic et al., 2008). The 
interface of Irga6, which is responsible for Irga6 oligomerization and accelerated hydrolysis 
of the GTP is identified on the G-domain and includes the nucleotide-binding site and the 
switch regions the bound GTP substrate (Figure 4B). The engagement of the catalytic 
Figure 4. Crystal structure and catalytic interface of Irga6 protein A) Ribbon presentation of the 
GDP/Mg
2+
-bound Irga6 crystal consisting of  a Ras-like G-domain  (S1-H5 helix) in blue; N-terminal (αA-
C helix) and C-terminal (αF-αL helix) helical regions in cyan and dark blue; and a linker αE helix in grey 
(modified from (Ghosh et al., 2004)). B) The catalytic interface of Irga6 protein which was determined 
by the mutation of the depicted amino acids (modified from (Pawlowski et al., 2011)).  
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interface is also crucial for the activating interaction between Irga6 and Irgb6 and for the 
inhibitory interaction between Irga6 and the GMS protein Irgm3 (Pawlowski et al., 2011).  
 
1.4.3. Intracellular localization of the IRG proteins 
IRG proteins are distributed over different sub-cellular compartments. In non-infected, 
IFNγ-induced cells, GKS proteins Irgb6, Irgb10 and Irgd are predominantly cytosolic and 
Irga6 partitions between endoplasmic reticulum (ER) and the cytosol in a 60:40 ratio 
(Martens et al., 2004) (Coers et al., 2008).  
 
 
 
 
In contrast, GMS proteins are mainly membrane-bound (Martens et al., 2004). In 
IFNγ-induced cells Irgm1 localizes mainly to Golgi (Martens et al., 2004) (Butcher et al., 
2005) (Tiwari et al., 2009) and to lysosomes (Figure 5) (Butcher et al., 2005) (Zhao et al., 
2010), and has also been reported to localize to mitochondria (Tiwari et al., 2009) (Chang et 
al., 2011) (Springer et al., 2013), lipid droplets (Haldar et al., 2013), endosomes and 
Figure 5. Irgm1 co-localizes with lysosomes. Mouse embryonic fibroblasts (MEFs) were treated 
with 200 U/ml IFNγ for 24 hours. Cells were either fixed and stained for Irgm1 and LAMP1 (A, B) or 
incubated with 50 nM LysoTracker Red DND-99 for 30 minutes and stained for Irgm1 (C, D). Irgm1 
was found to co-localize with LAMP1 positive compartments (A, B) and with the LysoTracker 
positive compartments (C, D) (Modified from (Zhao et al., 2010)). 
 14 
 
1. INTRODUCTION 
RODUCTION 
peroxisomes  (Tiwari et al., 2009) (Haldar et al., 2013). Irgm2 was reported to localize to 
Golgi (Hunn et al., 2008) (Martens and Howard, 2006) and Irgm3 localizes to the ER and 
lipid droplets (Taylor et al., 1997) (Martens et al., 2004) (Hunn et al., 2008)  (Bougneres et 
al., 2009). Thus, endogenously expressed GMS proteins probably localize to every 
endocellular membrane.  
Interestingly, in IFNγ-induced wild-type cells, none of the GMS proteins were 
observed to localize to the plasma membrane. Therefore, plasma membrane probably 
represents the only membrane in the cell which is not GMS-coated (further discussed in 
chapter 4.2.). GMS proteins were found to target this membrane only under the following 
conditions: Firstly, upon phagocytosis of latex beads, Irgm1 was found to co-localize with the 
phagocytic cups (Martens et al., 2004); Secondly, truncated Irgm1, that includes only the G-
domain and C-terminus of this protein, was shown to exclusively co-localize with the plasma 
membrane (Martens et al., 2004).  
 Targeting of Golgi and lysosomal membranes by Irgm1 is highly dependent on a 
sequence in the C-terminal domain, which corresponds to the amphipathic αK-helix of Irga6 
(Martens et al., 2004) (Martens and Howard, 2006) (Zhao et al., 2010). It has been also 
shown that a similar sequence is essential for intracellular membrane targeting of the other 
GMS proteins (Zhao et al., 2010). 
The mechanism of association of the GKS proteins with the sub-cellular 
compartments is also not completely understood. It has been reported that a myristoyl group, 
which is attached to the N-terminal Glycine-2 of Irga6 protein, is important for the membrane 
binding of Irga6 (Martens et al., 2004) (Steinfeldt et al., 2010). Mutations of the Glycine-2 
abolished presence of Irga6 in the membrane-bound fraction (Zhao et al., 2010). Non-
myristoylated Irga6 is also described to show defects in conformational transition associated 
with GTP-dependent activation (Papic et al., 2008).  
 
1.4.4. GMS proteins regulate GKS protein interaction 
When Irga6 is expressed in the IFNγ-induced cell, immunofluorescence staining of 
these cells reveals a smooth pattern of non-aggregated Irga6 (Martens et al., 2004). 
However, when Irga6 is transfected in unstimulated mouse cells, it accumulates in 
aggregate-like structures. In T. gondii infected IFNγ-induced cells, Irga6 accumulates at the 
parasitophorous vacuolar membrane (PVM) resulting in membrane disintegration and 
parasite death. Aggregated Irga6 cannot accumulate at the PVM. To this end, it has been 
suggested that correct cellular localization of Irga6 requires concomitant expression of 
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additional IFNγ-inducible factors, which possibly could be other IRG proteins (Hunn et al., 
2008). 
Indeed, when mouse cells that stably express Irga6 with an inducible promoter were 
co-transfected with Irgm1, Irgm2 and Irgm3, smooth, non-aggregated pattern of Irga6 was 
restored. When these GMS-transfected cells were infected with T. gondii, Irga6 could 
accumulate on the PVM, as in IFNγ-induced cells (Hunn et al., 2008). Therefore, all three 
GMS proteins are necessary for the proper localization and function of Irga6. 
The nucleotide-bound status of Irga6 is apparently crucial for its proper function. The 
constitutively active Irga6-K82A mutant forms aggregate-like structures when expressed in 
non-induced cells. These structures do not resolve upon IFNγ-induction or GMS transfection. 
In contrast, constitutively inert mutant, Igra6-S83N does not form aggregates in non-induced 
or induced cells and does not accumulate at the T. gondii PVM. 
Immunofluorescence microscopy analysis with the monoclonal antibody 10D7, which 
in vivo detects specifically the GTP-bound form of Irga6, and 10E7, which detects both GTP- 
and GDP-bound Irga6, revealed that in IFNγ-induced uninfected cells Irga6 is in an inactive 
GDP-bound state. Irga6 that accumulates on the T. gondii PVM is in activated, GTP-bound 
and probably oligomerized state (Papic et al., 2008). 10D7 staining had also revealed that 
aggregate-like accumulations of Irga6 are GTP-bound, indicating off-target activation of this 
protein (Papic et al., 2008) (Hunn et al., 2008).  
The nucleotide-binding status of the GMS proteins is also crucial for Irga6 localization 
and function. Mutations that are homologous to Irga6-S83N, that also prevent GTP-binding, 
were introduced into the GMS proteins: Irgm1-S90N, Irgm2-S78N and Irgm3-S98N. When 
these mutated proteins, called GMN proteins, were transfected into the Irga6 expressing 
uninduced cells, Irga6 aggregate-like structures were not resolved and Irga6 could not 
accumulate at the T. gondii PVM (Hunn et al., 2008). 
 
As previously described, purified Irga6 forms enzymatically active GTP-dependent 
oligomers in solution (Uthaiah et al., 2003). Irga6 oligomers could not be isolated from IFNγ-
induced wild-type mouse cells (Papic et al., 2008).  In contrast, when the cells containing 
overexpressed Irga6, in the absence of GMS proteins, were treated with GTPγS or 
Aluminum-Fluoride (AlFx), the substances that prevent the shifts between GTP- and GDP-
bound state of the GTPases, the dimmers of Irga6 could be isolated (Papic et al., 2008). In 
accordance to that, Irga6 aggregate-like structures formed in GMS-deficient cells could 
represent transient GTP-dependent dimmers and possibly oligomers.  
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The yeast two-hybrid (Y2H) analysis of the GKS and GMS proteins showed 
homologous and heterologous interactions between the IRG proteins. Strong homotypic 
interaction was observed for Irga6, strengthening the reports concerning Irga6 
oligomerization (Uthaiah et al., 2003) (Papic et al., 2008). Irga6 was shown to interact with 
Irgm1, Irgm2 and Irgm3 and this interaction was abolished with respective GMN mutants. 
Likewise, Irga6-S83N did not interact with IRG proteins (Hunn et al., 2008). In addition, the 
GDP-dependent interaction of Irga6 and Irgm3 was also shown in pull-down assays (Hunn et 
al., 2008). 
Similarly to Irga6, overexpressed Irgb6 also forms aggregate-like structures that 
cannot accumulate at the PVM. These aggregates are also resolved upon GMS expression 
(Hunn et al., 2008). Homotypic interaction of Irgb6, as well as Irgb6 interaction with Irgm2, 
were also revealed by Y2H analysis (Hunn et al., 2008) and  Irga6 and Irgb6 were also 
shown to interact in pull-down assays (Pawlowski et al., 2011).  
 
1.4.5. IRG and GBP protein aggregation 
Living cells employ a sophisticated machinery for maintaining their proteome. 
Proteostasis refers to control of concentration, conformation, binding interactions and 
location of individual proteins. It is influenced by the chemistry of protein folding/misfolding 
and by numerous regulated networks of interacting and competing biological pathways 
(reviewed in (Balch et al., 2008)). Mismanagement of the protein folding and function by the 
proteostasis network is responsible for the wide range of diseases that include, among 
others, lysosomal storage disease, myelination diseases, cystic fibrosis and 
neurodegenerative diseases including Alzheimer‘s disease. One of the outcomes of the 
proteostasis network failure is the aggregation of permanently or temporary non-functional 
proteins, which can have toxic effects for the individual aggregate producing cell (cell 
autonomous toxicity) and/or for the other cells in the system (non-autonomous toxicity), 
thereby playing a role in many of previously numbered diseases (Reviewed in (Hutt et al., 
2009)).  
In 2004, it has been reported that Irga6 forms filamenous aggregate-like structures 
when expressed in unstimulated L929 fibroblasts (Martens et al., 2004). Thus far,  it has 
been reported that the GKS aggregates are also formed in Irga6-transfected non-induced 
mouse cells; mifepristone-induced Irga6 expressing GS 3T3 cells; IFNγ-induced Irgm1 KO, 
Irgm3 KO or Irgm1/Irgm3 KO mouse embryonic fibroblasts (MEFs) and other IFNγ-induced 
cells which lack at least one of the GMS proteins (Martens et al., 2004) (Hunn, 2008) (Hunn 
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and Howard, 2010) (Haldar et al., 2013). As previously described (chapter 1.4.4.), GKS 
protein aggregation is GTP-dependent and regulated by the GMS proteins. The presence of 
all Irgm1, Irgm2 and Irgm3 is necessary to obtain smooth non-aggregated appearance of 
Irga6 or Irgb6 in the cell.   
To this end, localization of most of the GKS aggregate-like structures is not clarified. 
Electron-microscopy images had shown that overexpressed Irga6 partially co-localizes with 
the ER (Kaiser, 2005) (Hunn et al., 2008). Recent reports had alsoshown that Irgb10 and 
Irga6 aggregate-like structures co-localize with the lipid droplets in IFNγ-induced Irgm1/Irgm3 
KO cells (Haldar et al., 2013), but the localization of Irga6 and other GKS proteins in other 
GMS-deficient cells has not been investigated.  
 
Interestingly, GKS protein aggregate-like structures are formed not only in the 
absence of the GMS proteins, but also in the absence of certain autophagy-related proteins. 
IFNγ-induced Atg5 KO cells were shown to contain Irga6, Irgb6, Irgd and Irgb10 aggregate-
like structures and Irgb10 accumulations were reported in IFNγ-induced Atg3 KO cells 
(Khaminets et al., 2010) (Traver et al., 2011) (Haldar et al., 2014). Similarly to Irga6 in GMS-
deficient cells, Irga6 aggregate-like structures in Atg5 KO cells are also GTP-bound and 
unable to accumulate at the T. gondii PVM (Khaminets et al., 2010). Aggregated Irgb10 in 
Atg3 and Atg5 KO cells cannot accumulate at Chlamydia trachomatis inclusions (Haldar et 
al., 2014). Irgb6 was also not able to load to the T. gondii PVM in IFNγ-induced Atg7 KO and 
Atg16L KO cells, probably due to aggregate formation (Ohshima et al., 2014). However, in 
the cells lacking Atg9a or Atg14 did not encounter this problem (Ohshima et al., 2014). 
Further yycharacteristics of these aggregate-like structures and their similarity to the 
aggregate-like structures in GMS deficient cells remain to be investigated. 
Not only IRG proteins, but also GBP-proteins are prone to aggregation in the absence 
of the GMS proteins. It has been shown that mouse Gbp2 protein forms aggregate-like 
structures in Irgm1 KO or Irgm3 KO MEFs and bone marrow-derived macrophages 
(BMDMs). Interestingly, over 80% of GBP aggregate-like structures were reported to co-
localize with Irga6 aggregate-structures, indicating that these accumulations are made of 
both IRG and GBP proteins (Traver et al., 2011). GBP proteins also form aggregate-like 
structures in Atg-deficient cells: Gbp2 accumulations could also be detected in IFNγ-induced 
Atg5 and Atg3 KO mouse cells (Traver et al., 2011) (Haldar et al., 2014). Whether the GBP 
proteins are also regulated by GMS and Atg proteins, remains to be clarified. 
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1.5. Parasite control by the IRG resistance system  
The analysis of IRG-deficient mouse resistance had suggested that IRG proteins are 
implicated in resistance against particular intracellular pathogens, namely against 
Toxoplasma gondii (Taylor et al., 2000) (Collazo et al., 2001) (Butcher et al., 2005) (Martens 
et al., 2005) (Zhao et al., 2009b) (Khaminets et al., 2010), Chlamydia trachomatis (Coers et 
al., 2008) (Al-Zeer et al., 2009) (Nelson et al., 2005) (Coers et al., 2011), Chlamydia psittaci 
(Miyairi et al., 2007), Encephalitozoon cuniculi (da Fonseca Ferreira-da-Silva et al., 2014) 
and Neospora caninum (Spekker et al., 2013) (Reid et al., 2012) (chapters 1.5.1. and 1.5.2.). 
In addition to these pathogens, Irgm1 knock-out (KO) mice have been reported to succumb 
to infection with Leishmania major, Trypanosoma cruzi, Listeria monocytogenes, 
Mycobacterium avium, M. tuberculosis and M. bovis, Salmonella typhimurium and other 
(chapter 1.6.1). However, it has been proposed that the susceptibility of Irgm1 KO mice 
might be a consequence of dysregulation of the other IRG proteins in the absence of Irgm1 
(Hunn and Howard, 2010) (chapter 1.6.3.). 
 
1.5.1. IRG resistance to Toxoplasma gondii 
Toxoplasma gondii is a obligate intracellular protozoan parasite which belongs to the 
phylum Apicomplexa. It has a broad host range and can infect most nucleated cells of any 
warm blooded animal (Levine, 1988) (Black and Boothroyd, 2000) (Sibley, 2003).  
The life cycle of T. gondii is complex and it includes sexual and asexual phase of 
reproduction (Boothroyd and Grigg, 2002). The sexual reproduction of Toxoplasma occurs 
only in members of the Felidae family, nowadays to a large extent in the domestic cat (Felis 
silvestris catus) (Hutchison, 1965). The cat gets infected by carnivorism and, after the sexual 
process, sheds environmentally resistant cysts of T. gondii, which can get taken up by any 
foraging warm-blooded animal (Dubey and Frenkel, 1972) (Dubey, 1995). After the asexual 
phase in any warm-blooded animal, T. gondii encysts in the tissues and resides there until 
the animal dies or gets eaten by another animal (Dubey and Frenkel, 1972) (Sims et al., 
1989) (Dubey et al., 1997).  
In the immunocompetent human hosts the acute phase of the disease toxoplasmosis 
is often asymptomatic and sometimes followed by flu-like symptoms. However, in 
immunocompromised individuals T. gondii infection can result in severe toxoplasmosis, 
which predominantly attacks the nervous system and can lead to fatal encephalitis 
(Lieberman and Hunter, 2002) (Suzuki et al., 1988). 
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For a long time, T. gondii population of Europe and North America was classified into 
three clonal lineages, named type I, II and III (Howe and Sibley, 1995). Although these 
lineages show less than 1 percent of genomic variation, there is a striking difference 
concerning their virulence in laboratory strains of mice. Nowdays, over 200 different 
genotypes of T. gondii (Shwab et al., 2013) with striking differences in virulence have been 
distinguished (Lilue et al., 2013). The highest Toxoplasma population diversity  is reported in 
South America, especially in Brazil (Shwab et al., 2013). 
 
IFNγ is crucial in controlling replication and dissemination of avirulent T. gondii in both 
myeloid and non-myeloid cells, which can both develop IFNγ-induced cell autonomous 
resistance mechanism to T. gondii (Suzuki et al., 1988) (Scharton-Kersten et al., 1996) 
(Halonen et al., 2001) (Butcher et al., 2005) (Martens et al., 2005). Thus, IFNγ-deficient mice 
die even after infection with avirulent T. gondii (Scharton-Kersten et al., 1996).  
IRG proteins represent IFNγ-inducible factors that play an essential role in mouse 
resistance to T. gondii. Namely, 100 percent of Irgm1 KO (Collazo et al., 2001), Irgm3 KO 
(Taylor et al., 2000) or Irgm1/Irgm3 KO mice (Henry et al., 2009) and about 50 percent of 
infected Irga6 KO (Liesenfeld et al., 2011) or Irgd KO (Collazo et al., 2001) die 10-12 days 
after infection with avirulent T. gondii strains.  
On a subcellular level T. gondii can actively invade any nucleated cell of the host and 
resides in it in a parasitophorous vacuole (PV) (Morisaki et al., 1995). The parasitophorus 
vacuolar membrane (PVM) is formed from the invaginated and modified host cell plasma 
membrane (Suss-Toby et al., 1996) and provides an intracellular niche, which shields the 
parasite from endogenous host defense mechanisms (Sibley, 2011). The PV does not fuse 
with the endolysosomal compartment and therefore its acidification is blocked (Sibley et al., 
1985). 
Immediately after Toxoplasma entry into an IFNγ-induced cell, effector IRG proteins, 
called GKS proteins, accumulate and activate at the PVM in a nucleotide-dependent manner 
(Martens et al., 2005) (Ling et al., 2006)  (Zhao et al., 2009b) (Hunn et al., 2008) (Papic et al., 
2008). IRG proteins load onto the PVM in a  cooperative and hierarchical manner with Irgb6 
and Irgb10 being the most efficient and also first to load (Khaminets et al., 2010). It has been 
proposed that, during this process, GTP-dependent heterooligomers are formed at the PVM 
(Khaminets et al., 2010) (Pawlowski et al., 2011) (Hermanns et al., manuscript in 
preparation). Regulatory IRG proteins, called GMS proteins, do not target the PVM (Irgm1), 
or target it only in a marginal extent (Irgm2, Irgm3), probably being brought there in complex 
with GKS proteins (Butcher et al., 2005) (Martens et al., 2005) (Khaminets et al., 2010) 
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(Haldar et al., 2013). After accumulation of the IRG proteins to the T. gondii PVM,  the 
effective surface area of the PVM is reduced by vesiculation and ruffling (Martens et al., 
2005)  (Ling et al., 2006) (Zhao et al., 2009b). Therefore, it has been proposed, that created 
membrane tension ultimately leads to PVM rupture (Zhao et al., 2009b) (Howard et al., 
2011). Once exposed to the cytosol, the parasite dies, followed by death of the host cell 
(Martens et al., 2005) (Ling et al., 2006) (Melzer et al., 2008) (Zhao et al., 2009b).  
The mechanism of parasite death and subsequent death of the host cell are not yet 
clarified. The host cell death is characterized by plasma membrane permeabilization and the 
release of the high-mobility group protein 1 (HMGB1) (Zhao et al., 2009b). Cytochrome C is 
not released from the mitochondria prior to death and no cleavage of caspase-3 or its 
substrate PARP could be seen (Zhao et al., 2009b). The cell death is also not caspase-1 
dependent (Zhao et al., 2009b), but preliminary data show that death of T. gondii infected 
cells can be inhibited by the inactivation of lysosomal cathepsins (Carolina Alves, 
unpublished data). Taken together, host cell death is currently characterized as necrosis-like 
cell death.  
In human, T. gondii control is also IFNγ-dependent. The mechanism behind the IFNγ-
dependent response to T. gondii is not well understood.  It has been shown that human IRG 
proteins do not accumulate at the PVM. However, T. gondii proliferation in human cells 
depends on IFNγ-inducible indoleamine-2,3-dioxygenase (IDO), which degrades amino acid 
tryptophan to kynurenine (chapter 1.2.). Since T. gondii cannot synthesize tryptophan on its 
own and scavenges it from the host cell,  depletion of tryptophan by IDO inhibits T. gondii 
replication (Pfefferkorn, 1984).  
 
1.5.2. IRG resistance to C. trachomatis, E. cuniculi and N. caninum 
a) IRG response to Chlamydia 
Chlamydiae are bacteria with obligatory intracellular lifestyle and biphasic life cycle 
(Moulder, 1991). The entry mechanism of Chamydia is not well understood, but it comprises 
some properties of clathrin-mediated endocytosis, and differs from conventional 
phagocytosis, calveolar-mediated endocytosis and macropinocytosis (Hybiske and 
Stephens, 2007). Early modifications of the nascent chlamydial vacuole prevent vacuolar 
fusion with the lysosomes (Hackstadt et al., 1995). 
Chlamydiae exibit a broad spectrum of natural host infection tropism (Morrison and 
Caldwell, 2002). Chlamydia trachomatis is prevalently human pathogen and Chlamydia 
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muridarum mainly infects the mouse (Cotter and Byrne, 1996). In contrast to the mouse 
response to C. muridarum, which is not IFNγ-mediated, response to Chlamydia trachomatis 
in mouse is mediated by IFNγ and IRG proteins (Nelson et al., 2005). 
 Firstly, it has been shown that Irgm1 KO and Irgm3 KO, but not Irga6 KO mice are 
susceptible to C. trachomatis infection (Coers et al., 2008). Secondly, it has been shown that 
Irga6 and Irgb10 proteins accumulate at C. trachomatis inclusions (Coers et al., 2008). 
Thirdly, Irgb10 ectopic expression reduces the number of inclusions (Coers et al., 2008). 
Fourthly, the inclusions in Irga6 KO cells were larger than in the WT cells. however, 
Irgm1/Irgm3 double KO mice rescued myeloid cell defects in C. trachomatis response that 
exist in Irgm1 KO mouse myeloid cells (Coers et al., 2011). C. muridarum probably can 
overcome IRG response due to gene TC438, whose homologue YopT is involved in Rho 
GTPase inactivation by removal of lipid modification in Yersinia. Thus, it has been proposed 
that TC438 is responsible for the inactivation of IRG proteins and therefore evasion of IRG 
response in mice (Nelson et al., 2005). 
IRG proteins are also shown to be involved in the response to Chlamydia psittaci, 
bacteria that cause severe pulmonary infections in humans. All Irgm3 KO mice that were 
infected with C. psittaci died several days after infection. These mice had also shown post-
infection weight loss and the cross sections of their spleen were coated with fibrin and 
infiltrated with inflammatory cells. All wild type C57BL/6 mice had survived C. psittaci 
infection and did not show the weight loss, but all the 129S1/SvImJ mice suffered from the 
weight loss and succumbed to infection. Since 129S1/SvImJ mice have low expression 
levels of Irgb10 protein, these data indicated that this protein might play important role in C. 
Psittaci resistance (Miyairi et al., 2007). Further linkage analysis using BXD recombinant 
inbred stains revealed a single effector locus at chromosome 11 encoding a cluster of three 
IRG proteins, Irgb10, Irgm2 and Irgm3 that plays a role in the resistance to C. psittaci (Miyairi 
et al., 2007). 
b) IRG response to Encephalitozoon cuniculi 
The microsporidian, Encephalitozoon cuniculi is an abundant obligate intracellular 
pathogen,  infecting primarily rodents, but is also pathogenic in immunologically deficient 
humans (Didier, 2005). Microsporidia have a very peculiar entry mechanism into host cell: it 
employs a filamentous tube, named the polar tube, which, upon an unknown trigger, can be 
suddenly extruded creating a deep and narrow invagination in any adjacent host cell plasma 
membrane. The E. cuniculi sporoplasm is transferred through the tube and resides in the 
host cytoplasm in a PVM derived from the invaginated plasma membrane (Bohne et al., 
2011).  
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The proliferation of E. cuniculi is also inhibited by IFNγ. IFNγ restriction suppresses E. 
cuniculi growth in murine peritoneal macrophages, mouse embryonic fibroblasts, human 
enterocyte cell lines and human monocyte-derived macrophages (Didier, 2005) (Choudhry et 
al., 2009) (Fischer et al., 2008) (da Fonseca Ferreira-da-Silva et al., 2014). Moreover, IFNγ 
KO mice are susceptible to E. cuniculi (Khan and Moretto, 1999). Recently, it has been 
shown that IRG proteins mediate E. cuniculi resistance in mouse cells:  Irga6, Irgb6, Irgd and 
Irgm2 were detected at the E. cuniculi parasitophorus vacuole, as on the T. gondii PVM. 
IFNγ-mediated inhibitory effects on E. cuniculi are lost in GMS-deficient cells, emphasizing 
an essential role of IRG proteins (da Fonseca Ferreira-da-Silva et al., 2014). 
c) IRG response to Neospora caninum 
A close relative of T. gondii, prevalently dog pathogen Neospora caninum, is also 
proposed to be controlled by the IRG resistance system. Irga6, Irgb6 and Irgd have been 
reported to accumulate on the PVM of N. caninum in infected murine cells (Spekker et al., 
2013) (Reid et al., 2012).  
 
1.6. GMS proteins: the role and the mechanism of action  
1.6.1. Susceptibility of GMS knock-out mice to infection 
Opinions about the mechanism of action of GMS proteins, especially of Irgm1, are 
divided (Chapter 1.6.4.). The lifespan and the weight of Irgm3 KO and Irgm1/Irgm3 KO mice, 
which are raised under SPF conditions, are indistinguishable from corresponding wild-type 
(WT) mice (Taylor et al., 2000). Irgm1 KO mice, which are grown under SPF conditions, 
weight slightly less than wild-type mice, but their life span is not affected (Collazo et al., 
2001) (personal communication with Gregory A. Taylor).  
In contrast to Irgm3 KO and Irgm1/Irgm3 KO mice, which are susceptible to the 
infection with T. gondii and C. trachomatis, Irgm1 KO mice succumb to infection with not only 
these, but also with variety of other very different pathogens, which will be described in this 
chapter. Irgm1 KO mice also die due to various non-pathogen induced inflammations, which 
do not have severe consequences in WT mice or in Irgm3 and Irgm1/Irgm3 KO mice 
(chapter 1.6.2.). Thus, Irgm1 is often proposed to have pan-anti-inflammatory and pan-
defensive roles. 
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a) Susceptibility to Listeria monocytogenes infection 
Experiments monitoring the survival of GMS KO mice after Listeria monocytogenes 
infection have shown that Irgm1 KO mice are fully susceptible to this infection. They die 4-5 
days after infection and have high parasite burdens in spleen and liver (Collazo et al., 2001). 
Contrary, Irgm3 KO mice survive and fully recover from the L. monocytogenes challenge 
(Taylor et al., 2000).  
b) Susceptibility to Trypanosoma cruzi 
Irgm1 KO mice were also reported to be susceptible to Trypanosoma cruzi and die 
14-19 days after infection (Santiago et al., 2005). The increased parasite burden is found in 
spleen, liver and heart of these mice. Infected Irgm1 KO animals also suffer from 
characteristic severe anemia, lymphopenia and thrombocytopenia together with lymphoid 
organ atrophy and bone marrow cell depletion (Santiago et al., 2005). In contrast, Irgm3 KO 
mice were reported to be fully resistant to T. cruzi infection (de Souza et al., 2003). 
c) Susceptibility to Mycobacteria infection 
The most extensive study on Irgm1 KO mouse resistance was performed with 
Mycobacterium avium infection by Carl Feng and his coworkers (Feng et al., 2004). M. avium 
infected Irgm1 KO mice die 10-20 days post infection and show increased bacterial burden in 
the lungs and liver. Irgm1 KO macrophages respond to M. avium infection by production of 
normal levels of pro-inflammatory mediators like tumor necrosis factor α (TNFα) and nitric 
oxide (NO). However, granuloma formation in these mice is impaired and, interestingly, 
infected Irgm1 KO mice suffer from striking lymphopenia. Splenic lymphocyte counts of these 
mice are a third of those in infected WT mice and both CD4 and CD8 T cell pools are 
depleted. Peripheral lymphocyte and thymocytes counts are also severely decreased (Feng 
et al., 2004). 
To investigate whether the lymphocyte depletion observed in M. avium infected Irgm1 
KO mice is exclusively caused by a lymphocyte defect, or also by defects in non-lymphoid 
compartments, naive T-lymphocytes from WT or Irgm1 KO donors were transferred into M. 
avium infected RAG-2 KO recipients, which lack mature lymphocytes, but express Irgm1 
(Shinkai et al., 1992). The bacterial growth was assayed 6 weeks post infection and both 
RAG-2 KO mice with naïve WT and Irgm1 KO lymphocytes showed equivalent infection 
control (Feng et al., 2004). Similar results were also reported when 2 week infected WT or 
Irgm1 KO mice were used as T-lymphocyte donors, indicating that the defective lymphocytes 
alone are not the cause of the death of Irgm1 KO mice after M. avium infection (Feng et al., 
2004). 
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Irgm1 KO mice are also highly susceptible to infection with Mycobacterium 
tuberculosis (Erdman-strain), while Irgm3 KO survive this infection as well as WT mice 
(MacMicking et al., 2003). In IFNγ-induced Irgm1 KO BMDMs, M. tuberculosis grows faster 
than in IFNγ-induced WT BMDMs and it has been shown that acidification of the 
Mycobacterial phagosome is impaired in Irgm1 KO BMDMs (MacMicking et al., 2003). 
d) Susceptibility to Salmonella typhimurium 
Infection of Irgm1 KO mice with Salmonella typhimurium also resulted in increased 
pathogen burden in spleen and liver and impaired granuloma formation, and finally in death 
of the animals (Henry et al., 2007). Again, Irgm3 KO mice were fully resistant to S. 
typhimurium (Henry et al., 2007). Surprisingly, Irgm1/Irgm3 KO mice were also fully resistant 
to S. typhimurium, with pathogen burden, spleen weight and granuloma formation similar to 
WT and Irgm3 KO mice (Henry et al., 2009). 
In vitro analysis confirmed that S. typhimurium proliferation in induced Irgm1 KO 
BMDMs is increased in comparison to WT BMDMs (Henry et al., 2007). 
e) Susceptibility to other pathogens  
Irgm1 KO mice were also reported to be susceptible to Leishmania major (Taylor et 
al., 2004). All the pathogens that caused Irgm1 KO mouse death have in common to induce 
IFNγ response and thereby IRG proteins, which then could act toxically in the absence of 
Irgm1 (Taylor et al., 2004). In accordance to that, Th-2 response to the helminth 
Schistosoma mansoni, which does not induce IFNγ responses, and does not stimulate IRG 
protein expression, did not cause death of Irgm1 KO mouse, indicating that the Irgm1 KO 
phenotype requires IFNγ induction (Feng et al., 2008b).  
 
1.6.2. Susceptibility of GMS KO mice to non-infective inflammation 
Irgm1 KO mice are also susceptible to a variety of inflammatory stimuli that are not 
directly induced by infection with a pathogen, but all directly or indirectly stimulate IFNγ 
production. Intraperitoneal LPS injection in concentrations resisted by all of the wild type 
mice, had caused death of all Irgm1 KO mice within 2 days post injection (Bafica et al., 
2007).  
Induction of colitis by addition of dextran sulfate-sodium (DSS) to drinking water had 
caused a severe phenotype in the Irgm1 KO mice. These mice exhibit greater degree of 
weight loss, altered stool consistency and rectal bleeding than WT mice. They also suffer 
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from significant atypical ileal injury including increased infiltration by lamina propria 
inflammatory cells, local epithelial denudation, mild goblet cell depletion and crypt epithelial 
cell hyperplasia. Paneth cells of these mice are morphologically changed and showed 
increased number of autophagosomes (Liu et al., 2013). 
The role of Irgm1 in experimental autoimmune encephalomyelitis (EAE), a mouse 
model of multiple sclerosis, and permanent middle cerebral artery occlusion (pMCAO), a 
mouse model for stroke, was also investigated. It was reported that Irgm1 KO mice treated 
with EAE inducer, myelin basic protein (MBP), had shown milder neuro-inflammatory 
phenotype of EAE and simultaneously increased death of CD4 positive cells in comparison 
to the induced WT mice  (Xu et al., 2010) (Wang et al., 2013). In the mouse model of stroke, 
infarct area in the Irgm1 KO mice was reported to be significantly larger than in the WT mice 
after pMCAO induction (He et al., 2012).  
Irgm1 was also proposed to be involved in the regulation of the oxLDL uptake by 
macrophages, suggesting the importance of this gene in artherosclerosis (Xia et al., 2013).  
Even though these preliminary reports in the involvement of the Irgm1 in a variety of 
diseases remain to be further investigated, it seems that every inflammatory disease that 
induces IRG protein expression has severe consequences for the Irgm1 KO mouse. 
 
1.6.3. Susceptibility of GMS KO cells to inflammation 
Analysis of Irgm1 KO-derived cells that express IRG proteins strengthens the 
hypothesis that Irgm1 KO mice can die after treatment with any stimulus that induces 
expression of other IRG proteins (chapters 1.6.1. and 1.6.2 ). 
After IFNγ induction, Irgm1 KO BMDMs have decreased adhesion and motility 
properties compared with WT BMDMs (Henry et al., 2007). However, even though the 
morphology of these cells is changed, their proliferation and cell death rate are similar to WT 
BMDMs (Henry et al., 2007).  
Analysis of isolated Irgm1 KO lymphocytes had shown that these cells encounter 
proliferation and survival problems after induction. Isolated CD4 positive lymphocytes from 
Irgm1 KO mice, induced with agonistic monoclonal antibodies (mAb) to CD3, display a 
growth defect shown by a thymidine incorporation test. Similarly, when splenic dendritic cells 
of Irgm1 KO OT-II mouse, which was created by crossing of Irgm1 KO and ovalbumin (OVA) 
TCR-transgenic mice, were stimulated by either OVA protein or OVA 323-339 peptide, the 
incorporation of thymidine and cell counts were lower. BrdU incorporation test showed that 
 26 
 
1. INTRODUCTION 
RODUCTION 
DNA synthesis in individual cells was not impaired, but the proliferation of these cells, as 
shown with CFSE staining, was decreased. The number of dead (Propidium-iodide (PI) 
stained) cells was increased in OVA-induced Irgm1 KO OT-II cells. EHej lectron-microscopy 
analysis showed an increase in autophagosome size and number in Irgm1 KO lymphocytes 
after IFNγ induction (Feng et al., 2008b). Lymphocyte survival and proliferation were fully 
rescued in Irgm1/Ifng double KO mice, indicating that these phenomena are indeed IFN-
dependent (Feng et al., 2008b). 
Hematopoietic stem cells (HSCs) of Irgm1 KO mice, which express IRG proteins 
without IFN-induction, were also analyzed (Ivanova et al., 2002) (Ramalho-Santos et al., 
2002) (Feng et al., 2008a) (King et al., 2011). After exposure to sublethal dose or irradiation, 
Irgm1 KO mice showed impaired recovery of bone marrow and thymic cellularity. In 
competitive and non-competitive bone marrow transplantation assays, Irgm1 KO HSC had 
failed to properly repopulate the hematopoetic system (Feng et al., 2008a). When challenged 
with hematopoetic ablation by 5-fluorouracil (5-FU) or by infection with M. avium, Irgm1 KO 
mice did not achieve the expected expansion response in stem and progenitor cell 
populations (Feng et al., 2008a). However, these self-renewal and repopulation defects were 
fully restored in Irgm1/Irgm3 double KO mice (King et al., 2011). 
Taken together, it seems that the IFNγ response and IRG protein expression affect 
cell survival and proliferation of Irgm1 KO lymphocytes and hematopoetic stem cells. 
However, the survival and proliferation of BMDMs are not affected, indicating that the 
phenotype of Irgm1 KO mice is not caused by the failure of every cell in the mouse, but 
rather particular cell groups. 
 
1.6.4. Models of Irgm1 function 
Due to its importance in the protective response to various pathogens, involvement in 
inflammation and maintenance of the HSC pool, different mechanisms of action have been 
suggested for Irgm1. In principle, three models concerning the molecular function of Irgm1 
have been proposed: the first one suggests Irgm1 involvement in the acidification of bacterial 
phagosome, the second one describes Irgm1 as an autophagy regulator and the third one 
proposes that Irgm1 is an essential negative regulator of other IRG proteins whose absence 
leads to pathological defects. 
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a) Irgm1 as a regulator of phagosomal acidification 
Irgm1 was firstly proposed to target the bacterial phagosome, to facilitate its transfer 
to lysosomes and induces phagosomal acidification (reviewed in (MacMicking, 2012)). This 
model is based on studies that analyzed the response of Irgm1 KO cells and mice to 
Mycobacterium tuberculosis infection (MacMicking et al., 2003). Irgm1 KO mice were 
reported to be highly susceptible to infection with Mycobacterium and Listeria (chapter 1.6.1.) 
and it has been claimed that Irgm1 localizes to mycobacterial and listerial phagosomes 
(Shenoy et al., 2007) (Tiwari et al., 2009). In WT macrophages, fusion of mycobacterial 
phagosomes and lysosome is enhanced in the presence of IFNγ and phagosomal 
acidification that follows. However, the pH drop could not be detected in infected, IFNγ-
induced Irgm1 KO macrophages, indicating that the fusion of phagosomes and lysosomes in 
these cells is impaired (MacMicking et al., 2003). Furthermore, Irgm1 was proposed to have 
a preference to bind lipids that are present, although not exclusively, at the nascent 
phagosomal membrane: phosphatidylinositol-3,4-biphosphate (PitIns(3,4)P2), 
phosphatidylinositol-3,4,5-triphosphate (PitIns(3,4,5)P3) and diphosphatydil-glycerol (DPG) 
(Tiwari et al., 2009).  
Therefore, it has been proposed that Irgm1 targets bacterial phagosomes and with 
the help of autophagic machinery, mediates their fusion with lysosomes (MacMicking et al., 
2003) (Shenoy et al., 2007) (Tiwari et al., 2009) (MacMicking, 2012). Recently, the claimed 
localization of Irgm1 to the Mycobacterial and Listerial phagosome has been disputed 
(Springer et al., 2013) and therefore the model of Irgm1 as a regulator of phagosomal 
processing needs to be re-evaluated. 
b) Irgm1 as an autophagy regulator 
A role of Irgm1 in the regulation of autophagy was proposed in several different 
models.  
On the one hand, the role of Irgm1 as an IFNγ-dependent direct effector and inducer 
of autophagic elimination of M. tuberculosis in macrophages has been suggested (Gutierrez 
et al., 2004) (Deretic, 2011).  This model is based on the report that transfection of Irgm1 in 
non-IFNγ induced macrophages increased the amount of autophagosomes in the cell and 
that transfected GFP-Irgm1 accumulates at the autophagosomes (Gutierrez et al., 2004) 
(Singh et al., 2006). It has been shown that autophagic induction in WT cells can increase 
the fusion of Mycobacterial phagosomes with lysosomes and enhance M. tuberculosis 
clearance (Gutierrez et al., 2004). However, one should keep in mind that GFP-tagged Irgm1 
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was shown to mislocalize in comparison to endogenous Irgm1 and therefore the indicated 
observations might be misinterpreted (Zhao et al., 2010). 
It has been also suggested that Irgm1 and Irgm3 are involved in autophagic 
degradation of the ubiquitinated GKS protein aggregates and therefore, GKS aggregates are 
formed in their absence (Traver et al., 2011). In addition, co-localization of IRG proteins and 
autophagic LC3-structures was observed in Irgm1/Irgm3 KO MEFs, suggesting involvement 
of autophagy in the IRG protein degradation (Haldar et al., 2013).   
 On the other hand, it was proposed that autophagy increase can induce the death of 
Irgm1 KO cells and thus that Irgm1 might inhibit autophagic cell death (Feng et al., 2008b) 
(Feng et al., 2009) (King et al., 2011).  This model was based on the reports that show that 
induced Irgm1 KO lymphocytes and hematopoietic stem cells (HSCs) have increased 
number of autophagosomes (Feng et al., 2008b) (Feng et al., 2008a) (King et al., 2011). 
When Irgm1 KO mice were exposed to dextran sulphate sulphate to induce intestinal 
inflammation, the number of LC3-positive autophagic structures was increased in their 
Paneth cells (Liu et al., 2013).  Induced Irgm1 KO lymphocytes also undergo cell death, 
which can be avoided by silencing of a protein of the autophagic cascade named Beclin-1 
(Feng et al., 2008b). However, the possibility that the autophagy in Irgm1 KO cells is the last 
attempt to rescue the cell before it dies has also been proposed (Deretic, 2011).  
It is important to note that these opposing models are based on experiments 
performed in very different cells under different conditions: on the one hand on the non-IFNγ-
induced, slow-dividing macrophages transfected with GFP-Irgm1 and, on the other hand, in 
the fast-dividing induced Irgm1 KO lymphocytes, HSC and intestine cells that are sensitive to 
stress and cell death (Feng et al., 2009). 
c) Irgm1 as a negative regulator of other IRG proteins 
 Instead of a role of Irgm1 as a direct effector involved in pathogen resistance, it has 
been proposed that the effects of losing this protein could be an indirect consequence of its 
function as a  negative regulator of GKS IRG proteins. This model originates from the 
experiments that show that GMS proteins play a role as a negative regulators of GKS protein 
activation and aggregation (Hunn et al., 2008) (Papic et al., 2008) (Hunn and Howard, 2010). 
As previously explained (chapter 1.4.4.), GMS proteins keep GKS proteins in the GDP-bound 
state and when even one GMS protein is missing, GKS protein form non-functional 
aggregates (Hunn et al., 2008). Moreover, it has been shown that susceptibility of GMS KO 
mice to T. gondii is caused by the inability of aggregated GKS proteins to relocalize to the 
PVM (Hunn et al., 2008). However, many other pathogens, like L. monocytogenes and M. 
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avium (chapter 1.6.1.), are still able to kill the Irgm1 KO mice, but not Irgm3 KO or 
Irgm1/Irgm3 KO mice. Thus, it has been proposed, that GKS aggregate-like structures in 
Irgm1 KO, Irgm3 KO or Irgm1/Irgm3 KO cells have different localization that influences their 
toxicity (Hunn and Howard, 2010) (Howard et al., 2011).  
 Considering that GMS proteins are localized to different endocellular membranes, it 
has been proposed that each GMS protein protect the particular cellular membranes from 
accumulation of GKS proteins in aggregate-like structures by preventing their activation and 
maintaining the GDP-bound state  (Hunn and Howard, 2010) (Howard et al., 2011). Irgm1 is 
the only GMS protein that localizes to the lysosomes and it is hypothesised that in the 
absence of Irgm1 activated GKS proteins can localize to the lysosomes. Likewise, the 
endoplasmic reticulum to which Irgm3 localizes, would accumulate activated GKS proteins in 
Irgm3 KO cells. Localization of activated aggregated GKS proteins to different endocellular 
membranes could have different consequences for the cell:  GKS proteins on the lysosomes 
in Irgm1 KO cells might cause cytopathic defects in the cells thorough dysfunction or damage 
to lysosomes, while GKS proteins on the ER in Irgm3 KO cells might not cause so severe 
phenotype (Howard et al., 2011). Recently it has been also been reported that in Irgm1/Irgm3 
KO cells, GKS proteins relocalize to the lipid droplets, a compartment carrying both Irgm1 
and Irgm3, indicating that GMS proteins indeed could regulate sub-cellular localization of the 
GKS proteins (Haldar et al., 2013). 
 It has been proposed that the role of GMS proteins is to help GKS proteins to 
recognize membrane-bounded vacuoles containing pathogens by “missing self” principle 
(Martens, 2004) (Hunn and Howard, 2010) (Haldar et al., 2013) (Coers, 2013) (da Fonseca 
Ferreira-da-Silva et al., 2014). Pathogens like T. gondii, C. trachomatis and E. cuniculi enter 
the cell by unusual mechanisms, retaining, but modifying the plasma membrane (Chapther 
1.5.1.). This modified vacuolar membrane, derived from plasma membrane, is not protected 
by GMS proteins, while all the endogenous intracellular membranes are probably coated with 
GMS proteins. Therefore, it has been proposed that the vacuolar membranes of these 
organisms, carrying no self GMS proteins, are unable to suppress the local activation of GKS 
proteins. Pathogens like Mycobacterium, that enter the cell via phagocytosis and are still 
protected by an unknown factor or effect that inhibits GKS activation at the unmodified 
plasma membrane are not attacked by GKS proteins (da Fonseca Ferreira-da-Silva et al., 
2014). IFNγ induction, which occurs in Mycobacteria and other infections, is sufficient to 
induce IRG protein expression. Therefore, in IFNγ-induced Irgm1 KO cells and infected 
Irgm1 KO mice, unregulated GKS proteins could relocalize to the lysosomes and impact the 
proper function of these organelles. However, in induced Irgm3 KO cells, activated GKS 
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proteins would preferentially occur on ER membranes with less severe consequences for the 
cell and for the mouse (Howard et al., 2011) (da Fonseca Ferreira-da-Silva et al., 2014). 
 
1.7. The aim of study 
A GMS protein Irgm1 was proposed to play very different roles: from a pan-defensive 
protein involved in resistance to a wide spectrum of pathogens, over important anti-
inflammatory regulator involved in a variety of intestinal and neurological diseases to the 
positive/negative regulator of autophagy. Nevertheless, it has been shown that, after 
infection with a variety of pathogens, Irgm1 deficient mice become strikingly leukopenic and 
die. However, Irgm3 deficient mice can fully recover from infection with the most of 
pathogens that kill Irgm1 KO mice. 
The aim of this study is to better understand the mechanism of Irgm1 action and the 
difference between Irgm1 and other GMS proteins involved in IRG protein regulation. 
Therefore, it has been proposed that GMS proteins, except for keeping GKS proteins in the 
the inactive GDP-bound state, also protect endocellular membranes from GKS proteins. 
Since Irgm1 is the only GMS protein reported at the lysosomes, it has been hypothesized 
that GKS proteins localize to the lysosomes in its absence. In accordance to that, since 
Irgm3 is the only GMS protein at the endoplasmic reticulum, it has been suggested that GKS 
would localize to this organelle in its absence. 
Thus, the first part of this study is dedicated to the analysis of GKS protein 
localization in the absence of GMS proteins. Moreover, the hierarchy of different GKS 
proteins during loading to cellular organelles and the importance of this hierarchy in mouse 
model have been investigated. 
In the second part of this study, the intracellular mechanism of Irgm1 action has been 
investigated. After describing accumulation of GKS aggregate-like structures to lysosomes in 
Irgm1 KO cells, the possible consequences of this accumulation, namely autophagic flux 
impairment, lysosomal acidity and lysosomal membrane permeablilization have been 
studied. 
In the third part, death of Irgm1 KO MEF and BMDM cells was analyzed, and finally, 
in the fourth part, solubility of the GKS aggregate-like structures was assessed. 
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2.1. Materials 
2.1.1. Instruments 
Microscopes and special devices Producer 
Zeiss Axioplan II fluorescence microscope  
AxioCam MRm camera 
Zeiss, Jena, Germany 
Zeiss, Jena, Germany 
Zeiss Axiovert 200 M motorized microscope 
Wrap-around temperature-controlled chamber 
AxioCam MRm camera 
Zeiss, Jena, Germany 
Zeiss, Jena, Germany 
Zeiss, Jena, Germany 
UltraVIEW VoX confocal microscope 
Spinning disc CSU-X1 
 
EMCCD C9100-50 CamLink camera 
Nikon, Tokyo, Japan  
Yokogawa Corporation of America, 
Newnan, GA 
CamLink, UK 
Minifold I 96 well Dot-Blot system   Whatman, Dassel, Germany 
OptimaTM TLX Ultracentrifuge Beckman Coulter, Krefeld, Germany 
 
2.1.2. Chemicals and supplies 
Chemicals and supplies Producer 
4’,6-Diamidino-2-phenylindol (DAPI) Roche Diagnostics, Mannheim, Germany 
Albumin fraction V (BSA) Carl Roth, Karlsruhe, Germany 
Bafilomycin Sigma-Aldrich, St Louis, MO 
Bradford reagent Bio-rad, Hercules, CA 
Coverslips and microscopy slides Paul Marienfeld, Lauda, Germany 
Gene ruler DNA ladder mix Thermo Scientific, Waltham, MA 
Guanosine-triphosphate (GTP) Sigma-Aldrich, St Louis, MO 
FuGene 6 DNA Transfection reagent Basel, Switzerland 
H-Leu-Leu-OMe HBr  Bachem, Bubendorf, Switzerland 
Hoechst 33342 (Bisbenzimide) Sigma-Aldrich, St Louis, MO 
Lipopolysaccharide (LPS) Sigma-Aldrich, St Louis, MO 
Lysotracker Red DND-99 Life Technologies, Carlsbad, CA 
µ-Slide I chambers Ibidi, Martisried, Germany 
Mifepristone Sigma-Aldrich, St Louis, MO 
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Mouse Interferon gamma Peprotech, Rocky Hill, NJ 
my-Budget 5x PCR-Master mix Biozym, Oldendorf, Germany 
Page ruler prestained protein ladder Thermo Scientific, Waltham, MA 
Pierce BCA protein assay Thermo Scientific, Waltham, MA 
Pierce ECL western blotting substrate Thermo Scientific, Waltham, MA 
ProLong Gold anti-fade reagent Life Technologies, Carlsbad, CA 
Propidium-Iodide  Life Technologies, Carlsbad, CA 
Rapamycin Sigma-Aldrich, St Louis, MO 
Saponin Sigma-Aldrich, St Louis, MO 
Super RX films Fujifilm, Tokyo, Japan 
X-treme GENE 9 DNA Transfection reagent Roche, Basel, Switzerland 
 
2.1.3. Antibodies 
Primary 
antibodies 
Antigen 
recognized 
Type Dilution Source 
165/3 Recombinant 
mouse Irga6 
rabbit polyclonal   IF 1:8000 (Uthaiah et al., 2003) 
(Martens et al., 2004) 
10E7 Recombinant 
mouse Irga6 
Mouse 
monoclonal  
IF 1:1000 (Zerrahn et al., 2002) 
(Martens et al., 2004) 
(Papic et al., 2008) 
10D7 Recombinant 
mouse Irga6 
Mouse 
monoclonal  
IF 1:1000 (Zerrahn et al., 2002) 
(Martens et al., 2004) 
(Papic et al., 2008) 
141/3 Mouse Irgb6 rabbit polyclonal  IF 1:5000 (Khaminets et al., 2010) 
81/3 Mouse Irgd rabbit polyclonal  IF 1:8000 AG Howard collection 
1D4B LAMP1  Rat monoclonal  IF 1:1000 1.Developmental 
Studies Hybridoma 
Bank, University of Iowa 
2.AbCam ab25245 
GM130 GM130  Mouse 
monoclonal  
IF 1:1000 BD Bioscience, 
Heidelberg, Germany 
L7543 LC3B Rabit polyclonal WB 
1:5000 
Sigma-Aldrich 
A2228 Β-Actin Mouse WB Sigma-Aldrich 
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monoclonal 1:5000 
AF965 Cathepsin B Goat polyclonal IF 1:1000 R&D systems 
FK2 Ubiquitin 
conjugates 
Mouse 
monoclonal 
WB 
1:1000 
Biotrend 
 
 
Secondary antibodies Dilution Source 
Alexa Fluor 488/555/647: 
 donkey anti-mouse,  
 donkey anti-rabbit,  
 donkey anti-rat 
 donkey anti-goat 
 IF 1:1000 Life Technologies, Carlsbad, CA 
HRP-conjugated:  
 goat anti-mouse  
 donkey anti-rabbit 
 goat anti-mouse 
 
WB 1:5000 
 
 
Sigma-Aldrich, St Louis, MO 
Sigma-Aldrich, St Louis, MO 
Pierce, Rockford, IL 
 
2.1.4. Buffers and media 
Buffer Recipe 
Phosphate buffer saline (PBS) 137 mM NaCl,  
2.7 mM KCl,  
10 mM Na2HPO4,  
1.8 mM KH2PO4 in H2O  
pH 7.4  
RIPA buffer 25 mM Tris pH 8  
150 mM NaCl 
0.1% sodium dodecyl sulfate  
0.5% sodium deoxycholat  
1% Nonidet P-40 
10% Glycerol  
2 mM EDTA  
Modified RIPA buffer 150 mM sodium chloride 
1.0%  SDS 
0.5% sodium deoxycholate 
0.1% Triton X 
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50 mM Tris, 
 pH 7.4 
IF fixation buffer 3% Paraformaldehyde (PFA) (w/v) in PBS 
IF washing buffer 0.1% Saponin (w/v) in PBS 
IF blocking buffer 3% bovine serum albumin (BSA) (w/v)  
0.1% Saponin (w/v) in PBS  
NP-40 cell lysis buffer 0,1% NP-40 (w/v) in PBS 
Laemmli buffer 
(10x SDS sample loading buffer) 
0.5 M Tris-HCl, pH 6.8 
50% Glycerol (v/v) 
10% SDS (w/v) 
0.025% Bromphenol blue (w/v) 
7% β-Mercaptoethanol (v/v)-right before use 
SDS running buffer 250 mM Tris  
1.92 M glycine  
34.67 mM SDS  
WB transfer buffer 250 mM Tris  
1.92 M glycine  
WB washing buffer 0,1% Tween 20 (w/v) in PBS 
WB blocking buffer 5% milk powder (w/v)  
0,1% Tween 20 (w/v)  
in PBS 
Triton X lysis buffer 0,1 % Triton X (w/v) in PBS 
TBST 50 mM Tris  
150 mM NaCl  
0.05% Tween 20  
pH 7.6 
Detection solution 1 88.5 ml H2O 
10 ml 1M Tris-HCl, pH 8.5 
1 ml 250 mM Luminol (3-Aminophthalhydrazide) in 
DMSO  
0.44 ml 90 mM p-Coumaric acid in DMSO 
Detection solution 2 90 ml H2O 
10 ml 1 M Tris-HCl pH 8.5 
60 µl 30% H2O 
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Cell culture reagents Recipe 
Medium for: 
 Mouse embryonic fibroblasts 
(MEFs)  
 A31 3T3 fibroblasts  
 GS 3T3 fibroblasts 
 Diaphragm-derived cells  
 RAW309 macrophages 
 Dulbecco’s modified Eagle’s medium (DMEM) 
high glucose   (2010-2012: PAA, Pasching, 
Austria; 2013-2014 Life Technologies) 
 10% fetal calf serum (FCS),( 2010-2012: 
PAA, 2013-2014 Biochrom, Berlin, Germany) 
 2 mM L-glutamine (PAA),  
 1 mM sodium pyruvate (PAA,  Life 
Technologies), 
 1x MEM non-essential amino acids (PAA, Life 
Technologies),  
 100 U/ml penicillin and 100 µg/ml 
streptomycin (PAA,  Life Technologies), 
 For GS 3T3 fibroblasts also: 50μg/ml 
Hygromycin and 200 μg/ml Zeocin (Life Tech) 
Bone-marrow derived macrophages 
(BMDMs) medium 
 Roswell Park Memorial Institute 
medium(RPMI) (2010-2012: PAA, Pasching, 
Austria; 2013-2014 Life Technologies) 
 25% fetal calf serum (FCS), 2010-2012: PAA, 
2013-2014 Biochrom, Berlin, Germany) 
 10% L929 P2 cell-conditioned medium 
 2 mM L-glutamine (PAA),  
 1 mM sodium pyruvate (PAA,  Life 
Technologies), 
 1x MEM non-essential amino acids (PAA, Life 
Technologies),  
 100 U/ml penicillin and 100 µg/ml 
streptomycin (PAA,  Life Technologies) 
Medium for cell freezing  
(Freeze mix) 
 10% Dimethyl-sulfoxide (DMSO) (v/v) 
 90% FCS 
Trypsin  5% Trypsin (1:250) (w/v) (Life technologies) 
 17 mM EDTA  
 145 mM NaCl  
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2.1.5. Constructs 
The following expression constructs were used:  
Construct Source 
pGW1H-Irgm1 (Martens et al., 2004) 
pGW1H-Irgm2 (Martens et al., 2004) 
pGW1H-Irgm3 (Martens et al., 2004) 
pmCherry-N3 (Zhao et al., 2010) 
pEGFP-Irga6-ctag1 (Zhao et al., 2010) 
pEYFP-Calreticulin Kindly provided by Astrid Schauss, CECAD 
Imaging Facility 
pEGFP-LC3 Howard lab collection, Yang Zhao 
 
2.1.6. Mice 
All mice were bred at the Institute for Genetics, University of Cologne (Cologne, 
Germany). The mice were kept on a 12/12 h light/dark cycle. Pelleted food (Altromin, Lage, 
Germany) and water were available ad libitum. A maximum of four animals were caged 
together.  
Irgm1 KO mice were generated as previously described (Collazo et al., 2001) and 
kindly donated by Dr. Gregory Taylor (Duke University, Durham, NC). Irga6 KO mice were 
generated as previously described (Liesenfeld et al., 2011) and bred at the Institute for 
Genetics.  
Irgm1-/-/Irga6-/- mice were generated by crossing Irgm1-/-/Irga6+/+ mice with 
Irgm1+/+/Irga6-/- to form heterozygous Irgm1+/-/Irga6+/- offspring. The heterozygous Irgm1+/-
/Irga6+/- mice were intercrossed and their offspring was weighted and genotyped 3 weeks 
after birth. 4-8 weeks old Irgm1-/-/Irga6-/-, Irgm1+/+/Irga6-/-, Irgm1-/-/Irga6+/+ and Irgm1+/+/Irga6+/+ 
mice were used for infection experiments with Listeria monocytogenes. 
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2.1.7. Cells 
Mouse embryonic fibroblasts (MEFs) 
MEFs were prepared from C57BL/6 mice at day 14 post coitum and propagated in 
supplemented DMEM medium maximal 15 passages. 
Immortalized MEFs 
Irgm1-/-, Irgm3-/-, Irgm1/Irgm3-/- (kindly provided by Dr Gregory Taylor) and WT MEFs 
or were immortalised by the simian virus 40 large T antigen, which alters the effect of the 
tumour suppressor proteins pRb and p53. Because the knock-out cells were already 
neomycin resistant an additional plasmid carrying a puromycin resistance gene was 
transfected. Therefore, 5 µg pSV3-neo plasmid and 0.5 µg pPur were mixed and co-
transfected. After 24 h, cells were put under selection with 3 µg/ml puromycin (Springer-
Frauenhoff, 2014). 
A31 3T3 cells 
 A31 3T3 BALB/C mouse fibroblasts were purchased from ATCC (stored in Howard 
lab collection) and propagated in supplemented DMEM medium.  
Gene Switch (GS) 3T3 fibroblasts 
Gene switch (GS) 3T3 cells contain hormone-inducible mamilian expression system 
that induces Irga6 production upon Mifepristone induction (Hunn, 2008). These cells were 
cultured in previously described medium with addition of 200 µg/ml Zeocin (Invivogen, San 
Diego, CA) and 50 µg/ml Hygromycin (Invivogen). Irga6 expression was induced with 1 nM 
Mifepristone (Life Technologies). 
Bone marrow derived macrophages (BMDMs) 
Primary bone marrow derived macrophages (BMDM) were isolated from tibia and 
femurs of 4- to 5-weeks old C57BL/6 mice and Irgm1 KO mice as previously described 
(Henry et al., 2007) and differentiated in 10 cm cell culture dishes in previously described 
medium for 7 days, with regular medium exchange. Differentiated cells were frozen.  
Diaphragm –derived cells (DDCs) 
Diaphragm-derived cells (DDCs) were prepared from diaphragm tissue (Antony et al., 
1989). Shortly, the diaphragm was removed under sterile conditions, washed thoroughly with 
PBS, homogenized, incubated with collagenase/dispase (1 mg/ml, Roche, Mannheim, 
Germany) for 1 h at 37°C and then centrifuged for 15 sec at 100 ×g. The supernatant was 
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collected, centrifuged for 5 min at 500 ×g and the pellet plated in DMEM. The remaining cell 
debris after collagenase/dispase-incubation were further incubated in 1× trypsin for 1 h at 
37°C, and then centrifuged for 15 sec at 100 ×g. The supernatant was collected, centrifuged 
for 5 min at 500 ×g and the pellet was plated. DDCs were grown until they had reached 
about 80 percent confluence and were then immortalized by transfection with 1 μg of psv3-
neo plasmid. Cells were grown and passaged for 5 weeks until immortalised clones had 
overgrown the culture.  
RAW309 macrophages 
RAW309 macrophages were purchased from ATCC and propagated in previously 
described medium. 
 
2.1.8. Software  
The images from Zeiss microscopes were processed with Axiovision 7.4. software. 
The images from spinning disc microscope were processed with Volocity 6.3 software (Zeiss, 
Jena, Germany). Cell death assay images were quantified with Volocity 6.3 software 
(PerkinElmer, Waltham, MA) using nuclei recognition selection filter.  
The intensities of the antibody-stained bands after SDS-PAGE/Western-Blot analysis 
were quantified with Quantity One software (Biorad, Hercules, CA). 
 
2.2. Methods 
2.2.1. Freezing and thawing the of the mammalian cells 
Mammalian cells were harvested by trypsinization (except for BMDMs), pelleted by 
spinning at 400 g for 5 min, and resuspended (4*106 cells/ml) in ice-cold sterile FCS with 
10% DMSO (v/v) and frozen at -80°C. Frozen cells were stored in liquid nitrogen for long-
term storage. BMDMs and RAW309 macrophages were not trypsinized, but detached by 5 
minute incubation on ice, and pelleted at 300g for 5 minutes. 
Cells were thawed at 37°C, immediately transferred into 10 ml of medium, pelleted 
and plated in fresh medium in a T75 flask.  
 
 39 
 
2. MATERIALS AND METHODS 
RODUCTION 
2.2.2. Passaging and seeding of the cells 
For passaging, cells were first washed once with sterile PBS and then detached by 2 
minute incubation with 5 ml trypsin solution at 37°C. After addition of 5 ml medium, cells were 
pelleted by centrifugation, resuspended in fresh medium and plated. 
Following amounts of cells were used for the following experiments: 
 Immunofluorescence microscopy on fixed cells: 150 000 Immortalized MEFs, 
A31 cells or GS 3T3 cells; 500 000 BMDMs per well of the 6 well plate 
 Live cell fluorescence microscopy: 60000 immortalized MEFs in µ-Slide I 
chambers  
 Cell death assay: 300 000 immortalized MEFs or 400 000 BMDMs in 6 cm cell 
culture dish.  
 LC3 turnover WB analysis: 300 000 immortalized MEFs per well of the 6 well 
plate 
 Filter trap assay and ultracenrifugation aggregate solubility assay: 300 000 GS 
3T3 cells per well of the 6 well plate 
 
2.2.3. Transfection  
Transient transfection of cells was conducted with 1:3 mixture of DNA (1-2 μg) and 
transfection reagents FuGene 6 or X-tremeGene 9. The DNA was mixed with 100μl of the 
serum-free DMEM or RPMI medium and transfection reagent was carefully added into the 
solution. After 15 minutes of incubation, mixture was spread over the cells in 6 well cell 
culture plates in a dropwise manner. Samples were analysed 24 h later.  
For the live cell imaging experiments, the 100μl transfection mixture containing 
maximum 0,5μg of DNA was added into the cell-filled channel of the of µ-Slide I chambers. 
The reservoirs of the chamber were also supplied with FCS-free medium. The total medium 
was replaced with FCS-containing medium 8 hours post transfection. 
 
2.2.4. Indirect immunofluorescence microscopy 
For immunocytochemistry, cells were grown on previously flamed cover slips in 6-well 
plates. After treatments, cells were carefully rinsed once with PBS to remove the medium, 
fixed in 3% paraformaldehyde for 10 minutes at the room temperature and then triple washed 
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with PBS. The cells were permeabilized with washing buffer for 15 minutes and treated with 
blocking buffer for 1 hour at the room temperature. Staining with primary or secondary 
antibodies, which were diluted in blocking buffer, was performed at the room temperature in 
the wet chamber for 1 hour or 30 minutes respectively. Between the staining steps cells were 
triple washed for 5 minutes per wash with IF washing buffer (0.1% saponin in PBS). Washed 
cover slips with stained samples were mounted on glass microscopic slides in ProLong Gold 
anti-fade reagent.  
The images were taken with an Axioplan II fluorescence microscope and AxioCam 
MRm camera at 630x magnification and processed by Axiovision 4.7 software. Alternatively, 
confocal images were taken with UltraVIEW VoX spinning disc (CSU-X1; Yokogawa 
Corporation of America) confocal microscope (Nikon, Tokyo, Japan) with EMCCD C9100-50 
CamLink camera at 630x magnification. Confocal images were processed with Volocity 6.3 
software (Perkin Elmer, Waltham, MA). 
 
2.2.5. Blind co-localization analysis 
Blind analysis of the samples was applied in all experiments in which it was possible. 
To analyze the co-localization of GKS proteins with endocellular membranes, prepared and 
labelled microscopic slides were blinded with tape before imaging. After imaging, the pictures 
of the samples were screened and the appropriate minimal size of the GKS-structure, which 
should be counted, was determined. GKS structures bigger than the given size were 
manually counted and for every structure was manually estimated whether it co-localizes 
with the marker of interest, for example with LAMP1 structures. The identity of the samples 
was revealed only upon full quantification and plotting of the data. 
 
2.2.6. Live cell imaging 
Live cell imaging was performed in µ-Slide I chambers (Ibidi, Martinsried, Germany). 
60 000 cells were seeded in each chamber. After 24 hours, cells were transfected with 0,5 µg 
DNA and 1,5 µl X-tremeGENE 9 transfection reagent as previously described and incubated 
for 24 hours. Directly before imaging, medium was exchanged with fresh phenol red free 
medium containing 50mM of Lysotracker Red.  Imaging was performed by Axiovert 200 M 
microscope with AxioCam MRM camera (Zeiss) at 630x magnification, which was fitted with 
a wrap-around temperature-controlled chamber at 37°C. The images were processed with 
Axiovision 4.7. software. 
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2.2.7. Cell death assay 
200 000 of immortalized MEFs or 300 000 BMDM cells were seeded on 6 cm cell 
culture dish in 2 ml of medium. Samples were induced with 200 U/ml IFNγ, 10 mM 
LeuLeuOMe, 500 ng/ml Lipopolysaccharide or left un-treated for 24, 48 or 72 hours. Before 
analysis, 500 µl of medium containing 2,5 µg/ml of Propidium Iodide and  2,5 µg/ml Hoechst 
33342 dye was added directly the cells without removal old medium and incubated for 15 
minutes at 37°C.   
10 images of each sample, each containing 500-1000 cells, were taken with the 
fluorescent Axiovert 200 microscope at 100x magnification. Number of Hoechst positive 
nuclei (blue) and PI positive (red) punctae was quantified with Volocity 6.3 software. 
 
2.2.8. SDS-PAGE/ Western Blot analysis  
Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) was used 
to separate proteins of cell lysates. A discontinuous gel-system concentrates polypeptides on 
the intersection of two gel phases before they get separated according to their molecular 
weight in the resolving gel. Upper ¼ of the gel consists of the stacking gel, with has 4% of 
acrylamid and pH 6.8 and bottom ¾ of the gel consists of the separating gel, which has 10% 
acrylamid and pH 8.8. Gels were casted in between two glass plates, which are separated by 
plastic spacers. Equal amounts of the protein samples and PageRuler™ Prestained Protein 
Ladder were loaded onto gels. The SDS-PAGE was run in electrophoresis buffer at a current 
20 mA for several hours.  
For immunodetection the separated proteins were transferred from the 
polyacrylamide gel onto nitrocellulose membrane by wet Western Blotting. Therefore, the gel 
was carefully placed on top of the membrane, sandwiched between eight sheets of Whatman 
paper and two electrodes and placed in a blotting chamber. The chamber was filled with 1x 
Electrophoresis Transfer buffer and 0.5 Volts were applied, so that the negatively charged 
proteins were migrating towards the anode onto the membrane. After 1 h at RT the 
successful transfer was confirmed by unselective staining of proteins on the membrane with 
Ponceau S solution. 
First the unspecific binding sites on the membrane were blocked with 5% milk powder 
in WB washing buffer for about 1h at room temperature. The primary antibody was diluted in 
1% FCS in PBS an incubated with the membranes over night at 4°C. The next day, the 
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membranes were washed three times with WB washing buffer for 10 min and subsequently 
incubated for 30 minutes with HRP-conjugated secondary reagents diluted in 1% FCS in 
PBS. The membranes were triple washed. Detection buffer 1 and 2 were mixed in a ratio 1:1 
and incubated with the membranes for 60 seconds. Membranes were dried and 
chemiluminescence was visualised by exposure of Super RX films (usually 5s, 30s, 1min to 
5min) and film development. 
 
2.2.9. LC3 turnover monitoring 
100 000 MEFs/well were seeded in 12 well cell culture plate. Samples were induced 
with 200 U/ml IFNγ for 24 hours, with 40 µg/ml Rapamycin or with 200nM Bafilomycin for 2 
hours, or left untreated. Samples were lysed with 80 µl modified RIPA buffer (0,1% NP-40 
and 1% SDS) by 5 minutes of shaking and 5 minutes of 95°C incubation. The amount of 
protein was quantified with BCA assay and 20 µg of samples were subjected to 10% SDS-
PAGE and Western blot analysis. Membranes were blocked in 5% non-fat dry milk in TBST 
buffer and probed for the proteins of interest with anti-LC3B and anti-β-Actin antibody and 
corresponding secondary antibodies. Membranes were triple washed with TBST buffer after 
primary and secondary antibody incubation. For the secondary antibody signal detection, 
membranes were incubated with Pierce ECL solution for 60 seconds.  The intensity of the 
Western Blot LC3 and β-actin bands was quantified with Quantity One software (Biorad, 
Hercules, CA). 
This experiment was performed in co-operation with Dr Susanne Bohlen at the 
Institute for Medical microbiology, immunology and hygiene, University of Cologne. 
 
2.2.10. Filter trap assay and ultracentrifugation solubility analysis 
1 000 000 RAW309 macrophages were seeded at 10 cm bacterial dishes, incubated 
for 24 hours and induced with 500 ng/ml LPS. After 12 hours cells were harvested and lyzed 
with the modified RIPA buffer. The protein content of the lysates was quantified with the 
Braford assay.  
300 000 GS 3T3 Irga6 cells were seeded in each well of 6 well cell culture plate, 
incubated for 24 hours and treated with 1nM Mifepristone or 200 U/ml IFNγ prior for 24 
hours. When stated, FCS-free medium containing 300μM AlCl3, 10μM NaF and/or 0,5 mM 
GTP was added to the cells prior to the lysis.  Cells were harvested, counted and lyzed in 
0,5% Thesit in PBS,  with AlCl3, NaF or GTP added when stated.  
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For filter trap assay the nitrocellulose membrane was placed in the dot blotter and 
incubated with the WB washing buffer for 15 minutes. 50 µg cell lysate for RAW309 
macrophages or labeled number of GS 3T3 cells was applied to each dot on the 
nitrocellulose membrane and filtered through the membrane. The filtration was followed by 
two washing steps with WB washing buffer. Membranes were treated similarly as in Western 
Blot analysis: blocked with WB blocking buffer, probed with particular antibodies, washed 
with WB washing buffer and detected with the detection solution. These experiments were 
preformed in collaboration with Dr Nadja Kettern at the Institute for Cell Biology, University of 
Bonn.  
For the solubility ultracentrifugation analysis, the lysates of 30 000 GS 3T3 Irga6 cells 
were ultracentrifuged at 13000 rpm, pellet and supernatant were separated and analyzed 
with SDS-PAGE/Western Blot, as described in chapter 2.2.7.  
 
2.2.11. Mouse genotyping 
For mouse genotyping, tail samples were taken with flamed scalpel from 
anesthesized mice. DNA was extracted from mouse tail tip with 100μl 50mM NaOH at 95°C 
for 30 minutes. The samples were neutralized with 30μl 1M TRIS buffer of pH7.  
The PCR mixture contained: 5μl of my-Budget 5x PCR-Master mix, 0,5μl of each 
primer, 17,5μl of water and 1μl of the isolated DNA. The following primers were used for 
Irgm1 and Irga6 genotyping:  
Primer name 5’-3’ sequence Application 
LRG1 GGAGAAAGTGAAGTACCC Irgm1 genotyping 
LRG3 CTCTGACACCGAGAGAAT Irgm1 genotyping 
NeoPr1 CATTTGTCACGTCCTGCA Irgm1 genotyping 
5 DEL (810) TTGTTATTCAGGGAAGCTAAG Irga6 genotyping 
3 DEL (811) TGTCTGGTGAATCTCATTAGC Irga6 genotyping 
5EX2 (812) CTCAGGTTATCTAACATTCTG Irga6 genotyping 
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PCR analysis was performed as stated in the table: 
Irgm1 typing 
95°C    5 min 
95°C    30 sec  | 
51°C    30 sec  | 
72°C    30 sec  | 
72°C    5 min 
4°C       ~   
| 34 cycles 
Irga6 typing 
94°C    2 min 
94°C    30 sec  | 
58°C    30 sec  | 
72°C    45 sec  | 
72°C    10 min 
4°C       ~   
| 35 cycles 
 
The amplified fragments were separated at 2% Agarose gel. The 400 bp band (for 
Irgm1) and 450 bp band (for Irga6) represent the KO genotype. The 200 bp band represents 
the WT genotype. 
 
2.2.11. Mouse infection with L. monocytogenes 
Listeria monocytogenes were grown overnight in brain-heard infusion (BHI) medium, 
resuspended in fresh BHI medium and harvested during mid-log phase.  
Four to eight week old WT, Irga6-/-, Irgm1-/- and Irgm1-/-/Irga6-/- mice (all offspring of 
Irgm1+/-/Irga6+/- mice) were intraperitoneally infected with 2400 L. monocytogenes, which was 
resuspended in 200μl PBS, and their survival was monitored for two weeks. 
The experiment was performed in cooperation with Dr Michael Schramm at the 
Institute for Medical microbiology, immunology and hygiene, University of Cologne. 
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3. RESULTS 
3.1. Localization of GKS proteins is regulated by GMS proteins 
3.1.1. Irga6 forms aggregates in the absence of GMS proteins 
It has been well established that GMS proteins regulate nucleotide binding and 
aggregation of GKS proteins (Chapter 1.4.4.) (Papic et al., 2008)  (Hunn et al., 2008). After 
IFNγ induction of mouse cells, endogenous GKS and GMS proteins are both expressed and 
immunostaining of these cells reveals that GKS proteins have a smooth, non-aggregated 
pattern (Martens et al., 2004) (Boehm et al., 1997) (Papic et al., 2008). However, 
immunostaining after expression of GKS proteins in the absence of GMS proteins results in 
formation of GKS aggregate-like structures (Martens et al., 2004) (Hunn et al., 2008) (Papic 
et al., 2008). When all three GMS proteins are co-transfected into these cells, the GKS 
proteins reconstitute a smooth non-aggregated pattern and re-gain the ability to load to the 
PVM of T. gondii (Hunn et al., 2008). 
To reproduce recent reports about GMS regulation of GKS proteins, experiments 
analyzing the aggregation of Irga6 in the absence of different GMS proteins were conducted 
(Hunn et al., 2008) (Figure 6). For this purpose, four samples were prepared in parallel. In 
the first sample, A31 3T3 fibroblasts were left untreated and therefore did not express any 
GMS or GKS proteins (Figure 6A). In the second sample, A31 3T3 fibroblasts were induced 
with IFNγ to express the full set of GMS and GKS proteins (Figure 6B). In the third sample, 
cells were transfected with pGW1H-Irga6 to express only the GKS protein Irga6 in the 
absence of all GMS proteins (Figure 6C). In the fourth sample, Irgm1 knock-out (KO) mouse 
embryonic fibroblasts (MEFs) were induced with IFNγ to express all GKS proteins and only 
two GMS proteins: Irgm2 and Irgm3 (Figure 6D). Cells were fixed, immunostained with the 
monoclonal antibody 10E7, which detects Irga6, and immunofluorescence microscopy 
images were taken. 
In accordance with previous reports (Martens et al., 2004) (Hunn et al., 2008), 
immunofluorescence analysis of these samples revealed that Irga6 was not expressed in 
non-treated cells (Figure 6A), but showed smooth cytosolic/ER localization in IFNγ-induced 
A31 3T3 fibroblasts (Figure 6B). In the absence of GMS proteins, transfected Irga6 formed 
aggregate-like structures in A31 3T3 cells (Figure 6C). Irga6 also formed aggregate-like 
structures in IFNγ-induced Irgm1 KO MEFs (Figure 6D), but of different appearance from 
those in Figure 6C, where all GMS proteins were absent. The transfected Irga6 in A31 3T3 
cells, where all three GMS proteins are absent, formed fiber-like structures. However, in 
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IFNγ-induced Irgm1 KO MEFs Irga6 aggregate-like structures had a ring-like shape. Clearly, 
Irga6 aggregates have different localizations depending on the presence of some or no GMS 
proteins. 
 
 
 
 
 
 
 
 
 
 
 
Figure 6. Irga6 forms aggregates in the absence of GMS proteins A31 3T3 fibroblasts were A) 
left untreated, B) induced with 200 U/ml IFNγ for 24 hours, C) transfected with pGW1H-Irga6, D) 
Irgm1 KO MEFs were induced with 200 U/ml IFNγ for 24 hours. Cells were fixed and stained with an 
antibody against Irga6 (10E7).  Representative images of Irga6 staining and Phase contrast (PhaCo) 
are shown. 
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3.1.2. Irga6 localizes to lysosomes in the absence of Irgm1 
It has been reported that certain GMS proteins localize to certain endomembranes 
(Chapter 1.4.3.) and keep the GKS proteins in a GDP-bound inactive state (Hunn et al., 
2008). Therefore, it has been proposed that particular GMS proteins protect particular 
endomembranes from the GKS protein accumulation and off-target activation and that in the 
absence of these GMS proteins, GKS proteins can accumulate at these membranes (Hunn 
and Howard, 2010).  
Up to now, Irgm1 is the only GMS protein reported to localize to the lysosomes (Zhao 
et al., 2010). Thus, in this study we examined the possibility that in the absence of Irgm1, 
GKS proteins could accumulate at the lysosomes in IFNγ-induced Irgm1 KO cells. Similarly, 
the absence of Irgm3 should give a different result with activated Irga6 expected at 
Endoplasmic reticulum (ER) membranes and not at lysosomes. 
a) Endogenous Irga6 co-localizes with lysosomes specifically in Irgm1 KO MEFs  
To test whether Irga6 localizes to the lysosomes in the absence of Irgm1, 
immortalized wild-type (WT) MEFs, Irgm1 KO MEFs, Irgm3 KO MEFs and Irgm1/Irgm3 KO 
MEFs were induced with IFNγ for 24 hours, immunostained for Irga6 (165/3 antiserum) and 
Lysosomal-Associated Membrane Protein 1 (LAMP1) (1D4B antibody) as late 
endosome/lysosome marker and subsequently analyzed by immunofluorescence microscopy 
(Figure 7A). Co-localization of Irga6 ring-like structures with LAMP1 was quantified by blind 
manual counting (materials and methods, chapter 2.2.5.) (Figure 7B).  
In Irgm1 KO cells, Irga6 formed clear ring-like structures of which over 95 percent co-
localized with LAMP1. In contrast, in Irgm3 KO cells less than 3 percent of Irga6 aggregate-
like structures co-localized with LAMP1. In Irgm1/Irgm3 double KO cells Irga6 structures did 
not co-localize with lysosomes, even though their surfaces are probably GMS-free. 
Lysosomes in IFNγ-induced Irgm1 KO cells appeared to be enlarged. The ring-like 
appearance of Irga6 at the lysosomes resembled the GKS protein rings that localize to the 
PVM of T. gondii. Hence, it might be that Irga6 ring-like structures do not represent 
conventional aggregates of non-functional missfolded proteins, but rather active GKS 
proteins that could be similar to GKS proteins at the PVM. 
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Figure 7. Irga6 co-localizes with LAMP1 in Irgm1 KO MEFs A) WT, Irgm1 KO, Irgm3 KO and 
Irgm1/Irgm3 KO MEFs were induced with 200 U/ml IFNγ for 24 hours. Cells were fixed and stained 
with immunoreagents against Irga6 (165/3) and LAMP1. Representative microscopic images of Irga6 
and LAMP1 are shown. Arrows point at the Irga6 structures that are magnified at the end of each panel 
(zoom in the following order: upper left: Irga6, upper right: LAMP1, lower left: overlay, lower right: 
phase contrast). Scale bars represent 10 μM. B) Quantification of 7A, showing percent of Irga6 
structures that co-localize with LAMP1. 100 cells per sample were counted and the means of three 
independent experiments +/- standard deviation are given. 
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To test whether Irga6 accumulations at the lysosomes are also in the GTP-bound 
state, similarly to previously described aggregates of transfected Irga6 (Martens et al., 2004) 
(Papic et al., 2008) and GKS accumulations on T. gondii PVM (Papic et al., 2008), IFNγ-
induced Irgm1 KO MEFs were stained for LAMP1 and with the 10D7 antibody, which 
exclusively detects the GTP-bound form of Irga6. The results of this experiment indicate that 
Irga6 accumulations at the lysosomes are indeed in the GTP-bound form (Figure S1). To 
exclude cross-reactivity during secondary staining of 10D7, which is a mouse antibody, and 
of 1D4B, which is a rat antibody, the control staining with each of the primary and secondary 
antibodies being omitted was performed (Figure S2).  
b) Transfected EGFP-Irga6 co-localizes with lysosomes in Irgm1 KO MEFs 
Further, it was investigated whether transiently transfected EGFP-tagged Irga6 also 
accumulates to LAMP1 structures in the same manner as endogenous Irga6. Therefore, 
Irgm1 KO MEFs were induced with IFNγ and simultaneously transfected with pEGFP-Irga6-
ctag1 construct. Cells were fixed, stained for LAMP1 and analyzed by immunofluorescence 
microscopy.  
Indeed, EGFP-Irga6 formed ring-shaped structures that co-localized with LAMP1 in 
the same manner as endogenous Irga6 (Figure 8). Therefore, transfected EGFP-Irga6 is also 
suitable for co-localization analysis when using endogenous Irga6 is not possible.  
 
 
 
c) Irga6 co-localizes with lysosomes in Irgm2 and Irgm3-transfected cells 
It was reported earlier that co-transfection of all three GMS proteins is necessary to 
reconstitute smooth non-aggregated structure of the tramsfected GKS proteins (Hunn et al., 
2008) (Chapter 1.4.4). To understand better how different GMS proteins affect GKS 
aggregation and accumulation at different sub-cellular compartments, combinations of 
different GMS constructs were transfected into cells that contained only Irga6.   
Figure 8. Transiently transfected EGFP-Irga6 co-localizes with LAMP1 in Irgm1 KO MEFs Irgm1 
KO MEFs were induced with 200 U/ml IFNγ for 24 hours and simultaneously transiently transfected 
with pEGFP-Irga6-ctag. Cells were fixed and immunostained for LAMP1. Representative microscopic 
images of Irga6 and LAMP1 are shown. Arrows point at the Irga6 structures which are magnified at 
the end of each panel (zoom in the following order: upper left: Irga6, upper right: LAMP1, lower left: 
overlay, lower right: phase contrast).Scale bars represent 10 μM. 
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To validate this approach, cells were initially co-transfected with different 
combinations of GMS constructs and stained with Irgm1, Irgm2 and Irgm3 antibodies, 
showing that all GMS proteins from a transfection mixture were expressed in the same cell 
(data not shown). To avoid staining for every individual GMS protein in the final experiment, 
cytosolic pmCherry was co-transfected with GMS constructs to identify transfected cells 
(data not shown).  
To test the localization of Irga6 in the presence of combinations of different GMS 
proteins, Gene Switch (GS) 3T3 cells, that stably express Irga6 under control of Mifepristone 
(MIF), were treated with MIF and transiently transfected with combinations of pGW1H-Irgm1, 
pGW1H-Irgm2, pGW1H-Irgm3 and mCherry. These cells were not treated with IFNγ, and 
thus did not express endogenous IRG proteins, but only Irga6 and transfected GMS proteins 
(Figure 9A). The cells were co-stained for Irga6 and LAMP1 and due to the round shape of 
the GS 3T3 Igra6 cells after induction and multiple transfections, analyzed by confocal 
microscope, which yielded slightly different look of lysosomes and Irga6 structures in 
comparison to other experiments.  The co-localization of Irga6 structures and LAMP1 was 
quantified in mCherry positive cells, which are presumably GMS-transfected (Figure 9B). 
When Irgm1 was transfected into the MIF-induced GS 3T3 Irga6 cells, less than 10 
percent of the Irga6 structures co-localized with the lysosomes, which is in accordance with 
the hypothesis that Irgm1 protects the lysosomes from GKS protein accumulation. Similarly, 
in Irgm1 and Irgm2 or Irgm1 and Irgm3 co-transfected MIF-induced GS 3T3 Irga6 cells, less 
than 20 percent of Irga6 co-localized with LAMP1, which also corresponds to the hypothesis 
that Irgm1 might protect the lysosomes from GKS accumulation. 
Opposingly, when Irgm2 and Irgm3 were co-transfected into these cells, more than 70 
percent of Irga6 structures co-localized with the lysosomes, which corresponds to the GKS 
co-localization with the lysosomes in Irgm1 KO cells. When Irgm3 alone was transfected into 
these cells, about 35 to 40 percent of the Irga6 structures co-localized with LAMP1, 
indicating that the Irga6 could be distributed between the lysosomes and the other structures 
which are not GMS coated, like for example Golgi. 
However, further results of this experiment indicate that simplistic model, by which 
GKS proteins would localize to any membrane that is not GMS-protected, is probably not 
correct. Firstly, in non-transfected, MIF-induced GS 3T3 Irga6 cells, in which all endocellular 
membranes are GMS free, less than 10 percent of Irga6 co-localized with LAMP1. Secondly, 
in Irgm2 transfected MIF-induced GS 3T3 Irga6 cells, in which Golgi should be protected 
from GKS accumulation and other membranes should be GMS-free, less than 20 percent of 
Irga6 co-localized with LAMP1. 
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d) Irga6 also co-localizes with lysosomes in Irgm1 KO DDCs and BMDMs 
Figure 9. Irga6 co-localization with LAMP1 in cells transiently transfected with GMS protein A) 
Gene Switch (GS) 3T3 cells stably transfected with inducible Irga6 were stimulated with Mifepristone 
and simultaneously transiently transfected with pGW1H-Irgm1, pGW1H-Irgm2 and pGW1H-Irgm3 and 
pmCherry for 24 hours. Cells were fixed and stained with anti-Irga6 antiserum 165/3 and with anti-
LAMP1 antibody. Pictures were taken with a confocal microscope. Representative microscopic images 
of Irga6 and LAMP1 are shown. Arrows point at the Irga6 structures which are magnified below each 
panel. B) Quantification of 9A, showing percent of Irga6 structures that co-localize with LAMP1. 50 cells 
per sample were quantified nd counts of tw  independent experiments are shown. C) Quantification of 
9A, showing percent of cells with aggregated, semi-aggregated and non-aggregated Irga6 structures. 
100 cells per sample were quantified. 
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    Previously, it has been shown that the co-transfection of all three GMS proteins is able 
reconstruct the smooth non-aggregated Irga6 pattern in MEF-induced GS 3T3 Irga6 cells 
(Hunn, 2008). The transfection of single GMS proteins also reconstructed the smooth Irga6 
pattern in 20-50 percent of these cells (Hunn, 2008). To reproduce and better understand 
these results, the percentage of GMS-transfected MIF-induced GS 3T3 cells with 
aggregated, semi-aggregated and non-aggregated Irga6 was blind counted (Figure 9C). As 
previously shown, almost 100 percent of IFNγ-induced cells had a smooth Irga6 pattern and, 
in contrast, over 80 percent of MIF-induced cells, which were not GMS-transfected, had Irga6 
aggregates (Hunn, 2008).  In the cells that were transfected with only one of the GMS 
proteins, 65 to 90 percent of them revealed aggregates. When these cells were transfected 
with two GMS proteins, 40 to 60 percent of them showed aggregates. However, when all 
three GMS proteins were co-transfected in GS 3T3 Irga6 cells, 70 percent of the cells 
reconstructed relatively smooth pattern of Irga6. 
 
d) Irga6 also co-localizes with lysosomes in Irgm1 KO DDCs and BMDMs 
To test whether co-localization of Irga6 with lysosomes is characteristic only for IFNγ-
induced Irgm1 KO mouse embryonic fibroblasts (MEFs) or also for other cell types, Irgm1 KO 
Diaphragm-Derived Cells (DDCs) and Bone Marrow Derived Macrophages (BMDMs) were 
subjected to analysis. 
DDCs were prepared from the diaphragm tissue of Irgm1 KO mouse, induced with 
200 U/ml IFNγ for 24 hours, fixed and stained with the immunoreagents against Irga6 (165/3) 
and LAMP1. Immunofluorescence microscopy images of stained cells were taken and co-
localization of Irga6 structures with LAMP1 was analyzed (Figure 10A). As in Irgm1 KO 
MEFs, almost all Irga6 aggregate-like structures were observed to co-localize with LAMP1. 
BMDMs were derived from the bone marrow of Irgm1 KO mice and induced with 400 
U/ml of IFNγ for 24 hours. Cells were fixed and stained for Irga6 and LAMP1. Confocal 
microscopy images of BMDMs were taken and co-localization of Irga6 with LAMP1 was 
analyzed (Figure 10B). In Irgm1 KO BMDMs, almost all Irga6 structures co-localized with the 
lysosomes. 
Taken together, Irga6 localizes to the endolysosomal compartment in the absence of 
Irgm1, but not when Irgm2 or Irgm3 are also missing from the GMS pool. The localization of 
Irga6 onto lysosomes in the absence of Irgm1 tested here in four different experimental 
setups suggests that Irgm1 functions as the lysosomal protector, preventing accumulation of 
GKS protein Irga6 on the lysosomes.   
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3.1.3. Irga6 localizes to the endoplasmic reticulum in Irgm3 KO cells 
Irgm3 is so far the only identified GMS protein that localizes to the endoplasmic 
reticulum (ER) (Taylor et al., 1997). Therefore, it was questioned whether in absence of 
Irgm3, Irga6 can accumulate at the ER. Previously, immuno-electron microscopy images had 
shown that transfected Irga6 can associate to the ER membranes in NIH fibroblasts in the 
absence of all GMS proteins and contribute to their enlargement (Kaiser, 2005) (Hunn et al., 
2008). However, the co-localization of Irga6 aggregates and ER was not analyzed in IFNγ-
induced Irgm3 KO cells. 
To examine this, Irgm1 KO, Irgm3 KO and Irgm1/Irgm3 KO MEFs were induced with 
IFNγ and simultaneously transfected with the ER marker pEYFP-Calreticulin. The cells were 
fixed, stained for Irga6 with 10D7 antibody, which specifically recognizes Irga6 in GTP-bound 
form, and microscopic pictures were taken (Figure 11A). The percentage of Irga6 structures 
that co-localize with Calreticulin was quantified (Figure 11B). In Irgm3 KO cells, more than 85 
percent of Irga6 structures apparently co-localized with Calreticulin. In contrast, less than 5 
percent of Irga6 structures co-localized with Calreticulin in Irgm1 KO and Irgm1/Irgm3 KO 
Figure 10. Irga6 co-localizes with LAMP1 in Irgm1 KO DDCs and BMDMs A) Irgm1 KO DDCs were 
induced with 200 U/ml IFNγ for 24 hours. Cells were fixed and stained with immunoreagents against Irga6 
(165/3) and LAMP1. Representative microscopic images of Irga6 and LAMP1 are shown. Arrows point at 
the Irga6 structures, which are magnified at the end of each panel (zoom in the following order: upper left: 
Irga6, upper right: LAMP1, lower left: overlay, lower right: phase contrast). Scale bars represent 10 μM. B) 
Irgm1 KO BMDMs were induced with 400 U/ml IFNγ for 24 hours. Cells were fixed and stained with 
antibodies against Irga6 (10D7) and LAMP1. Representative confocal microscopy images of Irga6 and 
LAMP1 are shown. Arrows point at the Irga6 structures which are magnified at the end of each panel (zoom 
in the following order: upper left: Irga6, upper right: LAMP1, lower left: overlay).  
 
 
 
 
 
 
of each panel (zoom in the following order: upper left: Irga6, upper right: LAMP1, lower left: overlay, lower 
right: phase contrast). Scale bars represent 10 μM. B) Quantification of 6A, showing percent of Irga6 
structures co-localizing with LAMP1. 100 cells per sample were blind counted and the means of three 
independent experiments +/- tandard deviation are shown. 
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MEFs and it even appeared that Irga6 structures excluded the ER network in these cells. 
Taken together, these results suggest that Irgm3 protects ER from the accumulation of Irga6. 
 
 
 
 
Figure 11. Irga6 co-localizes with calreticulin in Irgm3 KO cells A) Irgm1 KO, Irgm3 KO and 
Irgm1/Irgm3 KO MEFs were induced with 200 U/ml IFNγ and transfected with ER marker pEYFP-
Calreticulin for 24 hours. Cells were fixed and immunostained for Irga6 with monoclonal 10D7 
antibody. Representative microscopic images of Irga6 and Calreticulin are shown. Arrows point at the 
Irga6 structures which are magnified at the end of each panel (zoom in the following order: upper left: 
Irga6, upper right: Calreticulin, lower left: overlay, lower right: phase contrast). Scale bars represent 
10 μM. B) Quantification of 11A, that shows percent of Irga6 structures co-localizing with Calreticulin. 
50 cells per sample were quantified and the means of three independent experiments +/- standard 
deviation are shown.  
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3.1.4. Irga6 does not co-localize with the Golgi apparatus in the absence of 
GMS proteins 
Upon IFNγ induction, the Golgi apparatus is coated with two GMS proteins Irgm1 and 
Irgm2 (Martens et al., 2004) (Martens and Howard, 2006). To test whether Irga6 co-localizes 
to the Golgi in the absence of GMS proteins, WT, Irgm1 KO, Irgm3 KO and Irgm1/Irgm3 KO 
MEFs were induced with IFNγ, fixed and stained against Irga6 (165/3) and against the Golgi 
protein GM130. Immunofluorescence microscopy images were taken (Figure 12A) and 
frequency of Irga6 structures that co-localize with GM130 was quantified (Figure 12B). Less 
than 3 percent of the Irga6 aggregate-like structures co-localized with GM130 in all samples 
tested.  
However, in all these cases Irgm2 is expressed, which is accurately localized to the 
Golgi and therefore it was possible that Irgm2 prevents the accumulation of GKS proteins at 
the Golgi. This possibility was tested by the transfection experiment described in chapter 
3.1.2.c. GS 3T3 Irga6 cells were stimulated with MIF and simultaneously transiently 
transfected with combinations of pGW1H-Irgm1, pGW1H-Irgm2, pGW1H-Irgm3 and in each 
case with pmCherry as a transfection marker. The cells were fixed and stained for Irga6 and 
GM130. Co-localization of these two proteins was quantified in mCherry positive cells (Figure 
13, Figure 14). No apparent co-localization of Irga6 and GM130 could be observed in any 
samples. Even in cells transfected with Irgm3 alone, in which Golgi structures should 
presumably not be GMS protected and ER should be GMS coated, Irga6 did not co-localize 
with Golgi. No abnormalities were observed in Golgi structure, at least at the light 
microscopical level, in these cells. 
Taken together, Irga6 aggregate-like structures do not co-localize with Golgi even 
when no Golgi-localising GMS protein is present. Thus, it seems that the Golgi apparatus is 
not endangered by GKS aggregate-like structures and that this result also challenges the 
generality of the “missing self” model. 
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Figure 12. Irga6 does not co-localize with GM130 in GMS KO MEFs A) WT, Irgm1 KO, Irgm3 KO 
and Irgm1/Irgm3 KO MEFs were induced with 200 U/ml IFNγ for 24 hours. Cells were fixed and 
stained against Irga6 (165/3) and against the Golgi protein GM130. Representative microscopic 
images of Irga6 and GM130 are shown. Arrows point at the Irga6 structures which are magnified at 
the end of each panel (zoom in the following order: upper left: Irga6, upper right: GM 130, lower left: 
overlay). Scale bars represent 10μm. B) Quantification of 12A, showing percent of Irga6 structures 
that co-localize with GM130. 100 cells per sample were blind-counted. 
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Figure 13. Irga6 does not co-localize with Golgi in GMS transfected cells. Irga6-inducible Gene 
Switch 3T3 cells were stimulated with Mifepristone and simultaneously transiently transfected with 
pGW1H-Irgm1, pGW1H-Irgm2 and pGW1H-Irgm3 for 24 hours. Cells were fixed and stained with 
antiserum against Irga6 (165/3) and the antibody against the Golgi protein GM130. Representative 
microscopic images of Irga6 and GM130 are shown. Arrows point at the Irga6 structures which are 
magnified at the end of each panel (zoom in the following order: upper left: Irga6, upper right: GM130, 
lower left: overlay, lower right: phase contrast). Scale bars represent 10μm. 
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3.1.5. Irga6 co-localizes with lipid droplets in Irgm1/Irgm3 KO cells 
 A recent publication from the laboratory of Joern Coers (Haldar et al., 2013) also 
approached the “missing self” model from a standpoint similar to our own. In that study they 
showed that GKS proteins, Irgb10 and Irga6, both co-localize to lipid droplets (LDs) in IFNγ-
induced Irgm1/Irgm3 double KO cells. In addition, Irgb10 structures were shown to partially 
co-localize with LDs in Irgm3 KO cells and there was no Irgb10 co-localization with the LDs 
in Irgm1 KO MEFs (Haldar et al., 2013). The co-localization of Irga6 and LDs was never 
investigated in Irgm1 KO and Irgm3 KO MEFs. Since Irgm1 and Irgm3 were shown to 
localize to LDs in WT cells (Bougneres et al., 2009) (Haldar et al., 2013), this compartment 
should be GMS-free in Irgm1/Irgm3 KO cells, and therefore GKS localization to the LDs 
contributes to the idea that these proteins target the membranes by the “missing self” 
principle.  
In the present study it was observed that in IFNγ-induced Irgm1/Irgm3 KO MEFs 
Irga6 structures accumulate at the optically dense structures visible in phase contrast, which, 
in accordance to the data from the Coers lab, probably represent lipid droplets. To partially 
reproduce the data from that publication, Irgm1/Irgm3 KO MEFs, but also Irgm1 KO and 
Irgm3 KO MEFs, were induced with IFNγ and stained for Irga6. Unfortunately, the staining 
with Bodipy lipid dye, which was performed by the protocol described in the publication 
(Haldar et al., 2013) was not successful after multiple attempts and therefore co-localization 
of Irga6 and optically dense lipid droplet-like structures was quantified. In accordance to 
Figure 14. Irga6 does not co-localize with GM130 in GMS transiently transfected cells. 
Quantification of Figure 13, showing percent of Irga6 structures that co-localize with Golgi protein 
GM130  in GMS transfected MIF-induced GS 3T3 Irga6 cells. 50 cells per sample were quantified. 
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Haldar‘s data, 63 percents of Irga6 co-localized with the LD-like structures in Irgm1/Irgm3 KO 
cells, 15 percent did so in Irgm3 KO cells and only 4 percent of Irga6 co-localized with the 
LD-like structures in Irgm1 KO cells (Figure 15). 
 
 
 
 
 
Figure 15. Irga6 co-localizes with lipid droplet-like structures in Irgm1/Irgm3 KO MEFs A) Irgm1 KO, 
Irgm3 KO and Irgm1/Irgm3 KO MEFs were induced with 200 U/ml IFNγ for 24 hours, fixed and stained 
with an antibody against Irga6 (10E7). Representative microscopic images of Irga6 and LD-like structures 
are shown. Arrows point at the Irga6 structures which are magnified at the end of each panel (zoom in the 
following order: upper: Irga6, lower: phase contrast). Scale bars represent 10 μM. B) Quantification of 
15A, showing percent of Irga6 structures co-localizing with LD-like structures. 50 cells per sample were 
quantified. 
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To investigate the localization of Irgb6 structures in GMS KO cells, Irgm1 KO, Irgm3 
KO and Irgm1/Irgm3 KO MEFs were induced with IFNγ and stained for Irgb6. The co-
localization of Irgb6 and optically dense structures was quantified. More than 90 percent of 
Irgb6 co-localized with the LD-like structures in Irgm1/Irgm3 KO MEFs, 19 percent in Irgm1 
KO and 6 percent Irgm3 KO MEFs does so (Figure 16). 
 
 
 
Figure 16. Irgb6 co-localize with lipid droplet-like structures in Irgm1/Irgm3 KO MEFs A) Irgm1 KO, 
Irgm3 KO and Irgm1/Irgm3 KO MEFs were induced with 200 U/ml IFNγ for 24 hours, fixed and 
immunostained for Irgb6 (141/3). Representative microscopic images of Irgb6 and LD-like structures are 
shown. Arrows point at the Irga6 structures which are magnified at the end of each panel (zoom in the 
following order: upper left: Irgb6, upper right: phase contrast, lower left: overlay). Scale bars represent 10 
μM. B) Quantification of 16A, showing percent of Irgb6 structures that co-localize with LD-like structures. 
50 cells per sample were quantified. 
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 Taken together, in addition to previously described co-localization of Irgb10 and Irga6 
with the LDs in IFNγ-induced Irgm1/Irgm3 KO cells (Haldar et al., 2013), in this study it was 
reproduced that Irga6 co-localizes with optically dense LD-like structures and shown that 
Irgb6 also follows the pattern of LD localization in IFNγ-induced Irgm1/Irm3 KO cells. It was 
also first time shown that Irga6 does not co-localize with LD-like structures in Irgm1 KO cells 
and partially co-localize with LD-like structures in Irgm3 KO MEFs. 
 
3.1.6. Other GKS proteins also localize to lysosomes in Irgm1 KO cells  
It was further questioned whether GKS proteins generally accumulate at lysosomes in 
the absence of Irgm1, or whether this co-localization is specific for Irga6.                                                                                                                                                                                                                                                                                                                                                                                                                                                         
To answer this question, WT, Irgm1 KO, Irgm3 KO and Irgm1/Irgm3 KO MEFs were induced 
with IFNγ and stained for different GKS proteins: Irgb6, Irgb10 or Irgd and for LAMP1 (Figure 
17A) (images shown for Irgm1 KO cells). The amount of different GKS structures that co-
localize with LAMP1 was quantified. Indeed, over  90 percent of all tested GKS aggregate-
like structures co-localized with LAMP1 in Irgm1 KO MEFs and almost none did so in Irgm3 
KO and Irgm1/Irgm3 KO MEFs  (Figure 17B, C, D). 
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Figure 17. GKS proteins co-localize with LAMP1 in Irgm1 KO cells A) Irgm1 KO, Irgm3 KO and 
Irgm1/Irgm3 KO MEFs were induced with 200 U/ml IFNγ for 24 hours. Cells were fixed and stained 
with antisera against Irgb6 (141/3), Irgb10 (940/6) or Irgd (81/4) and an antibody against LAMP1. 
Representative microscopic images of GKS and LAMP1 in Irgm1 KO cells are shown. Arrows point 
at the GKS structures which are magnified at the end of each panel (zoom in the following order: 
upper left: GKS, upper right: LAMP1, lower left: overlay, lower right: phase contrast). Scale bars 
represent 10 μM. B) C) D) Quantification of 17A that shows percent of GKS structures that co-
localize with LAMP1. 50 cells per sample were quantified and results of two independent 
experiments are shown. 
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3.1.7. Different GKS proteins load to the same lysosomes in Irgm1 KO cells 
Different GKS proteins load onto the same T. gondii PVMs in a cooperative and 
hierarchical manner (Khaminets et al., 2010). The finding that different GKS proteins 
accumulate to LAMP1 structures in Irgm1 KO cells opened the question of whether these 
different GKS proteins localize to the same lysosomes. Moreover, it was questioned whether 
they also do so in a cooperative and hierarchical manner, like GKS proteins on the PVM of T. 
gondii. To answer these questions, IFNγ-induced Irgm1 KO MEFs were fixed, stained for 
LAMP1 and for several combinations of GKS proteins (Figure 18A). The percentage of GKS 
aggregate-like structures that together or alone co-localize with the lysosomes was quantified 
(Figure 18B).  
Co-staining of Irga6 and Irgb6 revealed that these proteins can be found at the same 
lysosomes. Irga6 was also often observed on lysosomes without Irgb6. However, Irgb6 was 
present at the lysosome almost always together with Irga6 and rarely alone. Similarly, co 
staining of Irgd and Irga6 revealed that Irgd could be also found on the lysosomes together 
with Irga6. Irga6 was also observed on the lysosomes without Irgd. As for Irgb6, Irgd was 
almost never observed on the lysosomes in the absence of Irga6. 
However, co-staining of Irga6 and Irgb10 showed that these proteins can be on the 
lysosomes together or alone. Similarly, co-staining of Irgb6 and Irgd had shown that these 
proteins could be observed on the lysosomes together, or both of them could be detected 
independently.  
The co-staining of Irgb6 and Irgb10 revealed that these proteins can localize to the 
lysosomes together. Irgb10 was also often observed on the lysosome without Irgb6, but Irgb6 
could almost never be found on the lysosome without Irgb10. 
Taken together, Irga6 and Irgb10 represent leading GKS proteins that accumulate at 
the lysosomes in IFNγ-induced Irgm1 KO MEFs. Irgb6 and Irgd were observed only on the 
lysosomes that are already Irga6 and/or Irgb10 coated. It is also important to note that, like 
IRG protein loading on the PVM of T. gondii, some lysosomes are not coated with any of the 
GKS protein couples tested. 
 
 64 
 
3. RESULTS 
RODUCTION 
 
 
 
Figure 18. Different GKS proteins co-localize to the same or different lysosomes in Irgm1 KO cells. 
A) Irgm1 KO MEFs were induced with 200 U/ml IFNγ for 24 hours, fixed and stained for Irga6, Irgb6 and 
LAMP1; Irgd, Irga6 and LAMP1; Irgb6, Irgd and LAMP1; Irga6, Irgb10 and LAMP1; or Irgb6, Irgb10 and 
LAMP1. Representative microscopic images of GKS structures and LAMP1 are shown. Arrows point at the 
GKS structures which are magnified at the end of each panel (zoom in the following order: upper left: first 
GKS protein, upper right: second GKS protein, lower left: LAMP1, lower right: overlay). Scale bar represents 
10μM. B) Quantification of 18A, showing the percent of GKS protein structure co-localization. 50 cells per 
sample were quantified. 
 65 
 
3. RESULTS 
RODUCTION 
3.2. Removal of Irga6 does not affect the Irgm1 KO mouse 
phenotype 
3.2.1. Irgm1/Irga6 double KO mice are susceptible to Listeria monocytogenes 
It has been well established that Irgm1 KO mice succumb to a variety of infections 
that do not affect the survival of Irgm3 KO, Irgm1/Irgm3 KO, Irga6 KO or Irgd KO mice 
(chapter 1.6.1.). As demonstrated in chapter 3.1.2., Irgm1 KO cells are the only IRG KO cells 
in which GKS aggregate-like structures localize to lysosomes. Even though the relationship 
between GKS proteins on the lysosomes in Irgm1 KO cells and the susceptibility of Irgm1 KO 
mice is not fully understood, there is a possibility that susceptibility of these mice is indeed 
caused by the GKS coating of the lysosomes. 
In Irgm1 KO cells, the GKS proteins that accumulate at lysosomes are predominantly 
Irga6 and Irgb10 (chapter 3.1.6.). Other GKS proteins, like Irgb6 and Irgd are found at the 
lysosomes only if Irga6 and/or Irgb10 are also present there, suggesting that loading of Irgb6 
and Irgd requires initial loading of Irga6 and/or Irgb10.  
This raised the question whether in Irgm1/Irga6 double KO mice the absence of Irga6 
would cause reduced loading of other GKS proteins on the lysosomes and possibly reduce 
post-infection lymphopenia and death.  
Irgm1/Irga6 double KO mice were generated by crossing Irgm1 KO mouse and Irga6 
KO mouse. Firstly, Irgm1-/- mice were crossed with Irga6-/- mice to generate Irgm1+/-/Irga6+/- 
mice. Then, heterozygous Irgm1+/-/Irga6+/- mice were crossed with the other Irgm1+/-/Irga6+/- 
mice and their offspring was genotyped and further analyzed. 
During Irgm1+/- mouse breeding under non-SPF conditions, it was observed that 
Irgm1-/- mice weight 20-30 percent less than their Irgm1+/+ and Irgm1+/- littermates. The 
reason for this weight difference is probably the presence of mild intercurrent infections that 
induce IFNγ and consequent unthriftiness in Irgm1-/- mice. Hence, the weight of the GMS KO 
mice raised under non-sterile conditions is probably correlated to their resistance to the 
pathogens. 
To have an insight into the resistance of Irgm1/Irga6 double KO mice, the weight of 
the Irgm1+/-/Irga6+/- offspring was measured 3 weeks after birth (Figure 19). The average 
weights of the mice with Irgm1+/+ or Irgm1+/- genotype was between 9 and 11 grams. 
However, the average weight of the mice with Irgm1-/-/Irga6+/+ genotype was only 5,5 grams 
and the average weight of the mice with Irgm1-/-/Irga6-/- was 7,2 grams. Thus, the weight of 
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Irgm1-/-/Irga6-/- mice is slightly higher than the weight of the Irgm1-/-/Irga6+/+ mice, but still 
much lower than the weight of the Irgm1+/+ and Irgm1+/- mice, no matter their Irga6 genotype.  
 
 
 
Previous studies had shown that Irgm1-/- mice die 4 to 5 days after infection with 
Listeria monocytogenes (Collazo et al., 2001). In collaboration with Dr. Michael Schramm 
(Institute for Medical microbiology, immunology and hygiene, University of Cologne), the 
resistance of Irgm1-/-/Irga6-/- mice to L. monocytogenes was tested. WT, Irga6-/-, Irgm1-/- and 
Irgm1-/-/Irga6-/- mice were intraperitoneally inoculated with 2400 L. monocytogenes per 
mouse (Figure 20). In accordance with published data, 100 percent of WT mice survived the 
infection and 80 percent of Irgm1-/- mice died within 4 days. Even though it was previously 
published that all Irga6-/- mice survive the infection with L. monocytogenes, two out of five 
Irga6-/- mice had died. Finally all four Irgm1-/-/Irga6-/- had also died within four days of 
infection. 
Taken together, these data indicate that Irgm1-/-/Irga6-/- mice are equally, or even 
slightly more susceptible to L. monocytogenes infection than Irgm1-/- mice. Therefore, even 
though very small sample was analyzed, the removal of Irga6 certainly does not reduce the 
phenotype of Irgm1-/- mouse. 
Figure 19.  Weight of Irgm1
+/-
/Irga6
+/-
 mouse offspring. The offspring of Irgm1
+/-
/Irga6
+/-
 x Irgm1
+/-
/Irga6
+/-
 mice was weighted and genotyped 3 weeks (+/- 1 day) after birth. Punctae represent the 
weights of individual mouse and mean values for every genotype group are depicted. Significant 
difference between Irgm1
-/-
/Irga6
+/+ 
and Irgm1
-/-
/Irga6
-/-
 was calculated with a two tailed T-test. More 
than 100 mice in total were analyzed. 
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3.2.2. Irgb6 can localize to the lysosomes independently of Irga6 and Irgb10 
 Next, it was questioned how does the removal of Irga6, which is suggested to act as 
one of the GKS-pioneers of lysosomal accumulation, influences the localization of other GKS 
proteins onto lysosomes in IFNγ-induced Irgm1 KO cells.  
As demonstrated in chapter 3.1.7., in Irgm1 KO cells, Irgb6 accumulates only at the 
lysosomes that are already Irga6 or Irgb10 positive. Therefore it was questioned if in the 
IFNγ-induced Irgm1/Irga6 KO cells, Irgb6 can accumulate only at the lysosomes that are 
already Irgb10 positive, or whether it can also load to the lysosomes that are not Irga6/Irgb10 
coated. 
To answer this question, diaphragm derived cells (DDCs) were generated from the 
Irgm1 KO and Irgm1/Irga6 KO mice. Irgm1 KO DDCs and Irgm1/Irga6 KO DDCs were 
induced with IFNγ for 24 hours, fixed and stained against Irgb6 (A20), Irgb10 (940/6) and 
LAMP1. Immunofluorescence images of the samples were taken (Figure 21A) and co-
localization of Irgb6 structures with Irgb10 structures and LAMP1 structures was quantified 
(Figure 21B). In Irgm1 KO DDCs, 60 percent of Irgb6 co-localizes with Irgb10. Considering 
the data from chapter 3.1.7., the other 40 percent of Irgb6 probably co-localizes with Irga6, 
which was not stained in these cells. In Irgm1/Irga6 KO DDCs, only 59 percent of Irgb6 co-
localized with Irgb10. Since Irga6 is absent from Irgm1/Irga6 KO cells, these results indicate 
Figure 20. Irgm1/Irga6 double KO mice are susceptible to L. monocytogenes. 4-8 weeks old WT 
(n=6), Irga6
-/- 
(n=5), Irgm1
-/-
 (n=5) and Irgm1
-/-
/Irga6
-/-
 (n=4) mice were intraperitoneally inoculated with 
2400 L. monocytogenes. The survival of the mice was monitored for 14 days. 
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that remaining 41 percent of Irgb6 can localize to the lysosomes that are not Irga6 or Irgb10 
coated. 
It has been also questioned if in the additional absence of Irga6, Irgb10 proteins can 
coat more lysosomes and form more aggregate-like structures than in Irgm1 KO cells. The 
percentage of lysosomes that co-localize with Irgb10 was quantified in IFNγ-induced Irgm1 
KO DDCs and IFNγ-induced Irgm1/Irga6 KO DDCs (Figure 21C). In Irgm1 KO DDCs, about 
27 percent of the lysosomes were Irgb10 coated, while in Irgm1/Irga6 KO DDCs, about 22 
percent of the lysosomes were Irgb10 coated. Thus, it seems that Irgb10 proteins do not 
spread to more lysosomes in the absence of Irga6. 
Taken together, these data indicate that Irga6 is not an irreplaceable factor in GKS 
aggregate localization to the lysosomes. Even though Irga6 and Irgb10 are the predominant 
proteins in lysosome localization, the presence of Irga6 on the lysosome is not a prerequisite 
for lysosomal localization of Irgb6, which is also shown for the loading of these two proteins 
onto the PVM of T. gondii in IFNγ-induced cells, although in that case Irgb6 is the leading 
protein. 
 
 
Figure 21. Irgb6 and Irgb10 lysosomal localization in Irgm1/Irga6 KO DDCs A) Irgm1 KO DDCs 
and Irgm1/Irga6 KO DDCs were induced with 200 U/ml IFNγ for 24 hours, fixed and stained for Irgb6, 
Irgb10 and LAMP1. Representative microscopic images of GKS structures and LAMP1 are shown. 
Arrows point at the GKS structures which are magnified at the end of each panel (zoom in the 
following order: upper left: Irgb6, upper right: Irgb10, lower left: LAMP1, lower right: overlay of Irgb6 
and Irgb10). Scale bar represents 10μM. B) Quantification of 21A, showing percent of Irgb6 structures 
that co-localize with Irgb10. 50 cells per sample were blind counted. C) Quantification of 21A, showing 
percent of LAMP1 structures that co-localize with Irgb10. 50 cells per sample were blind counted.  
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3.3. Lysosomal function is impaired in IFNγ-induced Irgm1 KO 
MEFs  
A role of Irgm1 in autophagy regulation has been suggested in a couple of different 
contexts (Chapter 1.6.4.). Irgm1 has been proposed to mediate autophagic degradation of 
bacterial phagosomes (Deretic, 2011). However, it has been also shown that induced Irgm1 
KO lymphocytes have increased the number of autophagosomes and undergo autophagic 
cell death, suggesting the role of Irgm1 as an autophagy inhibitor (Feng et al., 2008b). Thus, 
the role of Irgm1 in autophagic degradation is not fully understood and remains to be 
investigated.  
To complete the autophagic cycle, autophagosomes have to undergo fusion with 
lysosomes and to finally be degraded in these organelles (Feng et al., 2014) (Klionsky et al., 
2012). Since GKS proteins accumulate at the lysosomes in Irgm1 KO MEFs, we questioned 
whether these GKS coated lysosomes can fuse with and process autophagosomes in IFNγ-
induced Irgm1 deficient cells.  
 
3.3.1. The amount of autophagosomal protein LC3-II is increased in IFNγ-
induced Irgm1 KO MEFs 
To test whether the autophagic flux is altered in Irgm1 KO MEFs, lipidation of 
microtubule associated protein 1 light chain 3 (LC3), which is an essential step in 
autophagosome maturation, was monitored. In cooperation with Dr Susanne Bohlen 
(Institute for Medical microbiology, immunology and hygiene, University of Cologne), the 
turnover of non-lipidated LC3-I protein to lipidated LC3-II protein was analyzed by Western 
Blot. Thus, WT, Irgm1 KO, Irgm3 KO and Irgm1/Irgm3 KO MEFs were treated either with 
IFNγ, and/or an LC3 turnover inducer Rapamycin (RAP), and/or an inhibitor of lysosome 
acidification Bafilomycin A1 (BAF), or left untreated. The cell lysates were separated by SDS-
PAGE followed by Western Blots that were probed with anti-LC3 and anti-β-actin antibodies 
(Figure 22A, B, C, D). The intensities of the protein bands specific for LC3 staining and for 
the loading control actin were quantified by “Quantity one” software and the ratio of LC3-II 
band to Actin band was calculated (Figure 22E).  
. In accordance with previous reports, when cells were treated with the LC3 turnover 
stimulator Rapamycin, the intensity of the LC3-II band was increased and the intensity of the 
LC3-I band was decreased (Klionsky et al., 2012). When Bafilomycin was added to the cells, 
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lysosomal acidification and autophagosome processing were impaired and the intensity of 
the LC3-II band was increased without a decrease of LC3-I (Klionsky et al., 2012). In four 
independent experiments, no difference in LC3-II band intensity was observed between non-
treated or IFNγ-induced WT, Irgm3 KO or Irgm1/Irgm3 KO MEFs, but in IFNγ-induced Irgm1 
KO MEFs, the LC3-II band intensity was increased 3 to 8 fold in comparison to non-treated 
Irgm1 KO cells.  
 
 
 
 
Figure 22. LC3-II signal is increased in IFNγ induced Irgm1 KO MEFs WT (A, B, C, D), Irgm1 KO 
(A, B, C, D), Irgm3 KO (C,D) and Irgm1/Irgm3 KO (C,D) MEFs were induced with 200 U/ml IFNγ for 
24 hours, 40 µg/ml Rapamycin (RAP) and/or 200 nM Bafilomycin (BAF) for  2 hours or left untreated. 
Equal amounts of cell lysates were analyzed by SDS-PAGE and Western Blot. Membrane was 
probed with anti-LC3 and anti-Actin antibodies. E) Quantification of 22A, 22B, 22C and 22D, 
representing ratios between LC3-II and Actin band intensities for each sample. Results of four 
independent experiments are shown. Asterisk marks samples that were not included in the particular 
experiment. 
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In IFNγ treated Irgm1 KO MEFs, even though the intensity of LC3-II was increased, 
intensity of LC3-I was not reduced. Thus, LC3-II increase could be an outcome of two 
possible scenarios: either autophagy induction might be enhanced in IFNγ treated Irgm1 KO 
cells, or autophagosome processing might be impaired in these cells and LC3-II could not be 
further processed and degraded. Since the LC3-I level was not reduced in this sample, it 
seems that impairment of autophagic flux would be a more plausible scenario. 
 
3.3.2. The number of LC3 punctae is increased in IFNγ-induced Irgm1 KO MEFs 
To better understand the changes in autophagic flux that might cause the LC3-II 
increase in IFNγ-induced Irgm1 KO cells, microscopical analysis of the LC3 pattern in these 
cells was performed. WT MEFs and Irgm1 KO MEFs were treated with IFNγ and/or RAP or 
left untreated. Cells were fixed and stained with LC3 immunoreagent, which labels both the 
LC3-I and LC3-II (Figure 23A). Immunofluorescence pictures were taken and the number of 
LC3 punctae per cell was blind counted (Figure 23B).  
In the non-treated or IFNγ-treated WT cells, a small number of punctae could be 
observed. When WT cells were treated with RAP, large numbers of LC3-positive punctae 
were seen in the cell, confirming previous reports on LC3 behaviour in autophagy (Klionsky 
et al., 2012). Similarly, non-treated Irgm1 KO cells had only few LC3-punctae and when 
Irgm1 KO cells were treated with RAP, they showed a large amount of LC3-positive punctae. 
Unlike wild type cells, when Irgm1 KO cells were treated with IFNγ, a large number of LC3 
punctae were seen.  
Taken together, these data, together with Western Blot results from chapter 3.3.1., 
show that the number of autophagosomes in IFNγ-induced Irgm1 KO cells is increased. 
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Figure 23. Number of LC3 punctae is increased in IFNγ induced Irgm1 KO MEFs A) WT and 
Irgm1 KO MEFs were induced with 200 U/ml IFNγ for 24 hours and/or 40µg/ml RAP for 2 hours or 
left untreated. Cells were fixed and stained with the immunoreagent against LC3. Representative 
microscopic images of LC3 punctae and Phase Contrast are shown. Scale bars represent 10μm. B) 
Quantification of 23A, showing average number of LC3 punctae per cell. Arrow points at the 
unusually high number of LC3 punctae in IFNγ-induced Irgm1 KO cells. 50 cells per sample were 
blind counted and the results of two independent experiments are shown. 
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3.3.3. Autophagosomes are trapped in lysosomes in IFNγ-induced Irgm1 KO 
MEFs 
As proposed earlier, an increase in the LC3 punctae number and the LC3-II levels in 
IFNγ-induced Irgm1 KO MEFs could be a consequence of the autophagy induction in Irgm1 
KO cells (Feng et al., 2008b). However, as discussed in chapter 3.3.1., these results could 
also suggest that the processing of autophagosome is impaired in Irgm1 KO cells. 
Previously, it was shown that the lysosomes, which should process the autophagosomes, 
are coated with GKS aggregates in IFNγ-induced Irgm1 KO cells (chapter 3.1.2.). It was 
therefore possible that autophagosome processing could be impaired in these cells. To 
better understand autophagosome/lysosome fusion and processing, co-localization of 
autophagic LC3 punctae with the lysosomal marker LAMP1 was analyzed.  
WT MEFs and Irgm1 KO MEFs were treated with IFNγ for 24 hours and/or RAP for 2 
hours or left untreated. The cells were fixed and stained with immunoreagents against LC3 
and against LAMP1 (Figure 24). The percent of LC3 structures that co-localize with LAMP1 
was quantified. As expected, in WT cells, whether they were non-treated, IFNγ-treated, RAP-
treated or IFNγ- and RAP-treated, less than 15 percent of LC3 positive structures co-
localized with lysosomes (Figure 25), presumably reflecting efficient processing of 
autophagosomes. In non-treated and RAP-treated Irgm1 KO cells, only a few of the LC3-
punctae co-localized with the lysosomes. In contrast in IFNγ or IFNγ and RAP treated Irgm1 
KO cells, a 60 to 80 percent of LC3 punctae co-localized with lysosomes.  
This phenomenon was not dependent on the number of LC3 punctae in the cell. 
Thus, abundant autophagosomes in Irgm1 KO cells that were only treated with RAP did not 
co-localize with lysosomes. It seems that this phenomenon is IFNγ-dependent and that co-
localization of autophagosomes with lysosomes is enhanced whenever IFNγ alone or 
together with RAP was added to Irgm1 KO MEFs. 
These findings strongly indicate that, in IFNγ-induced Irgm1 KO cells, once 
lysosomes and autophagosomes fuse, the autophagosomes cannot be further processed 
and stay trapped in the lysosomes. Hence, autophagic flux of IFNγ-induced Irgm1 KO MEFs 
is probably impaired. 
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Figure 24. LC3 punctae co-localize with LAMP1 in IFNγ induced Irgm1 KO MEFs WT and Irgm1 
KO MEFs were induced with 200 U/ml IFNγ for 24 hours, 40µg/ml RAP for 2 hours or left untreated. 
Cells were fixed and stained with the immunoreagents against LC3 and LAMP1. Representative 
microscopic images of LC3 and LAMP1 are shown. Arrows point at the LC3 structures which are 
magnified at the end of each panel (zoom in the following order: upper left: LC3, upper right: LAMP1, 
lower left: overlay, lower right: phase contrast). Scale bars represent 10 μM.  
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3.3.4. GKS coated lysosomes cannot process autophagosomes 
The accumulation of GKS proteins at the lysosomes could be the cause of the 
autophagic flux impairment in Irgm1 KO MEFs. If so, it is possible that the lysosomes that are 
unable to process LC3 are the same ones that are coated with GKS aggregates  
To examine this question, Irgm1 KO MEFs were induced with IFNγ and triple-stained 
for LC3, LAMP1 and Irga6 (Figure 26A). Immunofluorescence microscopy images of these 
cells were taken and co-localization of LC3 with LAMP1 and of LC3 with LAMP1 and Irga6 
was quantified (Figure 26C). In accordance with results from chapter 3.3.3., about 60 percent 
of the LC3 structures co-localized with LAMP1 in IFNγ-induced Irgm1 KO MEFs. However, 
only 33 percent of LC3 and LAMP1 positive structures also co-localized with Irga6.   
As shown in chapter 3.1.7., Irga6 and Irgb10 are the leading GKS proteins which can 
localize to the lysosomes without the presence of the other GKS proteins. However, Irga6 
and Irgb10 do not always localize to the same lysosomes. Hence, it was hypothesized that 
the lysosomes that trap autophagosomes and are not coated with Irga6, are actually Irgb10 
coated. Hence, Irgm1 KO MEFs were again induced with IFNγ but this time, due to antibody 
incompatibility, transfected with EGFP-LC3. These cells were stained for Irga6 and Irgb10 
together in the red channel and LAMP1 in the far red channel (Figure 26B). 
Immunofluorescence images were taken and LC3 structures co-localizing with LAMP1 and 
with Irga6, Irgb10 and LAMP1 were quantified (Figure 26D). As in the previous experiment, 
70 to 90 percent of the LC3 co-localized with LAMP1 in IFNγ-induced Irgm1 KO cells. About 
Figure 25. LC3 punctae co-localize with LAMP1 in IFNγ induced Irgm1 KO MEFs. Quantification 
of Figure 23 that shows percent of LC3 structures that co-localize with LAMP1. 50 cells per sample 
were quantified and the results of two independent experiments are shown. 
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80 percent of LC3 and LAMP1 positive structures also co-localized with Irga6 and/or Irgb10. 
Thus, at least 80 percent of the autophagosomes are indeed trapped in the lysosomes that 
are GKS coated. To this end, GKS protein accumulations at the lysosomes in IFNγ-induced 
Irgm1 KO MEFs probably do affect the ability of these lysosomes to process 
autophagosomes. 
 
 
 
 
 
Figure 26. LC3 punctae co-localize with GKS covered lysosomes A) Irgm1 KO MEFs were induced 
with 200 U/ml IFNγ for 24 hours or left untreated. Cells were fixed and stained against LC3, LAMP1 and 
Irga6 (165/3). Representative microscopic images of LC3, LAMP1 and Irga6 are shown. Arrows point at 
the LC3 structures which are magnified at the end of each panel (zoom in the following order: upper left: 
LC3, upper right: Irga6, lower left: LAMP1, lower right: overlay of Irga6, LC3 and LAMP1). Scale bars 
represent 10 μM. B) WT and Irgm1 KO MEFs were transfected with EGFP-LC3 and induced with 200 
U/ml IFNγ for 24 hours or left untreated. Cells were fixed and stained against LAMP1, Irga6 (165/3) and 
Irgb10 (940/6). Representative microscopic images of LC3, LAMP1 and Irga6&Irgb10 are shown C) 
Quantification of 26A, showing percent of LC3 structures that co-localize with LAMP1 or with Irga6 and 
LAMP1. 50 cells per sample were quantified and the means of three independent experiments +/- SD are 
shown. D) Quantification of 26B, showing percent of LC3 structures that co-localize with LAMP1 or with 
Irga6, Irgb10 and LAMP1. 50 cells per sample were quantified and the results of two independent 
experiments are shown. 
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3.3.5. GKS coated lysosomes are not acidic 
In IFNγ-induced Irgm1 KO MEFs, autophagosomes were reported to be trapped in 
the GKS covered lysosomes (chapter 3.3.4.). Since lysosomes play an important role in 
degradation or activation of many crucial cellular components (De Duve, 1963), it was 
questioned whether degradation impairment of GKS covered lysosomes is autophagosome 
specific, or whether the processing of all lysosomal substrates is actually impaired in these 
cells. Hence, the lysosomal acidity status in IFNγ-induced Irgm1 KO MEFs was assessed. 
Irgm1 KO MEFs were induced with IFNγ and simultaneously transfected with EGFP-
Irga6-ctag1. After 24 hours, live non fixed cells were incubated with the pH sensitive 
lysosomal dye Lysotracker red. Pictures of live cells were taken (Figure 27A) and EGFP-
Irga6 structures that co-localized with Lysotracker were quantified (Figure 27B). Only about a 
quarter (3,1 out of 11,7) of EGFP-Irga6 structures per cell were Lysotracker positive. The 
possibility that EGFP-Irga6 aggregate-like structures do not accumulate at the lysosomes 
can be excluded due to clear co-localization of EGFP-Irga6 and LAMP1 in IFNγ-induced 
Irgm1 KO MEFs, which is shown in chapter 3.1.2.b. Thus, it seems that the pH of GKS-
coated lysosomes in IFNγ-induced Irgm1 KO cells is increased and these lysosomes cannot 
be detected with pH sensitive Lysotracker dye. Therefore, processing abilities of GKS-coated 
lysosomes are probably impaired not only during autophagy, but also during other important 
lysosome-dependent processes in the cell. 
 
 
 
Figure 27. Acidity of GKS-coated lysosomes is impaired A) Irgm1 KO MEFs were transfected with 
pEGFP-Irga6-ctag and simultaneously induced with 200 U/ml IFNγ for 24 hours. Non-fixed cells were 
incubated with 50 nM Lysotracker for 15 minutes and pictures of live cells were taken. Representative 
microscopic images of Irga6 and lysotracker are shown. Arrows point at the Irga6 structures which are 
magnified at the end of each panel (zoom in the following order: upper left: Irga6, upper right: 
lysotracker, lower left: overlay, lower right: phase contrast). Scale bars represent 10 μM.  B) 
Quantification of 27A that shows number of Irga6 structures that co-localizes with Lysotracker. 25 cells 
per sample were quantified and means of three independent experiments +/- standard deviation are 
shown.  
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3.3.6. Lysosomes are not permeabilized in IFNγ-induced Irgm1 KO MEFs 
When it was observed that GKS proteins localize to LAMP1 structures (chapter 
3.1.2.), we first hypothesized that these proteins can disrupt the lysosomal membrane in a 
similar manner as they mediate disruption of T. gondii PVM. Thus, lysosomal membrane 
permeablilization (LMP) could cause lysosomal enzyme leakage and induce cell death (Boya 
and Kroemer, 2008) (Repnik et al., 2014). To test the possibility that GKS proteins might 
permeabilize lysosomal membranes, LMP was assessed by cathepsin B staining in 
collaboration with intern Jessie Zhang. 
Cathepsin B is an enzyme that is transported from Golgi to lysosomes through 
endosomes as inactive pro-cathepsin B. Once pro-cathepsin B reaches the acidic 
environment of the lysosome, it is truncated into the active cathepsin B form (Dean, 1979) 
(Barrett and Kirschke, 1981). The immunofluorescence microscopy images of the resting WT 
cells stained with anti-cathepsin B antibody show marginal extra-lysosomal staining of the 
immature pro-cathepsin B and outstanding cathepsin B punctae (Tholen et al., 2014). 
To monitor the lysosomal membrane permeabilization, WT MEFs were treated with a 
reagent which induces lysosomal membrane permeabilization named H-Leu-Leu-OMe.HBr 
(shortly LeuLeuOMe) (Mizuta et al., 2002) (Uchimoto et al., 1999). The non-treated and 
LeuLeuOMe-treated WT MEFs were stained with anti-cathepsin B and anti-LAMP1 
antibodies. Indeed, in non-treated cells, cathepsin B stained punctae co-localized with non-
permeabilized LAMP1 stained lysosomes. However, when lysosomes were treated with 
LeuLeuOMe, and presumably permeabilized, cathepsin B was released into the cytosol and 
the number of punctae was reduced (data not shown).  
In order to establish a concentration of LeuLeuOMe that can induce LMP without 
killing the cell, Irgm1 KO MEFs were treated with different concentrations of this reagent for 
24 hours. Cell death was measured with PI/Hoechst staining assay as described in chapter 
3.4. 3.75mM was the highest tested concentration of LeuLeuOMe that did not strongly affect 
the cell survival (Figure 28A). 
It was further microscopically tested whether the degree of LMP is correlated to the 
number of cathepsin B punctae. To induce LMP, Irgm1 KO MEFs were treated with 2mM, 
3mM or 4mM of LeuLeuOMe or left untreated for 24 hours. Cells were fixed and stained with 
the anti-cathepsin B antibody. Pictures of the samples were taken and cathepsin B punctae 
in the cells were manually blind counted (Figure 28B). Samples treated with higher 
concentrations of LeuLeuOMe had fewer cathepsin B punctae per cell, indicating that 
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cathepsin B punctae staining corresponds to the extent of the LMP in dose-dependent 
manner. 
 
 
 
 
 
Figure 28. Cathepsin B punctae quantification in Irgm1 KO MEFs A) Irgm1 KO MEFs were treated 
with different concentrations of lysosomal permeabilization agent LeuLeuOMe or left untreated for 24 
hours. Cells were stained with Propidium Iodide and Hoechst dye and analyzed as in chapter 3.4. Percent 
of PI positive cells is shown. 5000-10000 cells per sample were quantified. B) Irgm1 KO MEFs were 
treated with 2mM, 3mM or 4mM of LeuLeuOMe or left untreated for 24 hours. Cells were fixed and 
stained with anti-cathepsin B antibody AF965. Average number of cathepsin B positive punctae per cell is 
shown. 50 cells per sample were blind counted. C) WT MEFs and Irgm1 KO MEFs were treated with 200 
U/ml IFNγ, 3 mM LeuLeuOMe or left un-treated for 24 hours. Cells were fixed and stained with anti-
cathepsin B antibody. Representative images of cathepsin B staining and Phase contrast are shown. D) 
Quantification of 28C, showing number of cathepsin B punctae per cell. 100 cells per sample blind 
counted and results of two independent experiments are shown. 
 
 
dent experiments are shown. 
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To analyze LMP in the cells of interest, WT MEFs and Irgm1 KO MEFs were left un-
treated, induced with IFNγ or treated with 3mM LeuLeuOMe. Cells were fixed and stained 
with the antibody against cathepsin B. Immunofluorescence images of cathepsin B staining 
were taken (Figure 28C) and the number of cathepsin B punctae per cell was blind manually 
counted (Figure 28D).  Both, LeuLeuOMe-treated WT and LeuLeuOMe-treated Irgm1 KO 
cells had fewer cathepsin B punctae than non-treated cells. However, the amount of punctae 
in IFNγ-induced Irgm1 KO MEFs was very similar to untreated Irgm1 KO MEFs as well as 
treated and untreated WT MEFs. Taken together, these data indicate that GKS proteins, 
which are localized to lysosomes, probably do not mediate lysosomal membrane 
permeabilization in IFNγ-induced Irgm1 KO cells. 
 
3.4. IFNγ does not induce death of Irgm1 KO MEFs and BMDMs  
Previously, it has been reported that Irgm1 KO lymphocytes and hematopoetic stem 
cells (HSCs) undergo cell death upon induction (Feng et al., 2008b) (Feng et al., 2008a) 
(King et al., 2011) (chapter 1.6.3.). However, it has been also shown that Irgm1 KO Bone 
marrow derived macrophages (BMDMs) do not die upon induction with IFNγ (Henry et al., 
2007).  Thus, it had to be clarified which Irgm1 cell types undergo cell death upon induction.  
WT and Irgm1 KO MEFs were induced with IFNγ, high concentration of LeuLeuOMe 
or left non-induced. After 24, 48 or 72 hours, non-fixed cells were stained with permeable 
DNA binding Hoechst dye, which stains nuclei of live and dead cells, and impermeable 
Propidium Iodide (PI), which stains only nuclei of dead cells (Figure 29A). Pictures of the 
cells were taken and PI positive and Hoechst positive cells were detected and enumerated 
with Volocity software. The percentage of PI-positive cells was calculated (Figure 29B). In 
LeuLeuOMe-induced cells, more than 80 percent of the Hoechst stained cells were also PI 
positive. In all other samples in this analysis, less than 10 percent of the cells were PI 
positive, indicating that IFNγ does not induce cell death in Irgm1 KO MEFs. 
Further, cell death was again tested in primary BMDMs. WT BMDMs and Irgm1 KO 
BMDMs were left untreated, induced with IFNγ or induced with LeuLeuOMe. In addition, 
these cells were also stimulated with the combination of IFNγ and Lipopolysaccharide (LPS). 
(Figure 29C).  
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Similarly to the analysis of cell death in MEFs, more than 80 percent of LeuLeuOMe 
treated WT and Irgm1 KO BMDMs were PI positive. Again, no difference in the percent of 
dead cells was observed between non-induced, IFNγ-induced or IFNγ and LPS induced WT 
and Irgm1 KO BMDMs. 
Taken together, the results of the cell death assay show that neither immortalized 
Irgm1 KO MEFs, nor primary Irgm1 KO BMDMs, undergo cell death after IFNγ-induction. 
Therefore, IFNγ-mediated cell death is probably characteristic for the particular sets of cells 
of the Irgm1 KO mouse, like, for example Irgm1 KO lymphocytes and HSCs (Feng et al., 
2008b) (Feng et al., 2008a) (King et al., 2011). 
Figure 29. Cell death of IFNγ induced Irgm1 KO MEFs and BMDMs A) WT and Irgm1 KO MEFs 
were induced with 200 U/ml IFNγ or treated 10 mM LeuLeuOMe for 24, 48 and 72 hours or left 
untreated. Cells were stained with nuclear dyes Hoechst and Propidium iodide and pictures of the 
cells were taken. Representative microscopic images of Hoechst staining, PI staining and Phase 
Contrast are shown. Scale bars represent 10μM. B) Quantification of 29A that shows percent of PI 
positive MEFs. Dye stained nuclei were quantified with Volocity software. 10 pictures (5000-10000 
cells) per sample were quantified and the means of three independent experiments +/- standard 
deviation are shown. C) WT and Irgm1 KO BMDM cells were induced with 200 U/ml IFNγ, 500 ng/ml 
LPS, 5 mM LeuLeuOMe for 24, 48 and 72 hours or left untreated. Experiment was performed as in 
29A, B. 10 pictures (5000-10000 cells) per sample were quantified and the means of three 
independent experiments +/- standard deviation are shown. 
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3.5. Irga6 aggregate-like structures are detergent soluble 
Initially, the GKS protein structures that are formed in the absence of GMS proteins 
were described as aggregates (Martens et al., 2004). However, after detailed analysis of 
Irga6 ring-like structures that localize to lysosomes in Irgm1 KO MEFs, it seems that so 
called GKS aggregates are more similar to GTP-bound GKS proteins at the PVM (Figure 
S1). To better characterize these GKS aggregate-like structures, their solubility was 
assessed. Thus, Filter Trap assay, a method for the isolation and analysis of aggregates 
optimized for Dendritic Cell Aggresome Like Structures (DALIS) (Kettern et al., 2011), was 
adjusted for GKS aggregate-like structure analysis in collaboration with Dr Nadja Kettern 
(Institute for Cell Biology, University of Bonn). 
To establish the method, the filter trap assay was first performed on DALIS.  RAW309 
macrophages were left untreated or treated with LPS for 12 hours, a time point in which 
DALIS formation reaches its peak. Macrophages were lysed in RIPA buffer and filtered 
though the nitrocellulose membrane. Under vacuum force, detergent soluble proteins were 
filtered though the membrane, and non-soluble DALIS were retained on the membrane. 
Since DALIS are highly ubiquitinated, nitrocellulose membrane was probed with anti-ubiquitin 
antibody FK2 (Figure 30A). A clear difference in the intensity of FK2 staining between LPS-
induced and LPS non-induced sample could be observed. 
To have an insight into the solubility of the GKS aggregate like structures, a filter trap 
assay used on DALIS was adjusted for GKS aggregate analysis. Irga6 stable transfected 
Gene Switch (GS) 3T3 cells express only Irga6 when induced with Mifepristone (MIF) 
(chapter 3.1.2.c). In the absence of GMS regulatory proteins, Irga6 forms aggregates in 
these cells. IFNγ-induced GS 3T3 Irga6 cells express the full set of IRG proteins and GMS 
proteins control GKS protein aggregation. Therefore, even though Irga6 is present in these 
cells, it does not form and should not accumulate on the membrane. 
GS 3T3 Irga6 cells were induced with MIF, IFNγ or left untreated for 24 hours. The 
cells were lysed in different lysis buffers composed of a variety of ionic and non-ionic 
detergents: 0,5 % Thesit (Figure 30B), RIPA buffer, 1% TritonX-100, 80mM n-Octyl β-D-
glucopyranoside or 1% Digitonin (data not shown) and filtered through nitrocellulose 
membrane. The membrane was probed with the antibody against Irga6 (10E7) (Figure 30B). 
Even though multiple Filter trap analysis attempts were performed with several detergents, 
no difference between Irga6 staining in MIF-induced, IFNγ-induced or non-induced cells 
could be observed. Therefore, it was hypothesized that GKS aggregate-like structures are 
actually detergent soluble. 
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Figure 30.  Irga6 aggregate-like structures are detergent soluble A) RAW309 macrophages 
were left untreated or stimulated with 500ng/ml LPS for 12 hours to induce formation of dendritic 
cell aggresome like structures (DALIS). Cells were lysed in RIPA buffer and 50mg of each cell 
lysate were vacuum filtered through a nitrocellulose membrane on a dot-blotter. Detergent insoluble 
ubiquitin conjugates were detected on the membrane with the FK2 antibody. B) GS 3T3 Irga6 cells 
were induced with IFNγ, MIF or left untreated for 24 hours. 50000 or 100000 cells were lysed in 0,5 
% Thesit, filtered through a nitrocellulose membrane and probed with Irga6 (10E7) antibody. C) GS 
3T3 Irga6 cells were treated as in 30B.  30000 cells were lysed in 0,5 % Thesit and centrifuged at 
45000 rpm for 30 minutes. Supernatant and the pellet were separated, analyzed by SDS-
PAGE/Western Blot and probed with anti-Irga6 (10E7) and anti-Calnexin reagents. Arrow points at 
the pellet fraction of MIF-induced GS 3T3 Igra6 cell lysates, in which insoluble Irga6 could not be 
isolated. D) GS 3T3 Irga6 cells were induced with IFNγ, MIF and/or left untreated for 24 hours. 
Following, cells were treated with AlCl3, NaF and/or GTP or left un-treated for 1 hour. 30000 cells 
were lysed in 0,5 % Thesit and centrifuged at 13000 rpm for 30 minutes. Supernatant and the pellet 
were separated, analyzed by SDS-PAGE/Western blot analysis and probed with anti-Irga6 and 
anti-Calnexin reagents. Arrow points at the pellet fraction of GS 3T3 Igra6 cell lysates that were 
pre-treated with MIF, AlFx and GTP, in which insoluble Irga6 is isolated. 
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To further test the solubility of Irga6 aggregates, cell lysates prepared with 0,5 % 
Thesit (Figure 30C), 80mM n-Octyl β-D-glucopyranoside or 1% Digitonin (Figure S3), as 
described in previous experiment, were utracentrifuged at 45000 rpm for 30 minutes. The 
pellet and supernatant were separated and analyzed by SDS-PAGE/Western Blot analysis 
probed with anti-Irga6 and anti-calnexin immunoreagents (Figure 30C). Calnexin, which is 
detergent soluble, was detected only in supernatant fraction. Irga6 could also be detected 
only in the supernatant fraction and not in the insoluble pellet of MIF-induced cells, indicating 
that the complete Irga6 in this sample is detergent soluble. 
Previously, it has been shown that Irga6 forms transient oligomers that can be 
permanently preserved by addition of Aluminium fluoride (AlFx) and excess of GTP (Papic et 
al., 2008) (chapter 1.4.4.).  Aluminum fluoride (AlFx) is the substance that locks the GTPases 
in the transition state and therefore prevents the shifts between GTP- and GDP-bound states 
(Wittinghofer, 1997). To this end, GS 3T3 Irga6 were treated with IFNγ or MIF for 24 hours or 
left untreated. In addition, these cells were treated with AlFx and GTP or left untreated. The 
samples were lysed with 0,5 percent Thesit and ultracentrifuged at 45000 rpm. The pellet 
and supernatant were separated, analyzed with SDS-PAGE/Western Blot and probed with 
the antibody against Irga6 (10E7).  Indeed, addition of AlFx and GTP yielded Irga6-positive 
band in the pellet fraction of MIF-induced cells (Figure 30D). Thus, the ultracentrifugation 
method can capture naturally or artificially formed GKS aggregates if they exist.  
 Taken together, Irga6 proteins probably form membrane-bound structures similar to 
the GTP-bound Irga6 accumulations at the PVM. Once the membranes are dissolved in 
detergent, these structures are also dispersed. 
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4. DISCUSSION 
4.1. How do GKS proteins function in the absence of GMS proteins? 
  The role of regulatory Immunity-related GTPases (IRGs), called GMS proteins is to 
keep the effector IRG proteins, called GKS proteins in the inactive, GDP-bound state and 
prevent them from activating on endomembranes (Hunn et al., 2008). The presence of GMS 
proteins on endomembranes but not on vacuolar membranes surrounding certain classes of 
pathogens enables GKS proteins to target the pathogen vacuolar membranes preferentially 
(Martens, 2004)  (Hunn and Howard, 2010) (Howard et al., 2011) (Haldar et al., 2013) 
(Coers, 2013) (da Fonseca Ferreira-da-Silva et al., 2014). 
 In this study, it was shown that GKS localization at the particular membranes is 
dependent on the presence of particular GMS proteins. GKS proteins can accumulate only 
on the membranes that are not GMS-coated (Figure 31). Namely, in IFNγ-induced Irgm1 KO 
cells, more than 90 percent of Irga6 and other GKS proteins accumulate at the lysosomes, 
which are normally coated with Irgm1 (chapters 3.1.2. and 3.1.6.). In accordance with that, in 
IFNγ-induced Irgm3 KO cells, more than 90 percent of Irga6 accumulates on the 
endoplasmic reticulum (ER), which is normally coated with Irgm3 (chapter 3.1.3.). The Golgi 
apparatus, which is coated with Irgm1 and Irgm2, is not coated with Irga6 in Irgm1 KO or 
Irgm3 KO cells (chapter 3.1.4.). As shown by (Haldar et al., 2013), in IFNγ-induced 
Irgm1/Irgm3 KO cells, GKS proteins accumulate on the lipid droplets (LDs), which are 
otherwise coated with Irgm1 and Irgm3 (Bougneres et al., 2009) (Haldar et al., 2013), but do 
not accumulate on the ER and lysosomes, which should also be GMS-free in these cells 
(chapter 3.1.5.). Taken together, GKS proteins accumulate at the membranes that are not 
GMS-coated, but probably prefer one type of membranes over another, when given a choice 
(further discussed in chapters 4.2. and 4.3.) 
 The consequences of GKS accumulation on the lysosomes in IFNγ-induced Irgm1 
KO cells were investigated. The hypothesis that GKS proteins disrupt the lysosomal 
membrane is probably not correct since lysosomal membrane permeabilization (LMP) and 
consequent cell death could not be observed in IFNγ-induced Irgm1 KO mouse embryonic 
fibroblasts (MEFs) (chapters 3.3.6. and 3.4.). However, the autophagic flux in these cells is 
impaired and the number of autophagosomes is increased (chapters 3.3.1. and 3.3.2). The 
impairment of the autophagic flux is probably caused by the inability of GKS-coated 
lysosomes to process autophagosomes after lysosomal fusion (chapters 3.3.3. and 3.3.4.). 
Finally, it was shown that the pH of GKS-coated lysosomes is unusually increased (chapter 
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3.3.5.), indicating that the substrate processing in these lysosomes must be impaired (further 
discussed in chapter 4.4.). 
 
  
 
 
 
 
The connection between lysosomal failure in IFNγ-induced Irgm1 KO cells and the 
striking lymphopenia that causes death of the Irgm1 KO mice after infection remains to be 
further investigated. In this study, it was shown and reproduced that Irgm1 KO MEFs and 
BMDMs do not die after IFNγ-induction (chapter 3.4.). Thus, it seems that the death of the 
Irgm1 KO mice is caused by a failure of specific subsets of cells, like lymphocytes and 
hematopoetic stem cells (HSCs), which do die upon induction (Feng et al., 2008b) (Feng et 
al., 2008a) (King et al., 2011) (further discussed in chapters 4.5. and 4.6.). 
Figure 31. Model of cytotoxic effect of dysregulated GKS proteins A) GMS proteins localize to 
different cellular endomembranes, like the ER, the Golgi and lysosomes, and keep GKS proteins in 
an inactive GDP-bound state B) When T. gondii enters the cell, GKS proteins accumulate and 
activate at the PVM, because of the absence of GMS proteins on PVM membrane. GKS proteins turn 
into active GTP-bound form and mediate membrane disruption C) In Irgm1 KO cells, GMS protein do 
not protect lysosomal membranes. Therefore, GKS proteins become activated, form GTP-bound 
structures and accumulate on the lysosome. Acidification and digestive abilities of these lysosomes 
are impaired. Thus, the lysosomes cannot properly process autophagosomes after 
lysosome/autophagosome fusion. Hence, autophagic flux of IFNγ induced Irgm1 KO cells is impaired 
D) In Irgm3 KO cells the ER cisternae are not protected by GMS proteins. GKS proteins accumulate 
on the ER, possibly cause ER deformation, which does not have as severe consequences for the cell 
as lysosomal impairment in Irgm1 KO cells. 
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 Finally, it was shown that up to now called GKS aggregates, which appear when GKS 
proteins are overexpressed in the absence of GMS proteins, are actually detergent soluble. 
Detergent solubility, together with the possibility to eliminate these accumulations with the 
addition of GMS proteins (Hunn and Howard, 2010) and discovery that they are in the GTP-
bound conformation (Papic et al., 2008), indicate that GKS protein accumulations rather 
resemble active GTP-bound structures, similar to the GKS proteins at the PVM of T. gondii, 
than the insoluble accumulations of missfolded inactive protein aggregates (further discussed 
in chapter 4.7.). 
  
4.2. How do IRG proteins recognize their targets? 
 As previously described (chapter 1.1.), host organisms can recognize their pathogens 
by different mechanisms: by recognition of “microbial non-self”, by recognition of “induced or 
altered self” and by recognition of “missing self”. Host recognition of pathogens by the 
“missing self” principle relies on the detection of gene products and products of metabolic 
pathways that are unique to host and absent from the pathogen. Therefore, host immunity 
effectors can target for destruction the structures which are not labeled as self for destruction 
(Medzhitov and Janeway, 2002).  
Even though the IRG response to T. gondii is relatively well described (chapter 1.5.1), 
the mechanism by which IRG proteins recognize the PVM and distinguish it from the other 
cellular membranes is not yet understood. One hypothesis for the IRG mechanism of action 
suggests that GKS proteins recognize the PVM by the “missing self” principle (Martens, 
2004) (Hunn and Howard, 2010) (Haldar et al., 2013) (Coers, 2013). By this principle, 
regulatory GMS proteins would label all the endocellular membranes and GKS proteins 
would accumulate to the only membranes in the cell that are not GMS-labeled, the 
parasitophorous vacuolar membrane (PVM) (da Fonseca Ferreira-da-Silva et al., 2014). 
In this study, the simplistic model of the host distinction between self and non-self 
membranes was shown to be partially true. In IFNγ-induced Irgm1 KO cells, lysosomes are 
not GMS-coated and GKS proteins accumulate on them (chapters 3.1.2. and 3.1.6.). In IFNγ-
induced Irgm3 KO cells, where the ER is not GMS coated, Irga6 localizes to the ER (chapter 
3.1.3.). 
However, certain findings from this and other studies indicate that the model by which 
GKS proteins can accumulate to any GMS-free membrane is not fully correct and that GKS 
proteins select the GMS-undefended membranes with certain preference. 
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Firstly, in IFNγ-induced Irgm1/Irgm3 KO cells, lipid droplets (LDs), lysosomes and ER 
are not coated with GMS proteins. GKS proteins were indeed reported to accumulate to LDs 
(Haldar et al., 2013) (chapter 3.1.5.), but no accumulation of GKS proteins onto lysosomes or 
the ER could be observed in these cells (chapters 3.1.2., 3.1.3. and 3.1.6.). Therefore, it 
seems that GMS proteins do not accumulate on every GMS-free membrane when given 
more options. 
Secondly, it seems that Irga6, when expressed in the absence of all GMS proteins, 
also prefers particular endomembranes. Namely, in the GS 3T3 Irga6 cells, which express 
Irga6 upon induction with Mifepristone (MIF), GMS proteins are not present. Hence, all 
endocellular membranes in these cells are not GMS-coated and all should be potential 
targets for the GKS proteins. However, in MIF-induced GS 3T3 Irga6 cells, less than 5 
percent of Irga6 structures accumulated to the lysosomes and Golgi apparatus (chapters 
3.1.2. and 3.1.4.), indicating that Irga6 probably prefers another compartment, possibly lipid 
droplets or ER, when given more options. In contrast, when Irgm2 and Irgm3 were co-
transfected in these cells, GMS-free membranes were probably limited to the lysosomes and 
thus in these cells more than 70 % of Irga6 structures accumulated at the lysosomes. 
Thirdly, when Irga6 and Golgi co-localization was analyzed in the GMS-transfected 
MIF-induced GS 3T3 Irga6 cells (chapter 3.1.4.), it was observed that in the sample with cells 
that were not GMS-coated, and even in the sample with cells that were transfected with 
Irgm3, Irga6 clearly did not accumulate to the Golgi, even though this compartment is GMS-
free. 
 Finally, one of the strongest arguments against the hypothesis that GKS proteins 
accumulate at any membrane that is not GMS-coated is the fact that neither GKS nor GMS 
proteins localize to the host plasma membrane of IFNγ-induced wild type mouse cell. 
 Recently, it has been proposed that another hypothetical unknown protein, named 
factor Y, could localize at the plasma membrane and protect it from the off-target activation 
of GKS proteins (da Fonseca Ferreira-da-Silva et al., 2014). The pathogens that are targeted 
by the GKS proteins all have unusual non-phagocytic entry mechanism into cell, which 
involves the formation of the PVM from heavily modified plasma membrane (Ling et al., 
2006) (Hybiske and Stephens, 2007) (Bohne et al., 2011). Therefore, it has been proposed 
that the hypothetic factor Y is excluded from the plasma membrane during formation of the 
PVM of these pathogens. Thus, the PVM, but not the plasma membrane, can be targeted by 
GKS proteins. Pathogens like M. tuberculosis and L. monocytogenes, which are taken up by 
phagocytosis, probably do not exclude factor Y from the phagosomal membrane, and cannot 
be targeted by GKS proteins (da Fonseca Ferreira-da-Silva et al., 2014). 
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 Another possibility, which could explain why the plasma membrane is not targeted by 
GKS proteins, could be that GKS proteins have a preference for membranes of particular 
lipid composition. As previously discussed, in IFNγ-induced Irgm1/Irgm3 KO cells, GKS 
proteins accumulate at LDs, even though lysosomes and ER are also not GMS coated. 
Similarly, it could be that GKS proteins have low affinity to accumulate at the plasma 
membrane. 
 Membrane binding mechanisms and lipid preferences of IRG proteins are not clarified 
up to date. It has been shown that myristoylation of Irga6 is important for its membrane 
binding (Papic et al., 2008). However, it is still not clear if Irga6 can bind membranes of any 
lipid composition. Moreover, Golgi membrane targeting of Irgm1 is shown to require by the 
αK helix of this protein (Martens et al., 2004) (Martens and Howard, 2006) (Zhao et al., 
2010). It has been reported that Irgm1 can bind lipid samples of phosphatidylinositol-3,4-
biphosphate (PitIns(3,4)P2), phosphatidylinositol-3,4,5-triphosphate (PitIns(3,4,5)P3) and 
diphosphatydil-glycerol (DPG), but cannot bind many other lipid samples (Tiwari et al., 2009). 
However, the significance of these results in vivo is not clear, because PitIns(3,4)P2 and 
PitIns(3,4,5)P3, were not found in the lysosomes or Golgi apparatus, the compartments to 
which Irgm1 normally localizes in WT cells (Kutateladze, 2010). However, DPG can be found 
in mitochondria, the compartments to which Irgm1 also localizes (Tiwari et al., 2009). Thus, 
the preference of the IRG proteins for membranes of particular lipid composition should be 
further investigated.  
 Taken together, GMS proteins indeed protect endocellular membranes from GKS 
accumulation and probably help the host to distinguish between self membranes and the 
pathogen. However, GKS proteins probably do not accumulate on every membrane that is 
not GMS coated and show some preference when choosing their targets. 
 
4.3. Is there hierarchy in GKS localization to the lysosomes? 
Irga6, Irgb6, Irgb10 and Irgd were shown to accumulate at the same PVMs of T. 
gondii after infection. It was proposed that they do so in cooperative and hierarchical manner 
(Khaminets et al., 2010). Co-staining for Irga6 and Irgb6 had shown that Irgb6 could be found 
at the PVM alone or together with Irga6 (Figure 32A). However, Irga6 could only rarely be 
present at the PVM without Irgb6. Similarly, Irgb10 could be detected at the PVM alone or 
with Irga6, but Irga6 could not be at the PVM without Irgb10. Irgb6 and Irgb10 could be 
detected at the PVM together or independently. In addition, time lapse microscopy analysis 
had shown that, when Irga6 and Irgb6 are co-transfected into cell, Irgb6 was always the first 
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one to start PVM accumulation and it was followed by Irga6. Taken together, these data 
indicate that Irgb6 and Irgb10 are the leading GKS proteins that localize to the PVM of T. 
gondii (Khaminets et al., 2010). 
Similarly, in IFNγ-induced Irgm1 KO cells, not only Irga6, but also Irgb6, Irgb10 and 
Irgd accumulate to the lysosomes (chapters 3.1.2.and 3.1.6.). However, the hierarchy of 
GKS loading to the lysosomes differs from the hierarchy of GKS loading to the PVM of T. 
gondii (chapter 3.1.7.) (Figure 32B). When IFNγ-induced Irgm1 KO cells were stained for 
combinations of two GKS-proteins and for LAMP1, it was observed that Irga6 and Irgb10 
could localize to the lysosomes alone or together with other GKS proteins. Contrary, Irgb6 
and Irgd could be detected at the lysosome only if Irga6 or Irgb10 were also there. Therefore, 
Irga6 and Irgb10 are probably the leading GKS proteins in the hierarchy of lysosomal 
accumulation in Irgm1 KO cells. 
 
 
 
 
 
 
Another interesting similarity between GKS accumulation onto lysosomes and onto 
the PVM is that some vacuoles and some lysosomes are never coated with up to now tested 
IRG proteins. Namely, after infection with avirulent strains of T. gondii, a majority of the 
PVMs are fully coated with the GKS proteins. However, certain fraction of PVMs are always 
GKS-free (Khaminets et al., 2010) no matter the time point of analysis. Similarly, certain 
percentages of the lysosomal membranes in Irgm1 KO cells are not GKS coated.  Even 
though, one cannot exclude the possibility that other GKS proteins, for example Irga4 or 
Irga8, which cannot be immunostained with existing antibodies, could accumulate at the 
Figure 32. Hierarchical loading of different IRG proteins onto the PVM of T. gondii and onto the 
lysosomes in Irgm1 KO cells. A) IRG proteins loaded onto the PVM of T. gondii were detected by co-
staining with pairs of specific antibodies directed against IRG proteins. Vacuoles containing one or two 
IRG proteins were quantified. Vacuoles not loaded with IRG proteins of interest were not included in 
the analysis (Modified from (Khaminets et al., 2010)). B) Irgm1 KO MEFs were induced with 200 U/ml 
IFNγ and immunostained with pairs of specific antibodies directed against IRG proteins and an 
antibody against LAMP1. Lysosomes containing one or both IRG proteins were quantified. Lysosomes 
that are not loaded with either IRG protein of interest were not included into analysis (modified from 
figure 18).  
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remaining lysosomes and PVMs, two other models were discussed to explain the difference 
between strongly loaded and non-loaded PVMs of T. gondii.  
First it was suggested that non-coated PVMs represent the membranes of T. gondii 
that got damaged or malfunctioned during cellular invasion. Therefore, there was not need to 
activate the IRG defence system against organisms that are not dangerous for the cell 
(Howard lab, personal communication). 
The second proposal suggests that discrimination of particular membranes is a 
consequence of the cooperativity and homo-/hetero-oligomer formation during PVM loading. 
According to this model, the first activated IRG protein molecule on the parasite membrane 
would encourage cooperative activation and oligomerization of further IRGs on the same 
membrane. Therefore, following GKS molecules would rather accumulate at the already 
“conquered” membranes and not to the GKS-free membranes (Khaminets et al., 2010). 
Assuming that lysosomes cannot be divided to “functional” and “failed”, the proposal which 
suggests easier cooperative loading of the GKS proteins to already coated membranes may 
be more plausible.  
 
It was possible that the absence of Irga6, which is, together with Irgb10, one of the 
leading proteins in lysosomal accumulation, would affect subsequent GKS accumulation at 
the lysosomes in Irgm1 KO cells and possibly also the phenotypic outcome of infected Irgm1 
KO mice. 
Unlike in Irgm1 KO cells, when IFNγ-induced Irgm1/Irga6 KO cells were stained with 
Irgb6 and Irgb10, it was observed that Irgb6 could localize to the lysosomes that were not 
Irgb10 stained and obviously not Irga6 positive (chapter 3.2.2.). In addition, preliminary data 
had shown that in MIF-induced GS 3T3 Irgb6 cells, which were also transfected with Irgm2 
and Irgm3, Irgb6 could form aggregates and accumulate at the lysosomes, even though 
Irga6 and Irgb10 were not expressed in the cell (Figure S4). Even though Irgb6 and Irgb10 
are the leading proteins in the hierarchy of PVM loading (Khaminets et al., 2010), in MIF-
induced GS 3T3 Irga6 cells, which were transfected with Irgm1, Irgm2 and Irgm3, Irga6 could 
accumulate at the PVM of T. gondii (Hunn et al., 2008). 
These results indicate that the leading GKS proteins, like Irga6 and Irgb10 at the 
lysosomes, are not a prerequisite for the other GKS proteins, like Irgb6, to accumulate at 
these endocellular membranes. Similarly, presence of Irgb6 and Irgb10 is not a prerequisite 
for Irga6 to accumulate to the PVM of T. gondii. However, there is evidence that the 
presence of Irga6 stabilises the binding of Irgb6 to the T. gondii PVM. Even though the 
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efficiency of the loading and the ability of Irga6 to independently disrupt the PVM remain to 
be investigated, these observations indicate that the hierarchy of GKS loading is not 
qualitatively required for the accumulation of GKS proteins. 
In accordance with the successful loading of the other GKS proteins in IFNγ-induced 
Irgm1/Irga6 KO cells, the phenotype of Irgm1/Irga6 KO mice is similar to the phenotype of 
Irgm1 KO mice. Firstly, the weight reduction, which is characteristic for Irgm1 KO mice grown 
in non-sterile conditions, was also observed in Irgm1/Irga6 KO mice (chapter 3.2.1). 
Secondly, Irgm1/Irga6 KO mice were equally susceptible to L. monocytogenes infection and 
succumbed within 5 days, as Irgm1 KO mice did (chapter 3.2.1.).  
Taken together, these results indicate that the absolute hierarchy, which was 
considered to be important in the GKS loading to the PVM, is not a prerequisite for 
successful accumulation of these proteins. However, it seems that cooperativity between 
GKS proteins is important and that accumulation of these proteins is enhanced when other 
GKS proteins are already there. 
 
4.4. Does GKS coating impair functionality of lysosomes? 
When GKS proteins were observed to accumulate to the lysosomes in IFNγ-induced 
Irgm1 KO cells, it was questioned whether this phenomenon could have severe 
consequences for the GKS-coated lysosomes, for the Irgm1 KO cells and for the Irgm1 KO 
mice.  
GKS proteins, which accumulate at the lysosomes, showed a shape and pattern that 
strongly resembles the ring-like appearance of GKS-oligomers at the PVM of T. gondii. 
Therefore, it was initially hypothesised that activated GKS proteins could disrupt the 
lysosomal membrane in a similar manner as they mediate the disruption of the PVM. 
Lysosomal membrane permeabilization (LMP) (reviewed in (Boya and Kroemer, 2008)), a 
process which includes the rupture of the lysosomal membrane, cytosolic release of 
lysosomal enzymes, and finally cell death, could be the cause of the lymphocyte death, 
lymphopenia and the death of the Irgm1 KO mice.  
However, quantification of cathepsin B-positive punctae, which are a marker for 
undisrupted lysosomes, showed that there is no difference in the punctae number between 
induced and non-induced WT cells or Irgm1 KO cells, suggesting that there is no lysosomal 
rupture and enzyme release in these cells (chapter 3.3.6.). The cell death of IFNγ-induced 
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Irgm1 KO MEFs and BMDMs was also not increased in comparison to uninduced cells, 
indicating that LMP is highly unlikely to occur in these cells (chapter 3.4.).  
Another hypothesis proposed that Irgm1 is directly or indirectly involved in the 
regulation of the autophagic pathway (Feng et al., 2008a) (Deretic, 2011) (King et al., 2011) 
(Haldar et al., 2013).  
Firstly, it was proposed that Irgm1 is an autophagy inducing factor (Gutierrez et al., 
2004) (Singh et al., 2006) (Deretic, 2011). This hypothesis was based on the observation that 
the turnover of the autophagic protein LC3 is increased in Irgm1-transfected cells that were 
not induced with interferon (Gutierrez et al., 2004) (Singh et al., 2006). It has been also 
shown that autophagic induction increased the fusion of Mycobacterial phagosomes with 
lysosomes and enhanced Mycobacterium tuberculosis clearance (Gutierrez et al., 2004). 
However, since these tests were performed with transfected Irgm1, in the absence of GKS 
proteins and other GMS proteins, they do not properly describe the consequences of the 
Irgm1 interaction with its targets, the GKS proteins.  
Secondly, opposing data had shown that LC3 turnover and autophagy are induced in 
stimulated Irgm1 KO lymphocytes, hematopoetic stem cells (HSC) and Paneth cells (Feng et 
al., 2008b) (King et al., 2011) (Liu et al., 2013).  In addition, electron microscopy (EM) 
images of induced Irgm1 KO lymphocytes had revealed enlarged multi-lamellar round 
structures that resemble enlarged autophagosomes (Feng et al., 2008b).  
The termination of the autophagic cycle requires that mature autophagosomes fuse 
with the lysosomes, where they get processed and degraded (Feng et al., 2014). Lysosomes 
that are GKS coated appear to be enlarged and swollen in IFNγ-induced Irgm1 KO cells 
(chapter 3.1.2.). Therefore, it was questioned whether the fusion of the lysosomes with 
autophagosomes and autophagosomal processing are still functional in these cells. The 
analysis of the autophagy protein LC3 revealed that the number of LC3-labeled 
autophagosomes and the level of the mature lipidated form of LC3, called LC3-II are both 
increased in IFNγ-induced Irgm1 KO cells, indicating that that there is a change of 
autophagic flux in these cells (chapters 3.3.1. and 3.3.2.). The increase in LC3-II levels, 
without the decrease in LC3-I levels, indicated that it is more likely that the autophagic flux is 
arrested, than that autophagy induction is enhanced in these cells.   
Analysis of autophagosome and lysosome co-localization in IFNγ-induced Irgm1 KO 
cells revealed that 60-80 % of the LC3-labeled autophagosomes co-localizes with LAMP1 
lysosomal marker (chapter 3.3.3.). In comparison, less than 10 % of autophagosomes co-
localized with lysosomes in induced and non-induced WT cells, and less than 5 percent did 
so in non-induced Irgm1 KO MEFs.  In immunofluorescence microscopy images, it appeared 
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that autophagosome structures were “trapped” inside lysosomal membranes. Hence, it was 
proposed that certain lysosomes in induced Irgm1 KO cells are unable to process the 
autophagosomes once they fuse with them. Thus, autophagic flux could be inhibited after 
fusion, and LC3-II levels could increase without decreasing LC3-I levels. It was further shown 
that the lysosomes that cannot process autophagosomes are exactly the same lysosomes 
that are coated with Irga6 or Irgb10 (chapter 3.3.4.). Therefore, the impairment of autophagic 
flux probably is the consequence of the GKS loading to the lysosomes. 
Apart from autophagosome degradation, lysosomes are also involved in degradation 
or activation of the variety of intra- and extracellular substrates. Not only autophagosomes, 
but also bacterial phagosomes and many enzymes are processed in the lysosomes (Feng et 
al., 2014). Thus, it was questioned whether the processing problems of the GKS-coated 
lysosomes affect only autophagosomes, or also other lysosomal substrates. The analysis of 
live in IFNγ-induced Irgm1 KO cells showed that Irga6-EGFP, which were previously shown 
to co-localize with LAMP1 structures (chapter 3.1.2.), did not co-localize with the acidotropic 
marker Lysotracker red, indicating that Irga6-coated lysosomes do not have as low pH, as 
other lysosomes in the cell (chapter 3.3.5.). Therefore, these non-acidic lysosomes probably 
cannot process autophagosomes and other lysosomal substrates in the cell. 
The early claim that Irgm1 plays an active role in the acidification of the mycobacterial 
phagosome was based on the observation that phagosomal acidification is impaired in IFNγ-
induced Irgm1 KO cells (MacMicking et al., 2003). This observation can be explained by the 
fact that lrga6 and other GKS accumulations prevent normal acidification of lysosomes in 
these cells. 
Taken together, in IFNγ-induced Irgm1 KO cells, GKS proteins that localize to the 
lysosomes inhibit lysosomal acidity. Non-acidic lysosomes cannot process autophagosomes 
and cause the arrest in the autophagic flux. How does lysosomal dysfunction and autophagy 
impairment influence the resistance of Irgm1 KO mice, remains to be investigated. 
 
4.5. How does lysosome impairment induce leukopenia and death 
of the in Irgm1 KO mice? 
 As previously discussed, Irgm1 KO mice undergo striking leukopenia and death not 
only after infection with a variety of pathogens, but also in non-pathogen induced 
inflammation (chapters 1.6.1. and 1.6.2.). Almost any described cause that leads to IFNγ 
induction and with it to IRG protein expression is probably fatal for the Irgm1 KO mouse 
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(Chapters 1.6.1., 1.6.2.). Hematopoetic stem cells (HSCs), which constitutively express GKS 
proteins, also show a variety of proliferation and replenishment defects (King et al., 2011) 
(Ivanova et al., 2002). Hypothetically, in every cell of the Irgm1 KO mouse which responds to 
IFNγ stimulation and produces other IRG proteins, the GKS proteins should accumulate at 
the lysosomes and cause an impaired lysosomal function. 
It is not understood how do GKS accumulation at the lysosomes, impairment of 
lysosomal functionality and autophagic flux arrest lead to leukopenia and death of Irgm1 KO 
mice. It is not clear why the particular sets of Irgm1 KO cells die after these events, while 
other sets of cells survive and continue to proliferate equally well as WT cells. Up to now, it 
has been reported that isolated Irgm1 KO lymphocytes, HSCs and intestinal cells undergo 
cell death and show proliferation defects upon induction (Feng et al., 2008b) (King et al., 
2011) (Liu et al., 2013). However, the proliferation and survival of induced Irgm1 KO BMDMs 
(Henry et al., 2009) (chapter 3.4.) and Igrm1 KO MEFs (chapter 3.4. and unpublished data) 
are not affected. In accordance to the selective death of the Irgm1 KO cells, Irgm1 KO mice 
are dying from striking leukopenia. 
The connection between autophagic flux inhibition and lymphocyte death remains to 
be better understood. However, it is clear that, after infection and IFNγ induction, lysosomes 
are stimulated to rapidly activate and proliferate. Since the resources for their expansion 
have to be rapidly processed, autophagy and lysosomal degradation probably have to be 
fully functional. Therefore, it can be proposed that fast dividing lymphocytes with impairment 
in the autophagic flux and lysosomal processing are stressed and especially prone to cell 
death and delay in proliferation. In addition, it seems that other fast dividing cells, like 
hematopoetic stem cells (HSC) and induced Paneth cells, also suffer from a variety of 
morphology, proliferation and cell survival defects in Irgm1 KO mice (Liu et al., 2013). 
 Thus, it can be proposed that fast proliferating Irgm1 KO cells are indeed the cells 
whose survival is mostly affected by lysosomal malfunction and autophagic flux impairment. 
 
4.6. Why Irgm3 KO and Irgm1/Irgm3 KO mice survive infections that 
are fatal for Irgm1 KO mice? 
Unlike Irgm1 KO mice, Irgm3 KO mice can survive and fully recover from infections 
with L. monocytogenes, M. tuberculosis and other pathogens. In this study it was shown that 
Irga6 co-localizes with the ER marker calreticulin in IFNγ-induced Irgm3 KO MEFs (chapter 
3.1.3). The consequences of the accumulation of activated GKS proteins onto the ER remain 
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to be investigated. When Irga6 was transfected in the NIH 3T3 mouse fibroblasts, in the 
absence of GMS proteins, it accumulated at the ER in the activated, GTP-bound state and 
the ER appeared to be enlarged and distorted in electron microscopy pictures (Figure 33.) 
(Kaiser, 2005) (Hunn et al., 2008). Thus, in IFNγ-induced Irgm3 KO cells, GKS 
accumulations probably also cause deformation of the ER structure. However, ER 
deformation and distortion might not have such severe consequences for proliferating Irgm3 
KO cells, as lysosomal processing impairment does for proliferating Irgm1 KO cells. 
Therefore, lysosomal impairment could be the reason why infected Irgm1 KO mice undergo 
lymphopenia and death and Irgm3 KO mice do not. 
 
 
 
The causes of the surprising phenotype of Irgm1/Irgm3 KO mouse are also not fully 
understood. After infection with pathogens that are directly targeted by the GKS proteins, like 
T. gondii, the Irgm1/Irgm3 KO mice die (Chapter 1.6.1.). However, when Irgm1/Irgm3 KO 
mice are infected with the pathogens which are not directly targeted by GKS proteins, like, 
for example, Salmonella typhimurium, these mice can fully recover (Henry et al., 2009).   
Considering that Irgm1 KO mice succumb to infection with a number of pathogens, 
which do not kill Irgm3 KO and Irgm1/Irgm3 KO mice, it was first hypothesised that Irgm3 is 
toxic for the cell and that it is negatively regulated by Irgm1. Thus, when Irgm3 is present in 
the cell without Irgm1, it can perform its toxic actions. When  Irgm3, or both Irgm1 and Irgm3, 
Figure 33. Non-regulated Irga6 induces endoplasmic reticulum deformation. Electron microscopy 
images of the endoplasmic reticulum in NIH 3T3 mouse fibroblasts that are not Irga6 transfected (left 
panel, blue arrow shows ER) or transfected with Irga6 (right panel, red arrow shows swollen ER). 
(Modified from (Kaiser, 2005)).  
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are absent, the mice do not encounter Irgm3-caused problems (Henry et al., 2009). The 
discovery that GMS proteins rather inhibit GKS protein activation and not each other, 
indicates that this hypothesis probably is not correct (Hunn et al., 2008).  
It has been proposed that activated GKS aggregate-like structures, as many other 
aggregates, are toxic for the cell and perform their toxic actions in the cell in dose dependent 
manner (Hunn and Howard, 2010). Namely, a Western Blot analysis of IFNγ-induced 
induced Irgm1 KO, Irgm3 KO and Irgm1/Irgm3 KO macrophages had revealed that these 
cells contain overall lower levels of Irgb6, and somewhat lower level of Irga6. Igrm1 KO and 
Irgm3 KO macrophages expressed less of Irgb6 than the wild type cells, but Irgm1/Irgm3 KO 
cells had even lower levels than the single knock-outs (Henry et al., 2009). Hence, it has 
been proposed that, due to lower level of GKS aggregates, Irgm1/Irgm3 KO cells can survive 
the infection, IFNγ-induction and uncontrolled GKS expression (Hunn and Howard, 2010).  .  
The report that different GMS KO cells contain different levels of GKS proteins has to 
be reproduced and analyzed into more details. The preliminary results in this study showed 
that Irgb6 levels are indeed reduced in all GMS KO MEFs, but the levels of Irga6, one of the 
leading GKS proteins in lysosomal accumulation, are not changed (Figure S5). The levels of 
Irgb10 and Irgd were also never investigated in GMS KO cells. Even if the levels of all GKS 
proteins are reduced in Irgm1/Irgm3 double KO cells in comparison to Irgm1 KO and Irgm3 
KO cells, this fact does not offer an explanation why Irgm1 KO mice and Irgm3 KO mice, that 
have very similar levels of GKS proteins after induction, show two opposing phenotypes. 
As in Irgm3 KO mice, the different localization of GKS accumulations might be the 
reason for essentially normal phenotype of Irgm1/Irgm3 KO mice. In Irgm1/Irgm3 KO MEFs, 
GKS proteins do not localize to the lysosomes, but rather to lipid droplets. Thus the levels of 
LC3-II in Irgm1/Irgm3 KO cells are not increased and the autophagic flux is normal. This 
suggests that the full recovery of the Irgm1/Irgm3 KO mice after infection could very well be 
related to the fact that lysosomes in these cells are not GKS coated and hence fully 
functional.  
As previously  discussed, in IFNγ-induced Irgm1/Irgm3 KO cells, GKS proteins Irga6, 
Irgb6 and Irgb10 accumulate at lipid droplets instead at lysosomes (Haldar et al., 2013) 
(chapter 3.1.5.). The events that follow GKS accumulation to the LDs are not fully 
understood. It has been reported that GKS-covered LDs are common targets of the 
autophagy protein p62 and that the overall mass of the lipid droplets is reduced in IFNγ-
induced Irgm1/Irgm3 KO cells. Therefore, it has been hypothesised that these LDs are 
targeted for autophagic degradation (Haldar et al., 2013). Even though the outcome of GKS 
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action at the LDs is not clear, the consequences of this accumulation are probably not as 
severe as the lysosomal failure and autophagic flux arrest.  
Taken together, Irgm3 KO mice and Irgm1/Irgm3 KO mice probably can survive the 
infections that kill Irgm1 KO mice, due to the fact that the lysosomes in their cells are not 
coated with GKS proteins. Therefore, autophagic flux and lysosomal function are presumably 
not impaired, and fast dividing cells probably can proliferate without major difficulties. 
 
4.7. Are GKS protein structures conventional aggregates? 
 When GKS proteins are expressed in the absence of GMS proteins, distinct GKS 
accumulations can be observed at the subcellular level. In the first description, these GKS 
accumulations were named aggregates (Martens et al., 2004). These accumulations were 
reported not to load to the PVM of T. gondii and thus aggregated GKS proteins cannot 
perform their function (Martens et al., 2004). Hence, the first hypothesis was that Irga6 
structures are simply clusters of missfolded aggregated non-functional IRG proteins, which 
are, like most aggregates, toxic for the cell (Martens et al., 2004). 
 However, a couple of years after those first observations, it was reported that 
aggregation of GKS proteins is inhibited by GMS proteins and that expression of three GMS 
proteins in the cell is sufficient to prevent GKS accumulation (Hunn et al., 2008).  Staining 
with the Irga6 10D7 antibody, which exclusively binds to the activated form of Irga6, had 
shown that these aggregates are GTP-bound (Papic et al., 2008). It was shown that Irga6 
aggregate-like structures are formed only transiently and that they can be isolated from the 
cell only when locked in the GTP-bound conformation (Papic et al., 2008). 
The first experiments in this study had revealed that GKS aggregate-like structures 
have different shape and localize to the different endocellular membranes in the absence of 
different GMS proteins (chapter 3.1.). The GKS accumulations look like the GKS protein 
rings that form at the PVM of T. gondii (chapter 3.1.). In this study, it was shown that GKS 
aggregate-like structures are detergent soluble and cannot be captured and isolated with 
Filter trap assay or with Ultracentrifugation assay (chapter 3.5.). Once the membrane is 
dissolved with the detergent, these aggregate-like oligomers are fully dispersed. However, 
when GKS proteins were treated with GTP and AlFx, the insoluble complexes could be 
captured by ultracentrifugation (chapter 3.5.). 
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Taken together, it was proposed that previously called GKS aggregates actually 
represent activated oligomerized GTP-bound proteins that are very similar to the GKS 
oligomers at the PVM of T. gondii. 
 
The GBP proteins were also shown to form the aggregates in the absence of GMS 
proteins in IFNγ-induced mouse cells (Traver et al., 2011). Therefore, there is a possibility 
that GMS proteins also regulate activation of the GBPs. Whether GBP aggregation is 
regulated in the same manner as the GKS protein aggregation remains to be investigated. 
Recently, it has been published that GBP proteins indeed accumulate at the same lipid 
droplets together with the GKS proteins in IFNγ-induced Irgm1/Irgm3 KO cells (Haldar et al., 
2013). It would be interesting to test whether mouse GBP proteins also co-localize with the 
lysosomes in the Irgm1 KO cells and contribute to the failure of lysosomal functionality. 
If GBP protein aggregation is regulated by the GMS proteins in mice, it is not clear 
which proteins would substitute GMS-regulatory role in humans. Even though it is tempting to 
propose that the only remaining GMS homologue in humans, IRGM protein, could be 
responsible for GBP protein regulation, this proposal should be taken with reserve. There are 
indications that non-IFN-inducible truncated human IRGM protein with non-functional G-
domain might play very different role than the mouse Irgm1 (Bekpen et al., 2005).  
It has also been reported that GKS proteins form the aggregates in the absence of 
autophagy proteins Atg5 and Atg3 (Khaminets et al., 2010) (Traver et al., 2011) (Haldar et 
al., 2014). These aggregates are also GTP-bound and unable to accumulate at the PVM of 
T. gondii  or at the inclusions of C. trachomatis  (Khaminets et al., 2010) (Haldar et al., 2014). 
GBP aggregates are also formed in Atg5 KO and Atg3 KO mouse cells (Traver et al., 2011) 
(Haldar et al., 2014). In IFNγ-induced Atg7 KO and Atg16L KO cells, Irgb6 and GBP proteins 
were not able to load to the T. gondii PVM probably also due to aggregate formation 
(Ohshima et al., 2014). However, Atg9a KO and Atg14 KO cells did not encounter this 
problem (Ohshima et al., 2014). Interestingly, Atg3, Atg5, Atg7 and Atg16 all play a role in 
the LC3-I to LC3-II turnover, while Atg9a and Atg14 are involved in the earlier stage of 
autophagy, the vesicle elongation, giving a hint that the late stages of autophagosome 
formation may be important for IRG control. 
The formation of GKS protein aggregates in Atg-deficient cells could indicate that 
GKS proteins are degraded by the autophagic pathway. It has been proposed that the failure 
of autophagy is blocking proper GKS protein degradation, and hence, these proteins 
accumulate in aggregate-like structures (Traver et al., 2011) (Haldar et al., 2014). Another 
hypothesis had proposed is that GMS proteins are regulated by the autophagic pathway, and 
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the failure in the GMS regulation leads to aggregate formation in Atg deficient cells 
(Khaminets et al., 2010). 
The preliminary results of live cell imaging microscopy revealed that, in EGFP-Irga6-
transfected non-induced WT MEFs, the number, the size and the shape of particular Irga6 
aggregate-like structures did not greatly change over a 12 hour analysis. New aggregate 
structures were also not formed during this period (data not shown). Thus, even if Irga6 
aggregate formation and degradation are dynamic processes, it is highly unlikely that whole 
accumulations of the aggregates are captured in autophagosomes and degraded.  
 
4.8. Why is Irgm1 the most conserved IRG gene? 
  IRG genes are extremely polymorphic and their presence largely varies among the 
species (Bekpen et al., 2005) (Hunn et al., 2008) (Lilue et al., 2013). The copy number and 
the sequence of the particular IRG genes can also greatly vary within different wild mouse 
strains (Lilue et al., 2013).  
The polymorphisms in GKS genes in mice are proposed to be related to the efficiency 
of the immune responses to virulent and avirulent strains of T. gondii and probably to other 
pathogens (Lilue et al., 2013). GKS proteins are directly involved in the response to certain 
intracellular pathogens, and are probably directly challenged to co-evolve together with the 
pathogen itself and combat pathogen virulence factors.  In accordance to that, a recent study 
had shown that certain wild mice have a particular set of GKS proteins that makes them 
greatly resistant to otherwise very virulent strains of T. gondii (Lilue et al., 2013). 
 The sequences of all GMS genes that were analyzed in the variety of wild and 
laboratory mouse strains are relatively conserved in comparison to those of the GKS genes. 
Irgm1 represents the most conserved IRG gene in mice and its sequence does not differ 
between wild mouse strains which, except for Irga6, otherwise have very polymorphic GKS 
gene sequences (Lilue et al., 2013). Thus, it could be that GMS proteins are not directly 
involved in interaction with the pathogen and hence not directly challenged to co-evolve with 
it.  
The conserved sequence and conformation of mouse GMS proteins is probably 
crucial for GMS interaction with GKS proteins, GKS inactivation and GMS localization to the 
particular intracellular membranes. Polymorphisms in Irgm1 sequence could, in some cases, 
result in the Irgm1 protein that cannot inhibit GKS protein activation, or Irgm1 which cannot 
properly bind to lysosomal membranes. In both cases, Irgm1 polymorphisms would cause 
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GKS protein off-target activation and its accumulation at the lysosomes. As previously 
explained, GKS proteins at the lysosomes would lead to lysosomal dysfunction, autophagic 
flux arrest, leukopenia and death of the mouse. Hence, the risks brought with Irgm1 
malfunction might cause that Irgm1 stays the most conserved IRG protein in mice.  
 
Even though IRG gene presence greatly varies between the species, IRGM gene 
remained present in many animals that have lost other IRGs (Hunn, 2008) (Bekpen et al., 
2005). Almost every species, in which the homologues of GKS proteins are reported, also 
has a homologue of IRGM. IRGM is also present in species which do not have 
representatives of "real" GKS gene homologues but only non-inducible IRGC and quasi-IRG 
protein IRGQ, like for example in humans (Hunn, 2008) (Bekpen et al., 2005). Therefore, it 
could be speculated that the role of Irgm1 homologues in the other species is also to keep 
remaining GKS proteins inactive.  
However, the function of IRGM homologues in other organisms but mice is not 
clarified up to date. Whether they also prevent the activation of GKS homologues remains to 
be investigated. Human IRGM is extremely truncated, its G-domain is not functional and it is 
only 51 percent homologous to the mouse Irgm1 (chapter 1.4.1.). IRGM is not IFNγ-
inducible, but constitutively expressed. Instead of 2 alternative splicing isoforms present in 
mouse, 5 different 3‘ isoforms can be formed in human. Therefore, human IRGM is unlikely 
to play a role in IRG or GBP protein regulation. 
As previously discussed (chapter 1.4.1.), it has been proposed that IRGM gene was 
disrupted due to the shift open reading frame (ORF) about 40 million years ago. Thus, the 
species like old and new world monkeys do not have IRGM. However, according to this 
proposal, the new change in ORF had caused the “resurrection” of the truncated IRGM about 
20 million years ago (Bekpen et al., 2009). Whether the function of IRGM remained the same 
before and after “resurrection” remains to be investigated. Recently, whole genome 
association studies had shown that specific IRGM haplotypes associate with increased risk 
of Crohn’s disease in humans (Fisher et al., 2008) (Parkes et al., 2007). However, it has 
been also demonstrated that 20,1 kb deletion upstream of IRGM also associates with 
Crohn’s disease and hence, these results need to be further researched (Bekpen et al., 
2009).  
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Figure S1. Irga6 structures at the lysosomes are in the GTP-bound state. Irgm1 KO MEFs were 
induced with 200 U/ml IFNγ for 24 hours. Cells were fixed and stained with immunoreagents against 
Irga6 (10D7) and LAMP1. Representative microscopic images of GTP-bound Irga6 and LAMP1 are 
shown. Arrows point at the Irga6 structures that are magnified below each panel. 
 
 117 
 
6. APPENDIX 
RODUCTION 
 
 Figure S2. There is no coss-reactivity between 10D7 and 1D4B antibodies. Irgm1 KO MEFs were 
induced with 200 U/ml IFNγ for 24 hours. Cells were fixed and stained with mouse antibody 10D7, 
which stains the Irga6 in GTP-bound state, and rat antibody 1D4B, which stains LAMP1 lysosomal 
marker. The antibodies were visualised with secondary antibodies Alexa 488 Donkey anti Mouse and 
Alexa 555 Goat anti rat. To test the cross-reactivity, one of the primary or secondary reagents was 
omitted in each sample. The images of stained cells were taken. Representative microscopic images of 
GTP-bound Irga6 and LAMP1 are shown, with omitted antibody being crossed.  
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Figure S3. Irga6 aggregate-like structures are detergent soluble. GS 3T3 WT or GS 3T3 Irga6 cells were 
induced with IFNγ, MIF or left untreated for 24 hours. 30000 cells were lysed in 0,5 % Thesit (A,B) , 1% 
Digitonin (A,B) or 80 mM Octyl-D-Glucopyranoside (C) and centrifuged at 45000 rpm for 30 minutes. 
Supernatant and the pellet were separated, analyzed by SDS-PAGE/Western Blot and probed with Irga6 
(10E7) and Calnexin antibody. Exposure times: 5-30 seconds. 
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Figure S4. Irgb6 co-localization with LAMP1 in cells transiently transfected with GMS protein A) 
Gene Switch (GS) 3T3 cells stably transfected with inducible Irgb6 were stimulated with Mifepristone 
and simultaneously transiently transfected with pGW1H-Irgm1, pGW1H-Irgm2 and pGW1H-Irgm3 and 
pmCherry for 24 hours. Cells were fixed and stained with anti-Irgb6 antiserum A20 and with anti-
LAMP1 antibody. Representative microscopic images of Irgb6, LAMP1 and Cherry are shown. Arrows 
point at the Irgb6 structures which are magnified at the end of each panel (zoom in the following order: 
upper left: Irgb6, upper right: LAMP1, lower left: Cherry, lower right: overlay of Irgb6 and LAMP1). 
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Figure S5. Irga6 levels in GMS KO cells. WT, Irgm1 KO, Irgm3 KO and Irgm1/Irgm3 KO MEFs were 
induced with 200 U/ml IFNγ for 24 h or left untreated. 200 000 cells were lysed in 100μl of 0,5% NP-40 
and 5, 10 or 20 μl of the lysate were analyzed by SDS-PAGE/Western blot. Membranes were probed with 
anti-Irga6 (10E7) and anti-Calnexin immunoreagents. Exposure times are between 5 and 30 seconds. 
(A,C,E). Intensities of Irga6 and Calnexin bands were quantified with appropriate software and ratios of 
Irga6/Calnexin band intensities are depicted (B,D,F). Results of 3 independent experiments (A,C,E) are 
shown. 
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Immunity-related GTPases (IRGs) play an important role in host immune response to 
a variety of intracellular pathogens by accumulation at the membranes of the pathogens and 
their disruption. However, it was never understood how exactly IRG proteins distinguish the 
membranes of the pathogen from the host membranes.  
Previously, it has been reported that regulatory IRG proteins, named GMS proteins, 
keep the effector IRG proteins, named GKS proteins, in the inactive GDP-bound state. In this 
study, it has been shown that GMS proteins also play an important role in protection of the 
endocellular compartments from GKS protein off-target activation. In the absence of the 
GMS protein Irgm1, which is localized at the lysosomes, GKS proteins Irga6, Irgb6, Irgb10 
and Irgd accumulate and activate at these organelles. In the absence of Irgm3, a GMS 
protein which is localized at the endoplasmic reticulum (ER), GKS protein Irga6 accumulates 
at the ER. However, in the cells that lack Irgm1 and Irgm3, GKS proteins accumulate only to 
lipid droplets, but not to lysosomes or ER, indicating that GKS structures do not accumulate 
at every GMS-free membrane. 
In the second part of the study, the consequences Irgm1 accumulation to the 
lysosomes are investigated. Irgm1 KO mice undergo leukopenia and succumb after a variety 
of infections and inflammatory states. The results of this study suggest that the failure of 
Irgm1 KO mice is rather an indirect consequence of the off-target action of the GKS proteins, 
than the direct consequence of the Irgm1 response to a variety of pathogens. The GKS 
proteins, that accumulate at the lysosomes in Irgm1 KO cells, affect the acidity of these 
organelles and therefore lysosomal ability to process autophagosomes. In IFNγ-induced 
Irgm1 KO mouse embryonic fibroblasts (MEFs) the mature autophagosome marker LC3-II 
level is enhanced, the number of autophagosomes is increased and the co-localization 
between autophagosomes and lysosomes is higher than in the non-induced cells. 
Therefore, in this study, it is proposed that the autophagic flux of IFNγ-induced Irgm1 
KO MEFs is impaired. The lymphocytes of the Irgm1 KO mice, that are stimulated to 
proliferate as a response to infection, could be the cells that are most affected by autophagic 
flux arrest and lysosomal acidification impairment. Thus, this effect could be the cause of 
described defects in lymphocyte proliferation and lymphocyte necrosis, which cause the 
death of the Irgm1 KO mouse 
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Die Immun-verwanden GTPasen (Immunity-related GTPases, IRGs) spielen eine wichtige 
Rolle in der Resistenz gegen intrazelluläre Pathogene, wofür sie vom Zytosol auf bestimmten 
Membranen der Erreger akkumulieren und jene Zerstörung einleiten. Bisher hat man es jedoch 
noch nicht wirklich verstanden, wie genau diese Interferon-induzierten IRG-Proteine ihre eigenen 
zellulären Membranen von Membranen der Pathogenen unterscheiden. 
Bislang wurde bekannt, dass die regulatorischen IRG-Proteine, auch GMS-Proteine 
genannt, die Effektor IRG-Proteine, auch GKS-Proteine genannt, in einem inaktiven GDP-
gebundenen Zustand halten. In der vorliegenden Arbeit wurde gezeigt, dass die GMS-Proteine 
ebenfalls die eigenen Endozellulären-Membranen vor deregulierten GKS-Proteinen schützen. 
Wenn das GMS-Protein Irgm1 fehlt, das unter anderem an Lysosomen zu finden ist, 
akkumulieren die GKS-Proteine Irga6, Irgb6, Irgb10 und Irgd an den Lysosomen. Wenn Irgm3 
fehlt, ein GMS-Protein an dem Endoplasmatischem Retikulum (ER), lokalisiert das GKS-Protein 
Irga6 an das ER. Wenn jedoch beide Proteine, Irgm1 und Irgm3, fehlen, finden sich GKS-
Proteine nur an den Lipid-Droplet Organellen, jedoch nicht auf den Lysosomen oder dem ER, 
obwohl diese Organellen auch keine GMS-Proteine tragen. Somit scheinen GKS-Proteine nicht 
wie erwartet auf jeder GMS-freie Membran zu akkumulieren. 
In dem zweiten Teil dieser Arbeit wurden die Folgen von Aggregat-Bildung auf 
Lysosomen in Zellen der Irgm1 knock-out Maus. Diese Mäuse leiden unter Leukopenie und 
sterben bei Infektion mit jeglichen Pathogenen und Entzündungsreaktionen. Die Ergebnisse der 
vorliegenden Arbeit unterstützen die Hypothese, dass der Tod von Irgm1 KO Mäuse durch 
deregulierte Aktivierung der GKS-Proteinen bedingt wird, und nicht eine direkte Folge von einer 
fehlenden Wirkung von Irgm1 ist.  Die GKS-Proteine, die an Lysosomen in Irgm1 KO Zellen 
akkumulieren,  vermindern den Säuregehalt der Lysosomen und somit den Abbau von 
Autophagosomen durch Lysosomen.  In IFNγ-induzierten Irgm1 KO Zellen ist LC3-II, ein Marker 
für reife Autophagosomen, gesteigert, die Anzahl der Autophagosomen ist erhöht und die 
Kolokalisierung zwischen Autophagosomen und Lysosomen ist auch höher als in nicht-
induzierten Zellen. 
Deshalb schlagen die Ergebnisse der vorliegenden Arbeit vor, dass der Autophagie-
Ablauf in IFNγ-induzierten Irgm1 KO MEFs gestört ist. Deswegen sind die Lymphozyten der 
Irgm1 KO Mäusen, die durch Infektionen stimuliert sich stark vermehren, möglicherweise die 
Zellen, die am meisten von den Störungen in Autophagie und Lysosome-Säuregehalt betroffen 
sind. Das könnte die Proliferation der Lymphozyten stören und sogar ihren Zelltod einleiten und 
schließlich den Tod der Irgm1 KO Mäuse verursachen.  
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